<SEC-DOCUMENT>0001193125-17-276837.txt : 20170905
<SEC-HEADER>0001193125-17-276837.hdr.sgml : 20170904
<ACCEPTANCE-DATETIME>20170905170104
ACCESSION NUMBER:		0001193125-17-276837
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20170904
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170905
DATE AS OF CHANGE:		20170905

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TELEFLEX INC
		CENTRAL INDEX KEY:			0000096943
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				231147939
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-05353
		FILM NUMBER:		171069375

	BUSINESS ADDRESS:	
		STREET 1:		550 E SWEDESFORD RD
		STREET 2:		SUITE 400
		CITY:			WAYNE
		STATE:			PA
		ZIP:			19087
		BUSINESS PHONE:		610-225-6800

	MAIL ADDRESS:	
		STREET 1:		550 E SWEDESFORD RD
		STREET 2:		SUITE 400
		CITY:			WAYNE
		STATE:			PA
		ZIP:			19087
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d452560d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT
TO SECTION 13 OR 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934</B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): September&nbsp;4, 2017 </B></P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>TELEFLEX INCORPORATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>1-5353</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>23-1147939</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>550 East Swedesford Road, Suite 400, Wayne, Pennsylvania, 19087 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices) (Zip Code) </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(610) 225-6800 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code) </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N/A </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or
former address, if changed since last report) </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933
(&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Emerging growth
company&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act. &#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;1.01. Entry into a Material Definitive Agreement. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Merger Agreement </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
September&nbsp;4, 2017, Teleflex Incorporated, a Delaware corporation (&#147;Teleflex&#148;), Teleflex Urology Limited, a private limited company incorporated under the laws of Ireland (&#147;Teleflex Urology&#148;), Naples Merger Sub Inc., a
Delaware corporation (&#147;Merger Sub&#148;) and a wholly-owned subsidiary of Teleflex Urology and an indirect wholly-owned subsidiary of Teleflex, NeoTract, Inc., a Delaware corporation (the &#147;NeoTract&#148;) and Shareholder Representative
Services LLC, a Colorado limited liability company, solely in the capacity as the stockholder representative, entered into an Agreement and Plan of Merger (the &#147;Merger Agreement&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Merger Agreement, Merger Sub will be merged with and into NeoTract (the &#147;Merger&#148;), with NeoTract as the surviving
corporation as a wholly-owned subsidiary of Teleflex Urology. At the closing, Teleflex Urology will pay a purchase price of $725 million in cash, subject to customary purchase price adjustments, and the Merger Agreement provides for additional
milestone payments by Teleflex Urology of up to $375 million in the aggregate, which milestone payments, as further described below, are each subject to certain net sales requirements with respect to sales of certain products as further described
below and in the Merger Agreement. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>2018 Initial Milestone Payment</I>. If Net Sales (as defined in the Merger Agreement) for the period from January&nbsp;1, 2018 through April&nbsp;30, 2018 are equal to or greater than $40,000,000, Teleflex Urology
will pay additional merger consideration of $75,000,000. If Net Sales for such period are less than $40,000,000, Teleflex Urology will pay additional merger consideration equal to the product of (A)&nbsp;$75,000,000 and (B)&nbsp;a fraction, the
numerator of which is Net Sales for such period and the denominator of which is $40,000,000. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Milestone 1 Payment (2018 Net Sales)</I>. Teleflex Urology will pay additional merger consideration equal to the product of (a)&nbsp;1.50 multiplied by (b)&nbsp;the difference between (x)&nbsp;Net Sales for the
period from January&nbsp;1, 2018 through December&nbsp;31, 2018 minus (y)&nbsp;Net Sales for the period from January&nbsp;1, 2017 through December&nbsp;31, 2017. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Milestone 2 Payment (2019 Net Sales)</I>. Teleflex Urology will pay additional merger consideration equal to the product of (a)&nbsp;1.50 multiplied by (b)&nbsp;the difference between (x)&nbsp;Net Sales for the
period from January&nbsp;1, 2019 through December&nbsp;31, 2019 minus (y)&nbsp;Net Sales for the period from January&nbsp;1, 2018 through December&nbsp;31, 2018 (or, if Net Sales for calendar year 2018 are lower than the then-applicable Net Sales
High-water Mark (as described below), the then applicable Net Sales High-water Mark). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Milestone 3 Payment (2020 Net Sales)</I>. Teleflex Urology will pay additional merger consideration equal to the product of (a)&nbsp;1.50 multiplied by (b)&nbsp;the difference between (x)&nbsp;Net Sales for the
period from January&nbsp;1, 2020 through December&nbsp;31, 2020 minus (y)&nbsp;Net Sales for the period from January&nbsp;1, 2019 through December&nbsp;31, 2019 (or, if Net Sales for calendar year 2019 are lower than the then-applicable Net Sales
High-water Mark (as described below), the then applicable Net Sales High-water Mark). </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">For purposes of the Merger Agreement, the Net Sales High-water Mark at any particular time means the highest Net Sales for any full calendar year, from and after (and inclusive of) calendar year 2017, completed prior to
such time. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The milestone payments are subject to a customary dispute resolution process and in the event of certain
Milestone Delay Events (as defined in the Merger Agreement) that generally relate to material decreases in sales as a result of governmental actions affecting Teleflex, there may be additional payments as further described in the Merger Agreement.
In no event shall the sum of such payments described in this paragraph together with the Milestone 1 Payment, Milestone 2 Payment and Milestone 3 Payment be greater than $300,000,000 and together with the 2018 Initial Milestone Payment, be greater
than $375,000,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The obligation of parties to consummate the Merger is subject to the satisfaction or waiver of customary closing
conditions as set forth in the Merger Agreement, including the expiration or termination of any waiting period applicable under the Hart-Scott Rodino Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Merger Agreement includes representations, warranties and covenants of the parties customary for a transaction of this nature, including
covenants (i)&nbsp;for each of the parties to use their reasonable best efforts to take, or cause to be taken, all appropriate action to consummate and make effective the Merger and the other transactions contemplated by the Merger Agreement,
(ii)&nbsp;for NeoTract to conduct its business in the ordinary course and to be bound by customary restrictions relating to the operation of its business until the closing, and (iii)&nbsp;for NeoTract not to solicit, encourage, initiate or engage in
discussions or negotiations with any person (other than Teleflex and the other parties to the Merger Agreement) concerning any alternative transactions with respect to NeoTract. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Merger Agreement includes certain termination provisions for both NeoTract and Teleflex and provides that either party to the Merger
Agreement, subject to certain exceptions and limitations, may terminate the Merger Agreement if the Merger is not consummated by November&nbsp;30, 2017. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing summary of the Merger Agreement and the transactions contemplated thereby does not purport to be complete and is subject to, and
qualified in its entirety by, the Merger Agreement, attached hereto as Exhibit 2.1, which is incorporated herein by reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
representations and warranties of the parties contained in the Merger Agreement have been made solely for the benefit of the other parties to the Merger Agreement. In addition, such representations and warranties (i)&nbsp;have been made only for
purposes of the Merger Agreement, (ii)&nbsp;have been qualified by confidential disclosures made to Teleflex, Teleflex Urology and Merger Sub in connection with the Merger Agreement, (iii)&nbsp;are subject to materiality qualifications contained in
the Merger Agreement which may differ from what may be viewed as material by investors, (iv)&nbsp;were made only as of the date of the Merger Agreement </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or such other date as is specified in the Merger Agreement and (v)&nbsp;have been included in the Merger Agreement for the purpose of allocating risk between the contracting parties rather than
establishing matters as facts. Accordingly, the Merger Agreement is included with this Form&nbsp;8-K filing only to provide investors with information regarding the terms of the Merger Agreement, and not to provide investors with any other factual
information regarding NeoTract or its subsidiaries or business. Investors should not rely on the representations and warranties or any descriptions thereof as characterizations of the actual state of facts or condition of the parties or any of their
subsidiaries or businesses. Moreover, information concerning the subject matter of the representations, warranties and covenants may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in
Teleflex&#146;s public disclosures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;9.01. Financial Statements and Exhibits. </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"><U>Exhibits</U>. The following exhibits are filed as part of this report: </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%" VALIGN="top" ALIGN="left">2.1*</TD>
<TD ALIGN="left" VALIGN="top">Agreement and Plan of Merger, dated as of September&nbsp;4, 2017, by and among Teleflex Incorporated, Teleflex Urology Limited, Naples Merger Sub Inc. and NeoTract, Inc. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Schedules and exhibits omitted pursuant to Item&nbsp;601(b)(2) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule to the Securities and Exchange Commission upon request.
</TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SIGNATURE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: September&nbsp;5, 2017 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TELEFLEX INCORPORATED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James J. Leyden</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">James J. Leyden</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President, General Counsel</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">and Secretary</TD></TR>
</TABLE></DIV>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT INDEX </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="92%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:26.20pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Number</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Description</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>2.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d452560dex21.htm">Agreement and Plan of Merger, dated as of September 4, 2017, by and among Teleflex Incorporated, Teleflex Urology Limited, Naples Merger Sub Inc. and NeoTract, Inc. </A></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Schedules and exhibits omitted pursuant to Item&nbsp;601(b)(2) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule to the Securities and Exchange Commission upon request.
</TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d452560dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Execution Version </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>among </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TELEFLEX
INCORPORATED, </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TELEFLEX UROLOGY LIMITED, </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NAPLES MERGER SUB INC., </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NEOTRACT, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Shareholder Representative Services LLC, as the Stockholder Representative </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dated as of September&nbsp;4, 2017 </B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="97%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE I THE CLOSING</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1. The Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2. Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3. Effective Time</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.4. Effects of the Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.5. Certificate of Incorporation and Bylaws of the Surviving Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.6. Directors and Officers of the Surviving Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE II Consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1. Closing Payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2. Effect on Capital Stock of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3. Treatment of Company Options and Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4. Determination of Purchase Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5. Post-Closing Purchase Price Adjustment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6. <FONT STYLE="white-space:nowrap">Earn-Out</FONT> Payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7. Paying Agent and Letter of Transmittals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.8. Appraisal Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.9. No Further Transfers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.10. Withholding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE COMPANY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1. Organization and Corporate Power</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2. Capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3. Authority</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4. Consents and Approvals; No Conflicts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5. Financial Statements and Undisclosed Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6. Absence of Certain Changes or Events</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7. Legal Proceedings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.8. Compliance with Laws; Permits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.9. Company Material Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10. Company Benefit Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11. Labor Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.12. Taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.13. Intellectual Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.14. Environmental Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.15. Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.16. Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.17. Certain Regulatory Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.18. Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.19. Product Liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.20. Transactions with Affiliates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="97%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.21. Stockholder Vote Required</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.22. Brokers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.23. No Other Representations or Warranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IV REPRESENTATIONS AND WARRANTIES OF PARENT, Buyer, AND MERGER SUB</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1. Organization and Corporate Power</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2. Authority</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3. Consents and Approvals; No Conflicts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4. Legal Proceedings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5. Brokers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6. Availability of Funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7. Absence of Parent Material Adverse Effect</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8. No Other Representations or Warranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE V COVENANTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1. Company Conduct of Business Prior to the Effective Time</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2. Access to Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3. Reasonable Best Efforts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4. Notification of Certain Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5. Publicity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6. Director&nbsp;&amp; Officer Indemnification</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7. Employee Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8. 280G Stockholder Vote</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 5.9. Payoff of Credit Facilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10. Stockholder Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11. Exclusivity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12. Debt Financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13. Tax Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14. Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15. Buyer and Merger Sub Compliance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VI CONDITIONS TO THE MERGER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1. Conditions to Obligations of Each Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2. Conditions to Obligations of Parent, Buyer and Merger Sub to Effect the
Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3. Conditions to Obligations of the Company to Effect the Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VII TERMINATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1. Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2. Effect of Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="97%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VIII Indemnification</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.1. Survival</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.2. Indemnification</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.3. Procedure for Indemnification</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.4. Release of Funds from Escrow and Offset of Milestone Payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IX MISCELLANEOUS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.1. Amendment and Modification</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.2. Extension; Waiver</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.3. Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.4. Notices</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.5. Entire Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.6. Third Party Beneficiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.7. Severability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.8. Assignment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.9. Governing Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.10. Exclusive Jurisdiction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.11. Specific Performance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.12. Stockholder Representative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.13. Legal Representation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.14. Counterparts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.15. Interpretation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.16. Definitions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit A &#150; Certificate of Incorporation of the Surviving Corporation </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit B &#150; Bylaws of the Surviving Corporation </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit C
&#150; Form of Escrow Agreement </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit D &#150; Form of Paying Agent Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit E &#150; Net Working Capital Calculation </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit F
&#150; Form of Warrant Termination Agreement </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit G &#150; Milestone Retention Plan </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEX OF DEFINED TERMS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(OTHER THAN TERMS DEFINED IN SECTION 9.15) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<DIV STYLE="position:relative;float:left; width:48%;padding-right:1%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2017 Net Sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.6(b)(i)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2018 Initial Milestone Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.6(a)(i)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2018 Initial Milestone Per Share Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.6(a)(iii)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2018 Net Sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.6(b)(i)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2019 Net Sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.6(c)(i)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020 Net Sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.6(d)(i)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">280G Shareholder Approval</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;5.8</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">510(k)s</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.17</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Aggregate Offset Amount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;8.4(c)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Aggregate Option Exercise Amount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.2(d)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Preamble</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Appraisal Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.8</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Arbitrator</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.5(c)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audited Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.5(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Base Purchase Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.2(d)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Buyer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Preamble</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Buyer Indemnified Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;8.2(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Buyer&#146;s Statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.5(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cancelled Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.2(a)(v)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capital Expenditure Budget</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;5.1(i)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;1.3</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;1.2</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;1.2</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Date Aggregate Option Payment Amount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.2(d)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Merger Consideration Per Share Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.2(d)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Preamble</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company 401(k) Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;5.7(d)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Capital Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.2(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.2(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Disclosure Letter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Article III Preamble</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Indemnified Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;5.6(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.2(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continuing Employees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;5.7(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion Election</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.2(d)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt Financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;5.12(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DGCL</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;1.1</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effective Time</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;1.3</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Environmental Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.14</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Escrow Agent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.1(c)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estimated Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.4(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estimated Closing Statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.4(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estimated Indebtedness</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.4(a)</P></TD></TR></TABLE>
</DIV><DIV STYLE="position:relative;float:left; margin-left:2%; width:48%;padding-right:1%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="45%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estimated Net Working Capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.4(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estimated Purchase Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.2(d)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estimated Transaction Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.4(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FDA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.17</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FDA Permits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.17</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Final Purchase Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.2(d)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.5(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fully Diluted Share Number</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.2(d)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnified Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;8.3(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnifying Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;8.3(b)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnity Escrow Funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.1(c)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnity Escrow Release Per Share Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.2(d)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.15(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Liquidation Preference</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.2(d)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.9(b)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Recitals</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger Sub</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Preamble</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Milestone 1 Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.6(b)(i)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Milestone 1 Per Share Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.6(b)(iii)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Milestone 2 Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.6(c)(i)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Milestone 2 Per Share Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.6(c)(iii)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Milestone 3 Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.6(d)(i)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Milestone 3 Per Share Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.6(e)(iii)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Milestone Delay Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.6(e)(i)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Milestone Delay Per Share Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.6(e)(iv)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Milestone Objection Statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.6(f)(iii)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Milestone Statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.6(e)(i)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice of Claim</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;8.3(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Objection Statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.5(c)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Offset Claims</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;8.4(c)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Offset Claims Per Share Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;8.4(c)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Offset Claims Resolution Amount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;8.4(c)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outside Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;7.1(b)(i)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Preamble</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Disclosure Letter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Article IV</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Party or Parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Preamble</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paying Agent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.7(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paying Agent Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.7(a)</P></TD></TR>
</TABLE>
</DIV><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<DIV STYLE="position:relative;float:left; width:48%;padding-right:1%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment Fund</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.7(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PMA&#146;s</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.17</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Potential 280G Benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;5.8</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;8.2(a)(iii)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase Price Adjustment Escrow Funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.1(c)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase Price Escrow Release Per Share Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.2(d)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase Price Increase Per Share Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.2(d)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;262</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.8</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seller Indemnified Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;8.2(d)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.2(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.2(b)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.2(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.2(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.2(b)</P></TD></TR></TABLE>
</DIV><DIV STYLE="position:relative;float:left; margin-left:2%; width:48%;padding-right:1%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="45%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series D Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.2(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Specified Representations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;8.1(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholder Representative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;9.12(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholder Representative Expense Funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.1(d)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholder Representative Unused Funds Per Share Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.2(d)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Straddle Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;8.2(a)(iii)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Surviving Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;1.1</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Surviving Corporation Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;2.2(c)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Claim</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;5.13(d)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unaudited Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;3.5(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unresolved Claims</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;8.4(b)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Waived Benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Section&nbsp;5.8</P></TD></TR>
</TABLE>
</DIV><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">v </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This AGREEMENT AND PLAN OF MERGER, dated as of September&nbsp;4, 2017 (this &#147;<U>Agreement</U>&#148;), is made and entered into by and
among Teleflex Incorporated, a Delaware corporation (&#147;<U>Parent</U>&#148;), Teleflex Urology Limited, a private limited company incorporated under the laws of Ireland (the &#147;<U>Buyer&#148;</U>), Naples Merger Sub Inc., a Delaware
corporation and an indirect wholly-owned Subsidiary of Parent and a direct wholly-owned Subsidiary of Buyer (&#147;<U>Merger Sub</U>&#148;), NeoTract, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;) and Shareholder Representative
Services LLC, a Colorado limited liability company, solely in its capacity as the Stockholder Representative. Parent, Buyer, Merger Sub and the Company are referred to individually as a &#147;<U>Party</U>&#148; and collectively as the
&#147;<U>Parties</U>.&#148; </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Recitals </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Buyer, an indirect wholly-owned subsidiary of Parent and the sole shareholder of Merger Sub, has agreed to acquire all of the
Company&#146;s issued and outstanding capital stock and, for the purposes of effecting such acquisition, the Parties intend that, on the terms and subject to the conditions set forth in this Agreement, Merger Sub will merge with and into the
Company, with the Company surviving the merger as the surviving corporation and a wholly-owned Subsidiary of Parent (the &#147;<U>Merger</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Boards of Directors of Parent, Buyer, Merger Sub and the Company have each determined it is advisable to engage in the
transactions contemplated hereby; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, David Amerson has entered into an employment agreement with the Company, which agreement shall
be effective as of the Closing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing and the representations, warranties, covenants and
agreements contained herein, and intending to be legally bound hereby, the Parties agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>THE CLOSING </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1. <U>The Merger</U>. Upon the terms and subject to the conditions set forth in this Agreement, and in accordance with the
General Corporation Law of the State of Delaware (the &#147;<U>DGCL</U>&#148;), at the Effective Time, and in exchange for the agreed payments set forth in <U>Article II</U> payable by Buyer, Merger Sub shall be merged with and into the Company,
whereupon the separate existence of Merger Sub will cease and the Company shall continue as the surviving corporation (the &#147;<U>Surviving Corporation</U>&#148;). As a result of the Merger, the Surviving Corporation shall become a wholly-owned
Subsidiary of Buyer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2. <U>Closing</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The closing of the Merger (the &#147;<U>Closing</U>&#148;) shall take place at the offices of Simpson Thacher&nbsp;&amp; Bartlett LLP, 425
Lexington Avenue, New York, New York 10017, at 9:00 a.m., New York City time, no later than the second Business Day following the satisfaction or waiver of the conditions set forth in <U>Article VI</U> (other than those conditions that by their
nature are to be satisfied at the Closing, but subject to the satisfaction of such conditions or waiver of those conditions), or at such other place, time and date as may be agreed to by Parent and the Company (such date, the &#147;<U>Satisfaction
Date</U>&#148;). The date on which the Closing occurs is referred to herein as the &#147;<U>Closing Date</U>.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding
<U>Section</U><U></U><U>&nbsp;1.2(a)</U> and any other provision of this Agreement to the contrary, if the Satisfaction Date occurs prior to October&nbsp;2, 2017, Parent may elect in its sole discretion (no more than a single time), by written
notice to the Company (the &#147;<U>Deferral Notice</U>&#148;), to defer the Closing to October&nbsp;2, 2017. In the event of the delivery of a Deferral Notice, (i)&nbsp;the conditions set forth in in <U>Section</U><U></U><U>&nbsp;6.1</U> and
<U>Section</U><U></U><U>&nbsp;6.2</U> shall be deemed to be fully satisfied from and after the Satisfaction Date through and including the Closing (if such conditions were satisfied at the Satisfaction Date), without regard to any change in
circumstances or other events that may occur after the Satisfaction Date, and Parent shall be deemed to have irrevocably waived as of the Satisfaction Date all rights to assert the failure of such conditions to be satisfied, (ii)&nbsp;Parent shall
be deemed to have irrevocably waived as of the Satisfaction Date any right to terminate this Agreement pursuant to <U>ARTICLE VII</U>, and (iii)&nbsp;the Satisfaction Date shall be deemed the Closing Date for purposes of calculating Estimated Net
Working Capital, Estimated Cash, and Estimated Indebtedness within the calculation of Estimated Purchase Price and Cash, Indebtedness and Net Working Capital within the calculation Final Purchase Price, and (iv)&nbsp;the Satisfaction Date shall be
deemed the Closing Date for all purposes under <U>Section</U><U></U><U>&nbsp;5.13</U> and <U>ARTICLE VIII</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding the
foregoing, if a Deferral Notice is delivered, from and after the Satisfaction Date, the Company shall not declare, set aside, make or pay any dividend or other distribution, with respect to any of Company Capital Stock or other shares of capital
stock or equity interests (except for any dividend or distribution by a wholly-owned Company Subsidiary to the Company or another wholly-owned Company Subsidiary). Any breach by the Company of this <U>Section</U><U></U><U>&nbsp;1.2(c)</U> shall be
exempt from the waivers by Parent contemplated by <U>Section</U><U></U><U>&nbsp;1.2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3. <U>Effective Time</U>. On
the Closing Date, the Company shall file with the Secretary of State of the State of Delaware the certificate of merger relating to the Merger (the &#147;<U>Certificate of Merger</U>&#148;), executed in accordance with the relevant provisions of the
DGCL. The Merger shall become effective at the time that the Certificate of Merger has been duly filed with the Secretary of State of the State of Delaware, or at such later time on the Closing Date as Parent, Buyer and the Company shall agree and
specify in the Certificate of Merger (the time the Merger becomes effective, the &#147;<U>Effective Time</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.4.
<U>Effects of the Merger</U>. At and after the Effective Time, the Merger shall have the effects set forth in this Agreement and the applicable provisions of the DGCL. Without limiting the generality of the foregoing, at the Effective Time, the
Surviving Corporation shall possess all the rights, powers, privileges and franchises and be subject to all of the obligations, liabilities and duties of the Company and Merger Sub, all as provided under the DGCL. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.5. <U>Certificate of Incorporation and Bylaws of the Surviving Corporation</U>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The certificate of incorporation of the Company, as in effect as of immediately prior to the Effective Time, shall be amended and
restated as of the Effective Time so as to read in its entirety as set forth in <U>Exhibit A</U>, and as so amended and restated shall be the certificate of incorporation of the Surviving Corporation, until thereafter amended in accordance with the
provisions thereof and applicable Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) The bylaws of the Company, as in effect as of immediately prior to the Effective Time, shall
be amended and restated as of the Effective Time so as to read in its entirety as set forth in <U>Exhibit B</U>, and as so amended and restated shall be the bylaws of the Surviving Corporation, until thereafter amended in accordance with the
provisions thereof and applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.6. <U>Directors and Officers of the Surviving Corporation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The directors of Merger Sub immediately prior to the Effective Time shall, from and after the Effective Time, be the directors of the
Surviving Corporation, until the earlier of their death, resignation or removal or until their respective successors are duly elected and qualified, as the case may be. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) The officers of Merger Sub immediately prior to the Effective Time shall, from and after the Effective Time, be the officers of the
Surviving Corporation, until the earlier of their death, resignation or removal or until their respective successors are duly elected and qualified, as the case may be. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CONSIDERATION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1. <U>Closing Payments</U>. At the Closing and immediately prior to the Effective Time, Buyer shall (and Parent shall cause
Buyer to): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) deposit with the Paying Agent, by wire transfer of immediately available funds, an amount equal to the aggregate Closing
Merger Consideration Per Share Payment and consideration to holders of Company Warrants to be paid, with respect to all shares of Company Capital Stock and Company Warrants, to the holders of Company Capital Stock and Company Warrants, for payment
by the Paying Agent to the holders thereof in accordance with <U>Section</U><U></U><U>&nbsp;2.7</U>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) deposit with the Company, by
wire transfer of immediately available funds, an amount, for the benefit of the holders of Company Options, equal to the Closing Date Aggregate Option Payment Amount, for payment to the holders thereof through the Company&#146;s payroll (or by check
for any holder who is not a current employee of the Company) in accordance with <U>Section</U><U></U><U>&nbsp;2.3</U>; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) deposit with SunTrust Bank(the &#147;<U>Escrow Agent</U>&#148;), by wire transfer of
immediately available funds, $36,250,000 (to be held in a separate account and together with all interest accrued thereon, the &#147;<U>Indemnity Escrow Funds</U>&#148;) and $2,000,000 (to be held in a separate account and together with all interest
accrued thereon, the &#147;<U>Purchase Price Adjustment Escrow Funds</U>&#148;), with the Indemnity Escrow Funds and Purchase Price Adjustment Escrow Funds to be held and released in accordance with the terms of this Agreement and the Escrow
Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) pay, to the Stockholder Representative, by wire transfer of immediately available funds, $1,000,000 (the
&#147;<U>Stockholder Representative Expense Funds</U>&#148;), to be held and used by the Stockholder Representative for its costs and expenses incurred in connection with its services as the Stockholder Representative under this Agreement, with any
funds remaining following the end of such service to be released in accordance with the terms of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) pay, on behalf of
the Company, by wire transfer of immediately available funds, all amounts owing as of the Closing Date under (or otherwise required in connection with the termination of) the Credit Facilities, as contained in the applicable payoff letters provided
at least two Business Days prior to the Closing Date; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) pay, on behalf of the Company, by wire transfer of immediately available
funds, the Transaction Expenses to the Persons and in the amounts as directed by the Company by written instruction provided to Buyer at least two Business Days prior to the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2. <U>Effect on Capital Stock of the Company</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) At the Effective Time, by virtue of the Merger and without any action on the part of Parent, Buyer, Merger Sub, the Company or any holder
of any shares of Company Capital Stock, and subject to <U>Section</U><U></U><U>&nbsp;2.8</U>: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) each issued and
outstanding share of Company Common Stock (other than the Cancelled Shares) shall be converted into the right to receive: (A)&nbsp;an amount in cash, without interest, equal to the Closing Merger Consideration Per Share Payment; (B)&nbsp;at such
time as the Final Purchase Price is determined in accordance with <U>Section</U><U></U><U>&nbsp;2.5</U>, an amount in cash, without interest, equal to any Purchase Price Increase Per Share Payment and/or Purchase Price Escrow Release Per Share
Payment; (C)&nbsp;to the extent set forth in <U>Section</U><U></U><U>&nbsp;2.6</U>, any 2018 Initial Milestone Per Share Payment, Milestone 1 Per Share Payment, Milestone 2 Per Share Payment, Milestone 3 Per Share Payment and/or Milestone Delay Per
Share Payment; (D)&nbsp;to the extent set forth in <U>Section</U><U></U><U>&nbsp;8.4</U>, an amount in cash, without interest, equal to any Indemnity Escrow Release Per Share Payment; and (E)&nbsp;to the extent as set forth in
<U>Section</U><U></U><U>&nbsp;9.12</U>, an amount in cash, without interest, equal to the Stockholder Representative Unused Funds Per Share Payment; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) each issued and outstanding share of Company Preferred Stock for which a Conversion Election has been made prior to the
Effective Time shall be converted into the right to receive the same cash, without interest, that a share of Company Common Stock is entitled to receive pursuant to <U>Section</U><U></U><U>&nbsp;2.2(a)(i)</U>; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) each issued and outstanding share of Company Preferred Stock (other than
any share of Series C Preferred Stock) for which a Conversion Election has not been made prior to the Effective Time shall be converted into the right to receive the applicable Liquidation Preference for such share of Company Preferred Stock; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) each issued and outstanding share of Series C Preferred Stock for which a Conversion Election has not been made prior to
the Effective Time shall be converted into the right to receive its Liquidation Preference plus the same cash, without interest, that a share of Company Common Stock is entitled to receive pursuant to <U>Section</U><U></U><U>&nbsp;2.2(a)(i)</U>;
<U>provided</U> that in no event shall such share of Series C Preferred Stock be entitled to receive in excess of $4.41 per share (the &#147;<U>Series C Aggregate Cap</U>&#148;); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) any shares of Company Common Stock owned by the Company (including shares held as treasury stock or otherwise), Parent,
Buyer, or Merger Sub immediately prior to the Effective Time shall be automatically cancelled and shall cease to exist and no consideration shall be delivered in exchange therefor (the &#147;<U>Cancelled Shares</U>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) At the Effective Time, all shares of Company Capital Stock shall automatically be cancelled and shall cease to exist, and each holder of
shares of Company Capital Stock shall, in each case, cease to have any rights with respect thereto, except the right to receive the payments set forth in this <U>Article II</U>, subject to compliance with the procedures set forth in this <U>Article
II</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Each share of common stock of Merger Sub issued and outstanding immediately prior to the Effective Time shall be cancelled.
Upon the occurrence of the Effective Time, in consideration for the covenants and agreements contained herein, the Surviving Corporation shall issue 100 validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares of
common stock, par value $0.01 per share, which shall be issued to, and be acquired by, Buyer (the &#147;<U>Surviving Corporation Shares</U>&#148;). For the avoidance of any doubt, the consideration payable to the former holders of Company Capital
Stock by the Buyer as set forth in this <U>Article II</U> (including any of the Milestone Payments) will be fully applied to effect the acquisition of all of the Company Capital Stock and no such consideration shall be deemed to have been used to
acquire or subscribe for the Surviving Corporation Shares. The Surviving Corporation Shares issued in accordance with the foregoing shall be validly issued as fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares of common
stock of the Surviving Corporation without any additional consideration or subscription being made by the Buyer in respect thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d)
For purposes of this Agreement: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;<U>Aggregate Option Exercise Amount</U>&#148; shall mean the aggregate exercise
price of all Company Options that are outstanding immediately prior to the Effective Time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;<U>Aggregate Warrant
Exercise Amount</U>&#148; shall mean the aggregate exercise price of all Company Warrants that are outstanding immediately prior to the Effective Time, including any Company Warrants subject to a Warrant Termination Agreement or that are exercised
or deemed to be exercised in connection with the Merger pursuant to <U>Section</U><U></U><U>&nbsp;2.3(b)</U>, but excluding any Company Warrants to be terminated without consideration pursuant to <U>Section</U><U></U><U>&nbsp;2.3(b)(iii)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Date Aggregate Option Payment Amount</U>&#148; means the
aggregate amount payable as of the Effective Time to the holders of Company Options pursuant to <U>Section</U><U></U><U>&nbsp;2.3(a)(1)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Date Aggregate Liquidation Preference Payment Amount</U>&#148; shall mean the aggregate Liquidation
Preference payable as of the Effective Time to the holders of Company Preferred Stock who have not made a Conversion Election. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Merger Consideration Per Share Payment</U>&#148; means an amount equal to the quotient of (A)&nbsp;(i) the
Estimated Purchase Price <U>plus</U> (ii)&nbsp;the Aggregate Option Exercise Amount,<U> plus</U> (iii)&nbsp;the Aggregate Warrant Exercise Amount, <U>minus</U> (iv)&nbsp;the Closing Date Aggregate Liquidation Preference Payment Amount, minus
(v)&nbsp;the Indemnity Escrow Funds, <U>minus</U> (vi)&nbsp;the Purchase Price Adjustment Escrow Funds, <U>minus</U> (vii)&nbsp;the Stockholder Representative Expense Funds <U>divided by</U> (B)&nbsp;the then-applicable Fully Diluted Share Number.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;<U>Conversion Election</U>&#148; means (i)&nbsp;any election to convert any shares of Company Preferred Stock into
shares of Company Common Stock conditioned upon the Closing pursuant to the Amended and Restated Certificate of Incorporation of the Company in accordance with Section&nbsp;4 of Article IV thereof, including any &#147;Automatic Conversion&#148; as
defined therein and (ii)&nbsp;any conversion effected pursuant to the Charter Amendment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Purchase
Price</U>&#148; means an amount equal to (i) $725,000,000 (the &#147;<U>Base Purchase Price</U>&#148;) <U>plus</U> (ii)&nbsp;the amount, if any, by which the Estimated Net Working Capital exceeds the highest number in the Target Working Capital
Range, <U>minus</U> (iii)&nbsp;the amount, if any, by which the Estimated Net Working Capital is less than the lowest number in the Target Working Capital Range, <U>plus</U> (iv)&nbsp;the amount of Estimated Cash, <U>minus</U> (v)&nbsp;the amount of
Estimated Indebtedness, <U>minus</U> (vi)&nbsp;the amount of Estimated Transaction Expenses. For purposes of this definition, if the Estimated Net Working Capital is within the Target Working Capital Range, no adjustments shall be made pursuant to
clauses (ii)&nbsp;and (iii). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;<U>Final Purchase Price</U>&#148; means an amount equal to (i)&nbsp;the Base Purchase
Price, <U>plus</U> (ii)&nbsp;the amount, if any, by which the Net Working Capital, as of 11:59 p.m., New York time, on the day immediately prior to the Closing Date, as finally determined pursuant to <U>Section</U><U></U><U>&nbsp;2.5</U>, exceeds
the highest number in the Target Working Capital Range, <U>minus</U> (iii)&nbsp;the amount, if any, by which the Net Working Capital, as of 11:59 p.m., New York time, on the day immediately prior to the Closing Date, as finally determined pursuant
to <U>Section</U><U></U><U>&nbsp;2.5</U>, is less than the lowest number in the Target Working Capital Range, <U>plus</U> (iv)&nbsp;the amount of Cash of the Company and the Company Subsidiaries, as of 11:59 p.m., New York time, on the day
immediately prior to the Closing Date, as finally determined pursuant to <U>Section</U><U></U><U>&nbsp;2.5</U>, <U>minus</U> (v)&nbsp;the amount of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Indebtedness of the Company and the Company Subsidiaries, as of immediately prior to the Closing, as finally determined pursuant to <U>Section</U><U></U><U>&nbsp;2.5</U>, <U>minus</U>
(vi)&nbsp;the amount of unpaid Transaction Expenses, as of immediately prior to the Closing, as finally determined pursuant to <U>Section</U><U></U><U>&nbsp;2.5</U>. For purposes of this definition, if the Net Working Capital is within the Target
Working Capital Range, no adjustments shall be made pursuant to clauses (ii)&nbsp;and (iii). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fully Diluted Share
Number</U>&#148; means a number equal to (without duplication) the aggregate number of shares of Company Common Stock (other than any treasury shares) that are: (a)&nbsp;issued and outstanding immediately prior to the Effective Time;
(b)&nbsp;issuable upon full exercise of all Company Options that are outstanding immediately prior to the Effective Time; (c)&nbsp;issuable upon full conversion of all Company Preferred Stock that is outstanding immediately prior to the Effective
Time (<U>provided</U>, that (x)&nbsp;any Company Preferred Stock (other than Series C Preferred Stock) which has not made a Conversion Election shall be excluded from the calculation of the Fully Diluted Share Number, and (y)&nbsp;any Series C
Preferred Stock which has not made a Conversion Election shall be excluded from the calculation of the Fully Diluted Share Number from and after such time as such share of Series C Preferred Stock has received its Series C Aggregate Cap) and
(d)&nbsp;issuable upon full exercise and conversion (including any net exercise) of all Series A Warrants and Series C Warrants that are outstanding immediately prior to the Effective Time (but excluding any Company Warrants to be terminated without
consideration pursuant to <U>Section</U><U></U><U>&nbsp;2.3(b)(iii))</U>. It is hereby acknowledged that, due to the operation of the Series C Aggregate Cap, the Fully Diluted Share Number may be a different amount with respect to any particular
payment (or within the calculation of any particular payment) contemplated by this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indemnity Escrow
Release Per Share Payment</U>&#148; means an amount equal to the quotient of (A)&nbsp;the amount of any remaining Indemnity Escrow Funds (which amount shall be calculated following the satisfaction of all indemnity claims in accordance with
<U>Section</U><U></U><U>&nbsp;8.4</U>) <U>divided by</U> (B)&nbsp;the then-applicable Fully Diluted Share Number; <U>provided</U> that, for the avoidance of doubt, if the entire amount of the Indemnity Escrow Funds is released to the Buyer
Indemnified Parties pursuant to <U>Section</U><U></U><U>&nbsp;8.4</U>, the Indemnity Escrow Release Per Share Payment shall equal $0. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liquidation Preference</U>&#148; means (a)&nbsp;with respect to each share of Series A Preferred Stock, $1.20 per
share, (b)&nbsp;with respect to each share of Series B Preferred Stock, $1.26 per share, (c)&nbsp;with respect to each share of Series C Preferred Stock, $1.26 per share and (d)&nbsp;with respect to each share of Series D Preferred Stock, $1.94 per
share, plus, in each case of clauses (a)&nbsp;through (d), a further amount equal to any dividends declared but unpaid on such share. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchase Price Escrow Release Per Share Payment</U>&#148; means an amount equal to the quotient of (A)&nbsp;the
amount of any remaining Purchase Price Adjustment Escrow Funds (which amount, if the Final Purchase Price is less than the Estimated Purchase Price, shall be calculated following the release of funds by the Escrow Agent to Parent pursuant to
<U>Section</U><U></U><U>&nbsp;2.5(e)(i)</U>) <U>divided by</U> (B)&nbsp;the then-applicable Fully Diluted Share Number; <U>provided</U> that, for the avoidance of doubt, if the entire amount of the Purchase Price Adjustment Escrow Funds is released
to Parent pursuant to <U>Section</U><U></U><U>&nbsp;2.5(e)(i)</U>, the Purchase Price Escrow Release Per Share Payment shall equal $0. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchase Price Increase Per Share Payment</U>&#148; means an amount
equal to the quotient of (A)&nbsp;(i) the Final Purchase Price minus (ii)&nbsp;the Estimated Purchase Price <U>divided by</U> (B)&nbsp;the then-applicable Fully Diluted Share Number; <U>provided</U> that if the Final Purchase Price is equal to or
less than the Estimated Purchase Price, the Purchase Price Increase Per Share Payment shall equal $0. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;<U>Stockholder Representative Unused Funds Per Share Payment</U>&#148; means an amount equal to the quotient of
(A)&nbsp;the amount of any remaining Stockholder Representative Expense Funds following the payment by the Stockholder Representative of all costs and expenses incurred by the Stockholder Representative, in its capacity as such <U>divided by</U>
(B)&nbsp;the then-applicable Fully Diluted Share Number. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3. <U>Treatment of Company Options and Warrants</U>.<SUP
STYLE="font-size:85%; vertical-align:top"> </SUP> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) With respect to Company Options: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) At the Effective Time, each Company Option, whether vested or unvested and whether subject to time-based or
performance-based vesting, that is outstanding as of immediately prior to the Effective Time, shall, by virtue of the Merger and without any action on the part of Parent, Buyer, Merger Sub, the Company or the holder of such Company Option, become
fully vested and exercisable as of immediately prior to the Effective Time and shall be cancelled in exchange for the right to receive (1)&nbsp;an amount in cash equal to the product of (i)&nbsp;the excess, if any, of the Closing Merger
Consideration Per Share Payment less the applicable per share exercise price of such Company Option <U>multiplied by</U> (ii)&nbsp;the number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time,
(2)&nbsp;at such time as the Final Purchase Price is determined in accordance with <U>Section</U><U></U><U>&nbsp;2.5</U>, an amount in cash, without interest, equal to any Purchase Price Increase Per Share Payment and/or Purchase Price Escrow
Release Per Share Payment; (3)&nbsp;to the extent set forth in <U>Section</U><U></U><U>&nbsp;2.6</U>, any 2018 Initial Milestone Per Share Payment, Milestone 1 Per Share Payment, Milestone 2 Per Share Payment, Milestone 3 Per Share Payment and/or
Milestone Delay Per Share Payment; (4)&nbsp;to the extent set forth in <U>Section</U><U></U><U>&nbsp;8.4(b)</U>, an amount in cash, without interest, equal to any Indemnity Escrow Release Per Share Payment; and (5)&nbsp;to the extent set forth in
<U>Section</U><U></U><U>&nbsp;9.12</U>, an amount in cash, without interest, equal to the Stockholder Representative Unused Funds Per Share Payment, in each of clauses (2)&nbsp;through (5), multiplied by the number of shares of Company Common Stock
subject to such Company Option immediately prior to the Effective Time. The payments set forth in this <U>Section</U><U></U><U>&nbsp;2.3</U> shall be made through payroll (or by check for any holder who is not a current employee of the Company) as
soon as practicable following the time any holder becomes entitled to such a payment hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Without limiting the foregoing, the Company and the Company Board, or a
duly authorized committee thereof, shall adopt appropriate resolutions and take all reasonably necessary and appropriate action, including under the appropriate Company Benefit Plans and the stock option agreements evidencing the Company Options
and, to the extent necessary, obtaining consent of the holders of the Company Options, to effectuate the actions contemplated by this <U>Section</U><U></U><U>&nbsp;2.3</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) With respect to the Company Warrants: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) At the Effective Time, each Company Warrant for which a Warrant Termination Agreement has been executed which makes an
Conversion Election with respect to the shares of Company Preferred Stock subject to such Company Warrant and that is outstanding as of immediately prior to the Effective Time, shall, by virtue of the Merger and without any action on the part of
Parent, Buyer, Merger Sub, the Company or the holder of such Company Warrant, be cancelled in exchange for the right to receive (1)&nbsp;an amount in cash equal to the product of (i)&nbsp;the excess, if any, of the Closing Merger Consideration Per
Share Payment less the applicable per share exercise price of such Company Warrant <U>multiplied by</U> (ii)&nbsp;the number of shares of Company Common Stock receivable upon the conversion of the shares of Company Preferred Stock subject to such
Company Warrant immediately prior to the Effective Time, (2)&nbsp;at such time as the Final Purchase Price is determined in accordance with <U>Section</U><U></U><U>&nbsp;2.5</U>, an amount in cash, without interest, equal to any Purchase Price
Increase Per Share Payment and/or Purchase Price Escrow Release Per Share Payment; (3)&nbsp;to the extent set forth in <U>Section</U><U></U><U>&nbsp;2.6</U>, any 2018 Initial Milestone Per Share Payment, Milestone 1 Per Share Payment, Milestone 2
Per Share Payment, Milestone 3 Per Share Payment and/or Milestone Delay Per Share Payment; (4)&nbsp;to the extent set forth in <U>Section</U><U></U><U>&nbsp;8.4(b)</U>, an amount in cash, without interest, equal to any Indemnity Escrow Release Per
Share Payment; and (5)&nbsp;to the extent set forth in <U>Section</U><U></U><U>&nbsp;9.12</U>, an amount in cash, without interest, equal to the Stockholder Representative Unused Funds Per Share Payment, in each of clauses (2)&nbsp;through (5),
multiplied by the number of shares of Company Common Stock receivable upon the conversion of the shares of Company Preferred Stock subject to such Company Warrant immediately prior to the Effective Time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) At the Effective Time, each Company Warrant for which a Warrant Termination Agreement has been executed which does not
make a Conversion Election with respect to the shares of Company Preferred Stock subject to such Company Warrant and that is outstanding as of immediately prior to the Effective Time, shall, by virtue of the Merger and without any action on the part
of Parent, Buyer, Merger Sub, the Company or the holder of such Company Warrant, be cancelled in exchange for the right to receive the payment contemplated by <U>Section</U><U></U><U>&nbsp;2.2(a)(iii)</U>, or
<U>Section</U><U></U><U>&nbsp;2.2(a)(iv)</U>, as applicable, less the applicable per share exercise price of such Company Warrant, for each share of Company Preferred Stock subject to such Company Warrant. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) At the Effective Time, each Company Warrant for which a Warrant Termination Agreement was not executed and which was not
previously exercised by its holder in accordance with its terms shall be terminated or deemed to be exercised in accordance with its terms. Any Company Warrant that is deemed to be exercised in accordance with its terms shall receive either the
payment contemplated by <U>Section</U><U></U><U>&nbsp;2.2(a)(ii)</U> or <U>Section</U><U></U><U>&nbsp;2.2(a)(iv)</U>, based on whether such holder delivers a Conversion Election with respect to the shares of Company Preferred Stock subject to such
Company Warrant, for each share of Company Preferred Stock subject to such Company Warrant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) Without limiting the foregoing, the Company shall deliver such notices to
the holders of the Company Warrants as are required pursuant to the terms thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4. <U>Determination of Purchase
Price</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Promptly after determination of the anticipated Closing Date (and at least two Business Days prior to the Closing Date,
and in the event that Parent delivers a Deferral Notice, at least five Business Days prior to the Closing Date), the Company will deliver to Buyer a written statement (the &#147;<U>Estimated Closing Statement</U>&#148;) containing the Company&#146;s
good faith calculation of (i)&nbsp;the estimated Net Working Capital, as of 11:59 p.m., New York time, on the day immediately prior to the Closing Date (&#147;<U>Estimated Net Working Capital</U>&#148;), (ii) the estimated Cash of the Company and
the Company Subsidiaries, as of 11:59 p.m., New York time, on the day immediately prior to the Closing Date (&#147;<U>Estimated Cash</U>&#148;), (iii) the estimated Indebtedness of the Company and the Company Subsidiaries, as of immediately prior to
the Closing (&#147;<U>Estimated Indebtedness</U>&#148;), and (iv)&nbsp;the estimated unpaid Transaction Expenses, as of immediately prior to the Closing (&#147;<U>Estimated Transaction Expenses</U>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) During the period after the delivery of the Estimated Closing Statement and prior to the Closing Date, Buyer shall have an opportunity to
review the Estimated Closing Statement and the Company shall cooperate with Parent in good faith to mutually agree upon the Estimated Closing Statement in the event Buyer disputes any item proposed to be set forth on such statement; <U>provided</U>
that if the Company and Buyer are not able to reach mutual agreement prior to the Closing Date, the Estimated Closing Statement provided by the Company to Parent, as modified to include any changes agreed to by the Company and Buyer, shall be the
Estimated Closing Statement for purposes of this <U>Section</U><U></U><U>&nbsp;2.4</U> and otherwise in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5.
<U>Post-Closing Purchase Price Adjustment</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) As promptly as practicable and in any event within sixty days after the Closing Date,
Buyer shall prepare and deliver to the Stockholder Representative a statement (the &#147;<U>Buyer&#146;s Statement</U>&#148;) setting forth in reasonable detail its calculation of (i)&nbsp;the Net Working Capital, as of 11:59 p.m., New York time, on
the day immediately prior to the Closing Date, (ii)&nbsp;the Cash of the Company and the Company Subsidiaries, as of 11:59 p.m., New York time, on the day immediately prior to the Closing Date, (iii)&nbsp;Indebtedness of the Company and the Company
Subsidiaries, as of immediately prior to the Closing and (iv)&nbsp;the unpaid Transaction Expenses, as of immediately prior to the Closing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) After delivery of the Buyer&#146;s Statement, Buyer shall give the Stockholder Representative reasonable access to review the work papers,
schedules, memoranda and other documents prepared or reviewed by Parent, the Surviving Corporation and their respective Representatives in connection with the preparation of the Buyer&#146;s Statement and Buyer and the Surviving Corporation shall
cause their Representatives to reasonably cooperate with and respond to such inquiries and otherwise reasonably cooperate with the Stockholder Representative in the review of the Buyer&#146;s Statement, including by providing reasonable access to
the books and records of the Surviving Corporation in connection therewith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Within 45<B><I> </I></B>days after delivery of the Buyer&#146;s Statement to the Stockholder
Representative, the Stockholder Representative will advise Buyer in writing whether it agrees with the Buyer&#146;s Statement or whether the Stockholder Representative objects to it. If the Stockholder Representative disputes any amounts reflected
on the Buyer&#146;s Statement, it shall deliver to Parent a statement setting forth its objections thereto, setting forth, in reasonable detail, the basis for such dispute, the dollar amounts involved and the Stockholder Representative&#146;s
calculation of the Buyer&#146;s Statement, within 45 days of Buyer&#146;s delivery of the Buyer&#146;s Statement to the Stockholder Representative (such written notice of objection, the &#147;<U>Objection Statement</U>&#148;). If an Objection
Statement is not delivered to Parent within 45 days after delivery of the Buyer&#146;s Statement to the Stockholder Representative, the Buyer&#146;s Statement shall be final, binding and <FONT STYLE="white-space:nowrap">non-appealable</FONT> by the
parties hereto. The Stockholder Representative and Parent shall negotiate in good faith to resolve any objections made by the Stockholder Representative, but if they do not reach a final resolution within thirty days after the delivery of the
Objection Statement, either the Stockholder Representative or Parent may submit the issues in dispute (including any issues not included in the Objection Statement) for final resolution BDO USA, LLP, or if BDO USA, LLP are unable to serve, to an
independent certified public accounting firm of national reputation mutually agreed by the Stockholder Representative and Parent (the firm so determined, &#147;<U>Arbitrator</U>&#148;). Each Party agrees to execute, if requested by the Arbitrator, a
reasonable and customary engagement letter, including customary indemnities. The Arbitrator shall consider only those items and amounts which Buyer and the Stockholder Representative are unable to resolve. In resolving any item of dispute, the
Arbitrator may not assign a value to any item greater than the greatest value for such item claimed by either Buyer and the Stockholder Representative or less than the smallest value for such item claimed by either Parent or the Stockholder
Representative. Buyer and the Stockholder Representative shall use their commercially reasonable efforts to cause the Arbitrator to resolve all disagreements as soon as practicable and in any event within thirty days after the submission of any
dispute to the Arbitrator. The resolution of the dispute by the Arbitrator shall be final, binding and <FONT STYLE="white-space:nowrap">non-appealable</FONT> on the parties hereto. The costs and expenses of the Arbitrator shall be borne by Buyer and
the Stockholder Representative (solely on behalf of the holders of shares of Company Capital Stock) based on the percentage which the portion of the contested amount not awarded to such Party bears to the amount actually contested by such Party, as
finally determined by the Arbitrator. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) If the Final Purchase Price is greater than the Estimated Purchase Price, no later than two
Business Days after the Final Purchase Price has been determined: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Buyer shall (and Parent shall cause Buyer to)
deposit (a)&nbsp;with the Paying Agent an amount equal to the aggregate Purchase Price Increase Per Share Payment owed, with respect to all shares of Company Capital Stock and Company Warrants, to the former holders of shares of Company Capital
Stock and Company Warrants and (b)&nbsp;with the Company an amount equal to the aggregate Purchase Price Increase Per Share Payment owed, with respect to all Company Options, to the former holders of Company Options; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Buyer and the Stockholder Representative shall jointly instruct the Escrow
Agent to release (a)&nbsp;to the Paying Agent an amount equal to the Purchase Price Escrow Release Per Share Payment owed, with respect to all shares of Company Capital Stock and Company Warrants, to the former holders of shares of Company Capital
Stock and Company Warrants and (b)&nbsp;to the Company an amount equal to the aggregate Purchase Price Escrow Release Per Share Payment owed, with respect to all Company Options, to the former holders of Company Options. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Paying Agent shall promptly disburse the funds received pursuant to this <U>Section</U><U></U><U>&nbsp;2.5(d)</U> to the former holders of
Company Capital Stock and Company Warrants and the Company shall promptly disburse, through the Company&#146;s payroll (or by check for any holder who is not a current employee of the Company), the funds received pursuant to this
<U>Section</U><U></U><U>&nbsp;2.5(d)</U> to the former holders of Company Options, in each case in accordance with this <U>Article II</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) If the Final Purchase Price is less than or equal to the Estimated Purchase Price, no later than two Business Days after the Final
Purchase Price has been determined: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Buyer and the Stockholder Representative shall jointly instruct the Escrow Agent
to release to Buyer from the Purchase Price Adjustment Escrow Funds (and then, only to the extent the Purchase Price Adjustment Escrow Funds are not sufficient, from the Indemnity Escrow Funds), an aggregate amount equal to the Estimated Purchase
Price <U>minus</U> the Final Purchase Price, which payment shall be Parent&#146;s sole and exclusive remedy with respect thereto; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) if there are any Purchase Price Adjustment Escrow Funds remaining following the payment set forth in
<U>Section</U><U></U><U>&nbsp;2.5(e)(i)</U> above, Buyer and the Stockholder Representative shall jointly instruct the Escrow Agent to release (i)&nbsp;to the Paying Agent an amount equal to the Purchase Price Escrow Release Per Share Payment owed,
with respect to all shares of Company Capital Stock and Company Warrants, to the former holders of shares of Company Capital Stock and Company Warrants, and (ii)&nbsp;to the Company an amount equal to the aggregate Purchase Price Escrow Release Per
Share Payment owed, with respect to all Company Options, to the former holders of Company Options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Paying Agent shall promptly
disburse the funds received pursuant to this <U>Section</U><U></U><U>&nbsp;2.5(e)</U> to the former holders of Company Capital Stock and Company Warrants and the Company shall promptly disburse, through the Company&#146;s payroll (or by check for
any holder who is not a current employee of the Company), the funds received pursuant to this <U>Section</U><U></U><U>&nbsp;2.5(e)</U> to the former holders of Company Options, in each case in accordance with this <U>Article II</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6. <U><FONT STYLE="white-space:nowrap">Earn-Out</FONT> Payments</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>2018 Initial Milestone Payment</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The &#147;<U>2018 Initial Milestone Payment</U>&#148; shall be equal to (x)
$75,000,000, if Net Sales for the period from January&nbsp;1, 2018 through April&nbsp;30, 2018 are equal to or greater than $40,000,000 or (y)&nbsp;if Net Sales for the period from January&nbsp;1, 2018 through April&nbsp;30, 2018 are less than
$40,000,000, an amount equal to the product of (A) $75,000,000 and (B)&nbsp;a fraction, the numerator of which is Net Sales for the period from January&nbsp;1, 2018 through April&nbsp;30, 2018 and the denominator of which is $40,000,000.
Notwithstanding the foregoing, the 2018 Initial Milestone Payment shall be subject to offset and reduction as provided for in <U>Section</U><U></U><U>&nbsp;8.4(c)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) On June&nbsp;30, 2018, Buyer shall (and Parent shall cause Buyer to) deposit (x)&nbsp;with the Paying Agent an amount
equal to the aggregate 2018 Initial Milestone Per Share Payment owed, with respect to all shares of Company Capital Stock, to the former holders of shares of Company Capital Stock and (y)&nbsp;with the Company an amount equal to the aggregate 2018
Initial Milestone Per Share Payment owed, with respect to all Company Options, to the former holders of Company Options. The Paying Agent shall promptly disburse the funds received pursuant to this <U>Section</U><U></U><U>&nbsp;2.6(a)</U> to the
former holders of Company Capital Stock and the Company shall promptly disburse, through the Company&#146;s payroll (or by check for any holder who is not a current employee of the Company), the funds received pursuant to this
<U>Section</U><U></U><U>&nbsp;2.6(a)</U> to the former holders of Company Options, in each case in accordance with this <U>Article II</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The &#147;<U>2018 Initial Milestone Per Share Payment</U>&#148; means an amount equal to the quotient of (A)&nbsp;the
2018 Initial Milestone Payment <U>minus</U> the Advisor Fees related to the 2018 Initial Milestone Payment <U>divided by</U> (B)&nbsp;the then-applicable Fully Diluted Share Number. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Milestone 1 Payment</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The &#147;<U>Milestone 1 Payment</U>&#148; shall be equal to the product of (a) 1.50 multiplied by (b)&nbsp;the difference
between (x)&nbsp;Net Sales for the period from January&nbsp;1, 2018 through December&nbsp;31, 2018 (&#147;<U>2018 Net Sales</U>&#148;) <U>minus</U> (y)&nbsp;Net Sales for the period from January&nbsp;1, 2017 through December&nbsp;31, 2017
(&#147;<U>2017 Net Sales</U>&#148;); <U>provided</U> that in no event shall the Milestone 1 Payment be greater than $300,000,000; <U>provided</U>, <U>further</U> that if 2018 Net Sales are less than or equal to 2017 Net Sales, there shall be no
Milestone 1 Payment (i.e., the Milestone 1 Payment shall equal $0). Notwithstanding the foregoing, the Milestone 1 Payment shall be subject to offset and reduction as provided for in <U>Section</U><U></U><U>&nbsp;8.4(c)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) If there is a Milestone 1 Payment pursuant to <U>Section</U><U></U><U>&nbsp;2.6(b)(i)</U> above, on the later of
March&nbsp;1, 2019 or the date of the final determination of the Milestone 1 Payment pursuant to <U>Section</U><U></U><U>&nbsp;2.6(f)</U>, Buyer shall (and Parent shall cause Buyer to) deposit (a)&nbsp;with the Paying Agent an amount equal to the
aggregate Milestone 1 Per Share Payment owed, with respect to all shares of Company Capital Stock, to the former holders of shares of Company Capital Stock and (b)&nbsp;with the Company an amount equal to the aggregate Milestone 1 Per Share Payment
owed, with respect to all Company Options, to the former holders of Company Options. The Paying Agent shall promptly disburse the funds received pursuant to this <U>Section</U><U></U><U>&nbsp;2.6(b)</U> to the former holders of Company Capital Stock
and the Company shall promptly disburse, through the Company&#146;s payroll (or by check for any holder who is not a current employee of the Company), the funds received pursuant to this <U>Section</U><U></U><U>&nbsp;2.6(b)</U> to the former holders
of Company Options, in each case in accordance with this <U>Article II</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The &#147;<U>Milestone 1 Per Share Payment</U>&#148; means an amount equal
to the quotient of (A)&nbsp;the Milestone 1 Payment <U>minus</U> the Advisor Fees <U>divided by</U> (B)&nbsp;the then-applicable Fully Diluted Share Number. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Milestone 2 Payment</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The &#147;<U>Milestone 2 Payment</U>&#148; shall be equal to the product of (A) 1.50 multiplied by (B)&nbsp;the difference
between (a)&nbsp;Net Sales for the period from January&nbsp;1, 2019 through December&nbsp;31, 2019 (&#147;<U>2019 Net Sales</U>&#148;) <U>minus</U> (b) 2018 Net Sales (or, if 2018 Net Sales are lower than the then-applicable Net Sales High-water
Mark, the then-applicable Net Sales High-water Mark); <U>provided</U> that in no event shall the Milestone 2 Payment be greater than $300,000,000 <U>minus</U> any Milestone 1 Payment; <U>provided</U> <U>further</U> that if 2019 Net Sales are less
than or equal to 2018 Net Sales, there shall be no Milestone 2 Payment (i.e., the Milestone 2 Payment shall equal $0). Notwithstanding the foregoing, the Milestone 2 Payment shall be subject to offset and reduction as provided for in
<U>Section</U><U></U><U>&nbsp;8.4(c)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) If there is a Milestone 2 Payment pursuant to
<U>Section</U><U></U><U>&nbsp;2.6(c)(i)</U>, on the later of March&nbsp;1, 2020 or the date of the final determination of the Milestone 2 Payment pursuant to <U>Section</U><U></U><U>&nbsp;2.6(f)</U>, Buyer shall (and Parent shall cause Buyer to)
deposit (a)&nbsp;with the Paying Agent an amount equal to the aggregate Milestone 2 Per Share Payment owed, with respect to all shares of Company Capital Stock, to the former holders of shares of Company Capital Stock and (b)&nbsp;with the Company
an amount equal to the aggregate Milestone 2 Per Share Payment owed, with respect to all Company Options, to the former holders of Company Options. The Paying Agent shall promptly disburse the funds received pursuant to this
<U>Section</U><U></U><U>&nbsp;2.6(c)</U> to the former holders of Company Capital Stock and the Company shall promptly disburse, through the Company&#146;s payroll (or by check for any holder who is not a current employee of the Company), the funds
received pursuant to this <U>Section</U><U></U><U>&nbsp;2.6(c)</U> to the former holders of Company Options, in each case in accordance with this <U>Article II</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The &#147;<U>Milestone 2 Per Share Payment</U>&#148; means an amount equal to the quotient of (A)&nbsp;the Milestone 2
Payment <U>minus</U> the Advisor Fees <U>divided by</U> (B)&nbsp;the then-applicable Fully Diluted Share Number. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) For
purposes of this <U>Section</U><U></U><U>&nbsp;2.6</U>, the &#147;<U>Net Sales High-water Mark</U>&#148; at any particular time means the highest Net Sales for any full calendar year, from and after (and inclusive of) calendar year 2017, completed
prior to such particular time, including, (A)&nbsp;for purposes of the Milestone 2 Payment, the higher of 2017 Net Sales and 2018 Net Sales, (B)&nbsp;for purposes of the Milestone 3 Payment, the highest of 2017 Net Sales, 2018 Net Sales and 2019 Net
Sales, and (C)&nbsp;for purposes of any Milestone Delay Payments, the highest of 2017 Net Sales, 2018 Net Sales, 2019 Net Sales, 2020 Net Sales, and Net Sales for any subsequent calendar year (e.g., 2021, 2022, etc.) for which a Milestone Delay
Payment may be measured. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <U>Milestone 3 Payment</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The &#147;<U>Milestone 3 Payment</U>&#148; shall be equal to the product of (a) 1.50 <U>multiplied by</U> (b)&nbsp;the
difference between (x)&nbsp;Net Sales for the period from January&nbsp;1, 2020 through December&nbsp;31, 2020 (&#147;<U>2020 Net Sales</U>&#148;) <U>minus</U> (y) 2019 Net Sales (or, if 2019 Net Sales are lower than the then-applicable Net Sales
High-water Mark, the then-applicable Net Sales High Water Mark); <U>provided</U> that in no event shall the Milestone 3 Payment be greater than $300,000,000 <U>minus</U> any Milestone 1 Payment <U>minus</U> any Milestone 2 Payment; <U>provided</U>
<U>further</U> that if 2020 Net Sales are less than or equal to 2019 Net Sales, there shall be no Milestone 3 Payment (i.e., the Milestone 3 Payment shall equal $0). Notwithstanding the foregoing, the Milestone 3 Payment shall be subject to offset
and reduction as provided for in <U>Section</U><U></U><U>&nbsp;8.4(c)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) If there is a Milestone 3 Payment
pursuant to <U>Section</U><U></U><U>&nbsp;2.6(d)(i)</U>, on the later of March&nbsp;1, 2021 or the date of the final determination of the Milestone 3 Payment pursuant to <U>Section</U><U></U><U>&nbsp;2.6(f)</U>, Buyer shall (and Parent shall cause
Buyer to) deposit (a)&nbsp;with the Paying Agent an amount equal to the aggregate Milestone 3 Per Share Payment owed, with respect to all shares of Company Capital Stock, to the former holders of shares of Company Capital Stock and (b)&nbsp;with the
Surviving Corporation an amount equal to the aggregate Milestone 3 Per Share Payment owed, with respect to all Company Options, to the former holders of Company Options. The Paying Agent shall promptly disburse the funds received pursuant to this
<U>Section</U><U></U><U>&nbsp;2.6(d)</U> to the former holders of Company Capital Stock and the Company shall promptly disburse, through the Company&#146;s payroll (or by check for any holder who is not a current employee of the Company), the funds
received pursuant to this <U>Section</U><U></U><U>&nbsp;2.6(d)</U> to the former holders of Company Options, in each case in accordance with this <U>Article II</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The &#147;<U>Milestone 3 Per Share Payment</U>&#148; means an amount equal to the quotient of (A)&nbsp;the Milestone 3
Payment <U>minus</U> the Advisor Fees <U>divided by</U> (B)&nbsp;the then-applicable Fully Diluted Share Number. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) <U>Milestone Delay
Payment</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) In the event that one or more Milestone Delay Event(s) occur, the &#147;<U>Milestone Delay
Payment</U>&#148; shall be equal to the product of (a) 1.50 <U>multiplied by</U> (b)&nbsp;the difference between (x)&nbsp;Net Sales for the period from January&nbsp;1 through December&nbsp;31 of the year after the end of the final year for which a
Milestone Payment was previously eligible to be paid (e.g., for the first Milestone Delay Payment, 2021; if the Milestone Delay Factor is over one, then for the second Milestone Delay Payment, 2022; if the Milestone Delay Factor is over two, then
for the third Milestone Delay Payment, 2023; with such additional years, if any, in accordance with the foregoing) <U>minus</U> (y)&nbsp;Net Sales for the period from January&nbsp;1 through December&nbsp;31 of the final year for which a Milestone
Payment was previously eligible to be paid (e.g., for the first Milestone Delay Payment, 2020; if the Milestone Delay Factor is over one, then for the second Milestone Delay Payment, 2021; if the Milestone Delay Factor is over two, then for the
third Milestone Delay Payment, 2022; with such additional years, if any, in accordance with the foregoing) (such year, the &#147;<U>Base Year</U>&#148;); <U>provided</U> that if Net Sales in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the then-applicable Base Year are lower than the then-applicable Net Sales High-water Mark, the then-applicable Net Sales High-water Mark shall be used for the determination of the amount in
clause (y); <U>multiplied by</U> (c)&nbsp;the Milestone Delay Factor; <U>provided</U> that in no event shall the Milestone Delay Payment be greater than $300,000,000 <U>minus</U> any Milestone 1 Payment <U>minus</U> any Milestone 2 Payment
<U>minus</U> any Milestone 3 Payment <U>minus</U> any previously paid Milestone Delay Payment; <U>provided</U> <U>further</U> that if Net Sales contemplated by clause (x)&nbsp;above are less than or equal to Net Sales contemplated by clause
(y)&nbsp;above, there shall be no Milestone Delay Payment (i.e., the Milestone Delay Payment shall equal $0). Notwithstanding the foregoing, the Milestone Delay Payment shall be subject to offset and reduction as provided for in
<U>Section</U><U></U><U>&nbsp;8.4(c)</U>. It is hereby acknowledged that there may be multiple Milestone Delay Events, and that a Milestone Delay Payment may be eligible to be paid in multiple years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) For purposes of this <U>Section</U><U></U><U>&nbsp;2.6(e)</U>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">A &#147;<U>Milestone Delay Event</U>&#148; means any cessation or material decrease in the sales of the Product in the United
States that lasts for a period of at least 30 consecutive calendar days which is caused by a corporate warning letter issued by the FDA to Parent or its Affiliates or a consent decree (or other Order) from a Governmental Entity against Parent or its
Affiliates; <U>provided</U> that a Milestone Delay Event shall be deemed to have not occurred if such corporate warning letter, consent decree or other Order resulted from the Products or operation of the Company Business. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">The &#147;<U>Milestone Delay Factor</U>&#148; shall be a number equal to (x)&nbsp;the number of aggregate days for all
Milestone Delay Event(s), <U>divided by</U> (y) 365 days. In the event that the Milestone Delay Factor is greater than one, then the Milestone Delay Factor will be deemed to be one for the first annual period, and an additional Milestone Delay
Payment will be due for the immediately following annual period (or more annual periods as necessary), with this clause (g)&nbsp;to be applied mutatis mutandis, with the Milestone Delay Factor for any such year to be the lesser of (A)&nbsp;one and
(B)&nbsp;the Milestone Delay Factor (determined without regard for this sentence) minus any previous Milestone Delay Factors used in prior years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) If there is a Milestone Delay Payment pursuant to <U>Section</U><U></U><U>&nbsp;2.6(e)(i)</U>, on the later of
March&nbsp;1 of the subsequent calendar year or the date of the final determination of the Milestone Delay Payment pursuant to <U>Section</U><U></U><U>&nbsp;2.6(f)</U>, Buyer shall (and Parent shall cause Buyer to) deposit (a)&nbsp;with the Paying
Agent an amount equal to the aggregate Milestone Delay Per Share Payment owed, with respect to all shares of Company Capital Stock, to the former holders of shares of Company Capital Stock and (b)&nbsp;with the Surviving Corporation an amount equal
to the aggregate Milestone Delay Per Share Payment owed, with respect to all Company Options, to the former holders of Company Options. The Paying Agent shall promptly disburse the funds received pursuant to this
<U>Section</U><U></U><U>&nbsp;2.6(e)</U> to the former holders of Company Capital Stock and the Company shall promptly disburse, through the Company&#146;s payroll (or by check for any holder who is not a current employee of the Company), the funds
received pursuant to this <U>Section</U><U></U><U>&nbsp;2.6(e)</U> to the former holders of Company Options, in each case in accordance with this <U>Article II</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) The &#147;<U>Milestone Delay Per Share Payment</U>&#148; means an amount
equal to the quotient of (A)&nbsp;the Milestone Delay Payment <U>minus</U> the Advisor Fees <U>divided by</U> (B)&nbsp;the then-applicable Fully Diluted Share Number. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) <U>Calculation of Milestone Payments</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) As promptly as practicable and in any event within 45 days after the end of the period for determining Net Sales
applicable to, as the case may be, the 2018 Initial Milestone Payment, the Milestone 1 Payment, the Milestone 2 Payment, the Milestone 3 Payment and Milestone Delay Payment, Buyer shall prepare and deliver to the Stockholder Representative a
statement (the &#147;<U>Milestone Statement</U>&#148;) setting forth in reasonable detail its calculation, as applicable, of the 2018 Initial Milestone Payment, the Milestone 1 Payment, the Milestone 2 Payment, the Milestone 3 Payment and Milestone
Delay Payment, as well as the information required in an Update Report pursuant to <U>Section</U><U></U><U>&nbsp;2.6(g)(i)</U> below. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) After delivery of the applicable Milestone Statement, Buyer shall give the Stockholder Representative reasonable access
to review the work papers, schedules, memoranda and other documents prepared or reviewed by Buyer, the Surviving Corporation and their respective Representatives in connection with the preparation of the applicable Milestone Statement and Buyer and
the Surviving Corporation shall cause their Representatives to reasonably cooperate with and respond to such inquiries and otherwise reasonably cooperate with the Stockholder Representative in the review of such Milestone Statement, including by
providing reasonable access to the books and records of the Surviving Corporation in connection therewith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Within
45 days after delivery of the applicable Milestone Statement to the Stockholder Representative, the Stockholder Representative will advise Buyer in writing whether it agrees with the Net Sales for the applicable period set forth such Milestone
Statement or whether the Stockholder Representative objects to such Net Sales. If the Stockholder Representative disputes the Net Sales included on such Milestone Statement, it shall deliver to Buyer a statement setting forth its objections thereto,
setting forth, in reasonable detail, the basis for such dispute, the dollar amounts involved and the Stockholder Representative&#146;s calculation of such Net Sales and Milestone Statement, within 45 days of Buyer&#146;s delivery of such Milestone
Statement to the Stockholder Representative (such written notice of objection, the &#147;<U>Milestone Objection Statement</U>&#148;). If such Milestone Objection Statement is not delivered to Buyer within 45 days after delivery of such Milestone
Statement to the Stockholder Representative, such Milestone Statement shall be final, binding and <FONT STYLE="white-space:nowrap">non-appealable</FONT> by the parties hereto. The Stockholder Representative and Parent shall negotiate in good faith
to resolve any objections made by the Stockholder Representative, but if they do not reach a final resolution within 45 days after the delivery of such Milestone Objection Statement, either the Stockholder Representative or Buyer may submit the Net
Sales in dispute for final resolution to the Arbitrator. Each Party agrees to execute, if requested by the Arbitrator, a reasonable and customary engagement letter, including customary indemnities. The Arbitrator shall consider only those Net Sales
which Buyer and the Stockholder Representative are unable to resolve. In resolving any item of dispute, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Arbitrator may not assign a value to any item greater than the greatest value for such Net Sales item claimed by the Stockholder Representative or less than the smallest value for such Net Sales
item claimed by Buyer. Buyer and the Stockholder Representative shall use their commercially reasonable efforts to cause the Arbitrator to resolve all disagreements as soon as practicable and in any event within thirty days after the submission of
any dispute to the Arbitrator. The resolution of the dispute by the Arbitrator shall be final, binding and <FONT STYLE="white-space:nowrap">non-appealable</FONT> on the parties hereto, absent manifest error. The costs and expenses of the Arbitrator
shall be borne by Buyer and the Stockholder Representative based on the percentage which the portion of the contested amount not awarded to such Party bears to the amount actually contested by such Party, as finally determined by the Arbitrator. The
Arbitrator shall not resolve any other disputes relating to this <U>Section</U><U></U><U>&nbsp;2.6</U> other than the calculation of the Net Sales. For avoidance of doubt, acceptance by either party of the methodology for calculating any Milestone
Payment shall not be deemed to bind or prejudice such party with respect to the methodology of calculating any other Milestone Payment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) <U>Update Reports and Meetings</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Parent shall, within 10 Business Days after the date Parent files its Quarterly Report on Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> or Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for any fiscal quarter or end of fiscal year, as applicable, send to the Stockholder Representative a reasonably detailed report regarding
the status of efforts to achieve the Milestone Payments and Parent&#146;s calculation of Net Sales for such fiscal period (each such report, an &#147;<U>Update Report</U>&#148;), along with reasonable supporting detail (to the same extent that such
information is provided to the management of the Company prior to the date of this Agreement) by quarter of: (A)&nbsp;Net Sales by geographical region, including by region within the United States, (B)&nbsp;number of accounts purchasing Products in
the United States, (C)&nbsp;number of units of Product sold in the United States, (D)&nbsp;average price per unit of Product in the United States, (E)&nbsp;units revenue per Sales Employee in the United States, (F)&nbsp;average orders Net Sales by
account in the United States, and (G)&nbsp;same store sales growth in the United States. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Once per fiscal year in a
regularly scheduled meeting, and once per fiscal year at the Stockholder Representative&#146;s request (upon no less than 45 days&#146; prior notice), Representatives of Parent shall meet (in person at the Company&#146;s headquarters, unless
otherwise agreed) with the Stockholder Representative and/or its designees, to discuss the Update Report and/or any other matters relating to the Milestone Payments (each such meeting, an &#147;<U>Update Meeting</U>&#148;). Parent shall make
available for each such Update Meeting, a Representative of Parent with direct, overall managerial responsibility for the Product and such other of its employees and Representatives of Parent and/or its Affiliates as Parent may reasonably deem
appropriate and designate in writing from time to time or that the Stockholders Representative and/or its designees may reasonably request, who will respond to reasonable written inquiries of the Stockholder Representative and/or its designees
regarding the applicable Update Report. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Parent shall make available to the Stockholder Representative and/or its
designees information concerning the Products and the Milestone Payments as the Stockholder Representative may reasonably request in relation to the Update Report or to the Update Meeting; <U>provided</U> that Parent shall not be required to provide
such access or furnish such information if Parent in good faith reasonably believes that doing so would reasonably be expected to (i)&nbsp;breach or violate any applicable Law relating to the exchange of information, (ii)&nbsp;result in the loss of
attorney-client privilege or attorney work product privilege or (iii)&nbsp;violate any confidentiality obligation with respect to such information; <U>provided</U>, <U>further</U>, that the Parties agree to collaborate in good faith to make
alternative arrangements to allow for such access or disclosure in a manner that does not result in the events set out in clauses (i), (ii) or (iii)&nbsp;above. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) <U>Parent Obligations</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Parent, Buyer and the Company shall use Commercially Reasonable Efforts to achieve the maximum amount of the Milestone
Payments. None of Parent, Buyer and the Company shall take any action with the primary intent of avoiding or reducing any of the Milestone Payments. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Without limiting the generality of <U>Section</U><U></U><U>&nbsp;2.6(h)(i)</U> above: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="17%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top">to retain the U.S. employees whose function is the sales of the Products (the &#147;<U>Sales Employees</U>&#148;), until December&nbsp;31, 2018, Parent shall set, or shall cause the Surviving Corporation to set, for
each Sales Employee that is a Continuing Employee, the same sales incentive compensation for achievement of target amount, incentives for over-achievement of target amounts and accelerator provisions, as in place immediately prior to the Closing, as
set forth on <U>Section</U><U></U><U>&nbsp;2.6(h)(ii)(A)</U> of the Company Disclosure Letter; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="17%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top">until the second anniversary of the Closing Date, Parent, Buyer and the Company shall ensure that the Sales Employees assigned to the United States market are, dedicated exclusively to the sales and marketing of the
Products, <U>provided</U> that such Sales Employees may sell a <I>de minimis</I> amount of other products sold or marketed by Parent or its Affiliates; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="17%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top">until the second anniversary of the Closing Date, Parent, and its Affiliates shall not acquire or operate any business that develops, produces, markets or sells a Competing Product, <U>provided</U>, that Parent or its
Affiliates may acquire such a business solely if the Competing Product of such business is still under development and will not be initially commercialized until the second anniversary of the Closing Date. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Parent shall have the right, from time to time, to request from the
Stockholder Representative waivers or consents to the provisions of this <U>Section</U><U></U><U>&nbsp;2.6(h)</U>. In connection with such requests, Parent shall provide any information reasonably requested by the Stockholder Representative in
connection with evaluating such request, and, upon request by the Stockholder Representative, shall make available a Representative of Parent with direct, overall managerial responsibility for the Product to discuss such request. The Stockholder
Representative shall consider each such request in good faith and its approval with respect thereto shall not be unreasonably withheld, delayed or conditioned to the extent that the likelihood of achieving any Milestone Payment would not reasonably
be expected to be reduced as a result thereof, as determined in the Stockholder Representative&#146;s reasonable discretion. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)
<U>Acceleration</U>. In the event of the occurrence of any of the following events, any Milestone Payments that have not been paid shall be immediately due and payable in full: (1)&nbsp;Parent or the Surviving Corporation commences any proceeding in
bankruptcy or for dissolution, liquidation, <FONT STYLE="white-space:nowrap">winding-up,</FONT> or other relief under state or federal bankruptcy laws; (2)&nbsp;any such proceeding is commenced against Parent or the Surviving Corporation, or a
receiver or trustee is appointed for Parent or the Surviving Corporation or a substantial part of its respective property, and such proceeding or appointment is not dismissed or discharged within one hundred and twenty (120)&nbsp;days after its
commencement; (3)&nbsp;Parent or the Surviving Corporation makes an assignment for the benefit of creditors, or petitions or applies to any tribunal for the appointment of a custodian, receiver or trustee for all or substantially all of its assets
or has a receiver, custodian or trustee appointed for all or substantially all of its assets; or (4)&nbsp;a Change of Control is consummated. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) <U>Advisor Fees</U>. Parent shall pay or cause to be paid the amount of any Advisor Fees relating to any Milestone Payments to the
applicable advisor of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k) For the avoidance of doubt and notwithstanding anything herein to the contrary, in no event shall
the Milestone 1 Payment <U>plus</U> the Milestone 2 Payment <U>plus</U> the Milestone 3 Payment <U>plus</U> any Milestone Delay Payments(s) be in excess of $300,000,000. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(l) Certain payments shall be made on behalf of the holders of Company Capital Stock to the specified individuals on the terms set forth on
Section&nbsp;2.6(k) of the Company Disclosure Letter, with such payments to be funded by holders of Company Capital Stock from the applicable Milestone Payments in accordance with Section&nbsp;2.6(k) of the Company Disclosure Letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7. <U>Paying Agent </U><U>and Letter of Transmittals</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Prior to the Effective Time, Buyer and the Stockholder Representative shall enter into an paying agent agreement (the &#147;<U>Paying
Agent Agreement</U>&#148;), in substantially the form attached hereto as <U>Exhibit D</U>, with Acquiom Financial LLC (the &#147;<U>Paying Agent</U>&#148;). Any funds deposited with the Paying Agent shall be held in a
<FONT STYLE="white-space:nowrap">non-interest</FONT> bearing account (the &#147;<U>Payment Fund</U>&#148;) and used to satisfy the payments required to be made to the former holders of Company Capital Stock and Company Warrants in accordance with
this <U>Article II</U>. If for any reason the cash in the Payment Fund shall be insufficient (including </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
because of investment loss) to fully satisfy all of the payment obligations to be made pursuant to this <U>Article II</U>, Buyer shall promptly deposit into the Payment Fund the amount of cash
required to fully satisfy such cash payment obligations. Except as provided for in this Agreement, the Payment Fund shall not be used for any other purpose. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Subject to timely receipt by the Paying Agent of the form of letter of transmittal and addresses (including email addresses) for the
holders of Company Capital Stock and Company Warrants as described in the Paying Agent Agreement, at least ten Business Days prior to the Closing Date, the Paying Agent shall provide to all holders of Company Capital Stock and Company Warrants a
customary letter of transmittal (which shall be in a form and have such customary provisions as the Paying Agent, Buyer and the Company may reasonably agree prior to the Effective Time) and instructions for use in effecting the surrender of shares
of Company Capital Stock and Company Warrants in exchange for the payments contemplated by this <U>Article II</U>. If the Paying Agent receives a duly completed letter of transmittal from a holder of Company Capital Stock and Company Warrants at
least two Business Days prior to the Closing Date, the Paying Agent shall, on the Closing Date, make the payments contemplated by <U>Section</U><U></U><U>&nbsp;2.2(a)</U> and <U>Section</U><U></U><U>&nbsp;2.3(b)</U> to such holder of Company Capital
Stock and Company Warrants and otherwise, the Paying Agent shall as promptly as practicable after receipt of the executed letter of transmittal make the payments contemplated by <U>Section</U><U></U><U>&nbsp;2.2(a)</U> and
<U>Section</U><U></U><U>&nbsp;2.3(b)</U> to such holder of Company Capital Stock and Company Warrants. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Any portion of the Payment
Fund that remains undistributed to the former holders of Company Capital Stock and Company Warrants twelve months after the Effective Time shall be delivered to the Surviving Corporation upon its demand therefor, and any former holder of Company
Capital Stock and Company Warrants who has not theretofore complied with this <U>Article II</U> shall thereafter look only to the Surviving Corporation for payment of its claim for payment of consideration in accordance with this <U>Article II</U>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) Any Person claiming that a certificate representing shares of Company Capital Stock or Company Warrants has been lost, stolen or
destroyed shall only be entitled to receive the payments in accordance with this <U>Article II</U> for the shares of Company Capital Stock previously represented by such certificate or Company Warrants if such Person (a)&nbsp;provides an affidavit
(reasonably acceptable to the Paying Agent) that such certificate has been lost, stolen or destroyed, (b)&nbsp;posts a bond (in such reasonable amount as the Paying Agent may direct) as indemnity against any claim that may be made against Parent,
the Paying Agent or the Surviving Corporation with respect to such certificate and (c)&nbsp;has otherwise complied with this <U>Section</U><U></U><U>&nbsp;2.7</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.8. <U>Appraisal Shares</U><U>.</U> Notwithstanding anything in this Agreement to the contrary, shares (&#147;<U>Appraisal
Shares</U>&#148;) of Company Capital Stock that are outstanding immediately prior to the Effective Time and that are held by any Person who is entitled to demand and properly demands appraisal of such Appraisal Shares pursuant to, and who complies
in all respects with, Section&nbsp;262 of the DGCL (&#147;<U>Section</U><U></U><U>&nbsp;262</U>&#148;) shall not be converted into the right to receive the payments contemplated by this <U>Article II</U>, and instead, such Appraisal Shares shall
automatically be cancelled and shall cease to exist and the holders of such Appraisal Shares shall cease to have any rights with respect thereto except such rights as may be granted to such holders pursuant to Section&nbsp;262; <U>provided</U>,
<U>however</U>, that if any such holder shall fail to perfect or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
otherwise shall waive, withdraw or lose the right to appraisal under Section&nbsp;262, then such Appraisal Shares shall be deemed to have been converted as of the Effective Time into, and to have
become exchangeable solely for the right to receive, the payments contemplated by this <U>Article II</U>. The Company shall provide prompt notice to Buyer of any demands received by the Company for appraisal of any shares of Company Capital Stock,
withdrawals of such demands and any other instruments served pursuant to Section&nbsp;262 received by the Company and Buyer shall have the right to participate in all negotiations and Proceedings with respect to such demands. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.9. <U>No Further Transfers</U>. After the Effective Time, there shall be no further registration of transfers on the stock
transfer books of the Surviving Corporation of shares of Company Capital Stock that were outstanding immediately prior to the Effective Time. If, after the Effective Time, any certificates formerly representing shares of Company Common Stock are
presented to the Surviving Corporation or the Paying Agent for any reason, they shall be cancelled and exchanged for payment as provided in this <U>Article II</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.10. <U>Withholding</U>. Notwithstanding anything in this Agreement to the contrary, Parent, Buyer, the Surviving Corporation,
the Paying Agent and the Escrow Agent (and any Affiliate thereof or any other withholding agent) shall be entitled to deduct and withhold from the amounts payable pursuant to this Agreement (including to any holder of Company Capital Stock), such
amounts as are required to be deducted and withheld with respect to the making of such payment under the Code, or under any provision of state, local or foreign Law. Any amount so deducted or withheld and duly paid over to the applicable Tax
authority shall be treated as having been paid to the Person in respect of which such deduction or withholding was made. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>REPRESENTATIONS AND WARRANTIES OF THE COMPANY </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise disclosed in the corresponding section of the letter (the &#147;<U>Company Disclosure Letter</U>&#148;) delivered to
Parent by the Company at the time of the execution of this Agreement (it being agreed that disclosure of any item in any section or subsection of the Company Disclosure Letter shall be deemed disclosure with respect to any other section or
subsection to which the relevance of such item is reasonably apparent), the Company represents and warrants to Parent, Buyer and Merger Sub as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1. <U>Organization</U><U> and Corporate Power</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The Company is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Delaware and has all
requisite corporate power and authority to own, lease and operate its properties and assets and to carry on its business as now being conducted, except where the failure to have such power or authority, individually or in the aggregate, has not had
and would not reasonably be expected to have a Company Material Adverse Effect. The Company is duly qualified or licensed to do business in each jurisdiction in which the nature of its business or the ownership, leasing or operation of its
properties makes such qualification or licensing necessary, except for those jurisdictions in which the failure to be so qualified or licensed, individually or in the aggregate, has not had and would not reasonably be expected to have, individually
or in the aggregate, a Company Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) The Company has made available to Parent copies of the Constituent Documents of the Company
as in effect on the date of this Agreement. The Company is not in material violation of any provision of its Constituent Documents. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)
Each of the Company Subsidiaries is a corporation or other legal entity duly incorporated or formed, validly existing and in good standing under the Laws of its respective jurisdiction of incorporation or formation and has all requisite corporate
power and authority to own, lease and operate its properties and assets and to carry on its business as now being conducted, except where the failure to have such power or authority, individually or in the aggregate, has not had and would not
reasonably be expected to have a Company Material Adverse Effect. Each of the Company Subsidiaries is duly qualified or licensed to do business in each jurisdiction in which the nature of its business or the ownership, leasing or operation of its
properties makes such qualification or licensing necessary, except for those jurisdictions in which the failure to be so qualified or licensed, individually or in the aggregate, has not had and would not reasonably be expected to have, individually
or in the aggregate, a Company Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) The Company has made available to Parent copies of the Constituent Documents
of each of the Company Subsidiaries, each as in effect on the date of this Agreement. None of the Company Subsidiaries is in material violation of any provision of its respective Constituent Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2. <U>Capitalization</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The authorized capital stock of the Company consists of 176,000,000 shares of common stock, par value $0.001 per share (the
&#147;<U>Company Common Stock</U>&#148;), 18,538,317 shares of Series A Preferred Stock, par value $0.001 per share (the &#147;<U>Series A Preferred Stock</U>&#148;), 44,841,670 shares of Series B Preferred Stock, par value $0.001 per share (the
&#147;<U>Series B Preferred Stock</U>&#148;), 45,000,000 shares of Series C Preferred Stock, par value $0.001 per share (the &#147;<U>Series C Preferred Stock</U>&#148;) and 8,731,958 shares of Series D Preferred Stock, par value $0.001 per share
(the &#147;<U>Series D Preferred Stock</U>&#148; and together with the Series A Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock, the &#147;<U>Company Preferred Stock</U>&#148; and together with the Company Common
Stock, the &#147;<U>Company Capital Stock</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) There are (i) 22,945,154 shares of Company Common Stock issued and outstanding
as of the date of this Agreement, (ii) 18,474,328 shares of Series A Preferred Stock issued and outstanding as of the date of this Agreement and 52,084 shares of Series A Preferred Stock issuable pursuant to warrant agreements with the Company (the
&#147;<U>Series A Warrants</U>&#148;), (iii) 44,841,670 shares of Series B Preferred Stock issued and outstanding as of the date of this Agreement, (iv) 40,124,353 shares of Series C Preferred Stock issued and outstanding as of the date of this
Agreement and 2,157,756 shares of Series C Preferred Stock issuable pursuant to warrant agreements with the Company (the &#147;<U>Series C Warrants</U>&#148;), (v) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
7,731,958 shares of Series D Preferred Stock issued and outstanding and (vi) 23,953,450 shares of Company Common Stock reserved for, and subject to issuance upon, the exercise of outstanding
Company Options (whether or not presently exercisable). All of the issued and outstanding shares of capital stock of the Company are duly authorized and validly issued and are fully paid, <FONT STYLE="white-space:nowrap">non-assessable</FONT> and
free of preemptive rights. No Subsidiary of the Company owns any shares of Company Capital Stock. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;(i) The Company does not have
any shares of Company Capital Stock or other equity interests outstanding except as set forth in <U>Section</U><U></U><U>&nbsp;3.2(b)</U>, (ii) neither the Company nor any Company Subsidiary has issued, granted or is bound by any outstanding
options, equity-based awards, equity-linked securities, phantom stock, warrants, puts, calls, subscription rights, preemptive rights, redemption rights or securities convertible or exchangeable into Company Capital Stock or other equity securities
of the Company or any Company Subsidiary except as set forth in <U>Section</U><U></U><U>&nbsp;3.2(b)</U> and (iii)&nbsp;neither the Company nor any Company Subsidiary is party to any Contract obligating the Company or any Company Subsidiary to
(A)&nbsp;issue, transfer or sell any shares of Company Capital Stock or other equity interests of the Company or any Company Subsidiary or securities convertible into or exchangeable or exercisable for such Company Capital Stock or equity interests,
(B)&nbsp;issue, grant or be bound by any options, equity-based awards, equity-linked securities, phantom stock, warrants, puts, calls, subscription rights, preemptive rights, redemption rights or securities convertible or exchangeable into Company
Capital Stock or equity securities of the Company or any Company Subsidiary or (C)&nbsp;redeem, repurchase or otherwise acquire any Company Capital Stock or equity securities of the Company or any Company Subsidiary. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <U>Section</U><U></U><U>&nbsp;3.2(d)</U> of the Company Disclosure Letter contains a correct and complete list of outstanding Company
Options, including the holder, the date of grant, term (where applicable), number of shares of Company Common Stock underlying such Company Options and exercise price. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) Set forth on <U>Section</U><U></U><U>&nbsp;3.2(e)</U> of the Company Disclosure Letter is each Contract to which the Company or any
Company Subsidiaries is a party that restricts the transfer of, that relates to (or that provide a proxy for) the voting of, or that provides registration rights in respect of, the shares of Company Capital Stock or other equity interest of the
Company or any Company Subsidiary. There are no bonds, debentures, notes or other indebtedness of the Company or any of the Company Subsidiaries having the right to vote (or convertible into, or exchangeable for, securities having the right to vote)
on any matters on which holders of the Company Capital Stock may vote. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) <U>Section</U><U></U><U>&nbsp;3.2(f)</U> of the Company
Disclosure Letter sets forth a complete list of each Company Subsidiary, together with its jurisdiction of incorporation or formation and the ownership interest of the Company (or another Company Subsidiary) in such Company Subsidiary. The Company
and the Company Subsidiaries own, directly or indirectly, all of the issued and outstanding shares of capital stock or other equity interests of each of the Company Subsidiaries, free and clear of any Liens, other than transfer and other
restrictions under applicable securities Laws, and all of such outstanding shares of stock or other equity securities have been duly authorized and validly issued and are fully paid, <FONT STYLE="white-space:nowrap">non-assessable</FONT> and free of
preemptive rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) The Company and the Company Subsidiaries do not own, directly or indirectly, any capital
stock or equity interests of any other Person (other than the Company Subsidiaries). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3. <U>Authority</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The Company has all requisite corporate power and authority to execute and deliver this Agreement, to perform its obligations under this
Agreement and, subject to obtaining the Company Stockholder Approval, to consummate the Merger and the other transactions contemplated hereby. The execution, delivery and performance by the Company of this Agreement and the consummation by the
Company of the Merger and the other transactions contemplated hereby have been duly authorized by all necessary corporate action on the part of the Company, subject, in the case of the effectuation of the Merger, to receipt of the Company
Stockholder Approval. The Company has duly executed and delivered this Agreement and, assuming the due authorization, execution and delivery by Parent, Buyer, and Merger Sub of this Agreement, this Agreement constitutes the Company&#146;s legal,
valid and binding obligation, enforceable against it in accordance with its terms, except as limited by bankruptcy, insolvency, reorganization or similar Laws affecting creditors&#146; rights generally and by general principles of equity (the
&#147;<U>Enforceability Limitations</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) The Company Board, at a meeting duly called and held, unanimously adopted resolutions
(i)&nbsp;declaring that this Agreement and the transactions contemplated hereby, including the Merger, are fair to and in the best interests of the Company and the Company&#146;s stockholders, (ii)&nbsp;approving and declaring this Agreement and the
transactions contemplated hereby, including the Merger, advisable and (iii)&nbsp;recommending that the Company&#146;s stockholders adopt this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4. <U>Consents and Approvals; No Conflicts</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) No consent, approval, clearance, permit or authorization of, or registration or filing with, or notice to, any Governmental Entity is
required to be made or obtained by the Company or any Company Subsidiary in connection with the execution or delivery of this Agreement or the consummation of the transactions contemplated by this Agreement, except for (i)&nbsp;any notices or
filings by the Company with the HSR Act and the expiration or termination of any applicable waiting periods (or approval) thereunder, (ii)&nbsp;the filing of the Certificate of Merger with the Secretary of State of the State of Delaware in
accordance with the DGCL and (iii)&nbsp;the consents and approvals of the Governmental Entities set forth in <U>Section</U><U></U><U>&nbsp;3.4(a)</U> of the Company Disclosure Letter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) The execution, delivery and performance of this Agreement by the Company does not, and the consummation by the Company of the transactions
contemplated hereby will not: (i)&nbsp;conflict with or violate any provision of the Constituent Documents of the Company or any Company Subsidiary (assuming the Company Stockholder Approval is obtained), or (ii)&nbsp;assuming the filings, consents,
approvals and waiting periods referred to in <U>Section</U><U></U><U>&nbsp;3.4(a)</U> are duly made, obtained or satisfied and the Company Stockholder Approval is obtained (A)&nbsp;violate any Law or Order, in either case, applicable to the Company
or any Company Subsidiaries or any of their respective properties or assets or (B)&nbsp;violate, conflict with, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
result in the loss of any benefit under, require a payment or incur a penalty under, constitute a default (or an event which, with notice or lapse of time, or both, would constitute a default)
under, result in the termination of or a right of termination or cancellation under, accelerate the performance required by, or result in the creation of any Lien upon any of the respective properties or assets of the Company or any Company
Subsidiaries under, any Material Contract except, in the case of this clause (ii), for such matters as, individually or in the aggregate, have not had and would not reasonably be expected to result in material liability to the Company and the
Company Subsidiaries, taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5. <U>Financial Statements and Undisclosed Liabilities</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Section</U><U></U><U>&nbsp;3.5</U> of the Company Disclosure Letter sets forth true and correct copies of: (i)&nbsp;the Company&#146;s
audited consolidated balance sheets as of December&nbsp;31, 2016, December&nbsp;31, 2015 and December&nbsp;31, 2014 and statements of cash flows and changes in stockholders&#146; equity for the fiscal years ended December&nbsp;31, 2016,
December&nbsp;31, 2015 and December&nbsp;31, 2014 (the &#147;<U>Audited Financial Statements</U>&#148;); and (ii)&nbsp;the Company&#146;s unaudited consolidated balance sheet as of June&nbsp;30, 2017 (the &#147;<U>Balance Sheet Date</U>&#148;), and
the related statements of income or operations for the six months ended June&nbsp;30, 2017 (the &#147;<U>Unaudited Financial Statements</U>&#148;, together with the Audited Financial Statements, the &#147;<U>Financial Statements</U>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) The Financial Statement (i)&nbsp;have been derived from the accounting books and records of the Company and the Company Subsidiaries,
(ii)&nbsp;have been prepared in accordance with GAAP applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto) and (iii)&nbsp;fairly present, in all material respects, the consolidated financial
position of the Company and the Company Subsidiaries and the consolidated results of operations, stockholders&#146; equity and cash flows as of the dates and for the respective periods indicated (subject, in the case of the Unaudited Financial
Statements, to normal <FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments and the absence of notes, none of which individually or in the aggregate are material). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) The Company maintains internal controls over financial reporting that are designed to provide reasonable assurance that transactions are
recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the Company and the Company Subsidiaries are being made only in accordance with authorization of management and
directors of the Company and that are designed to provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&#146;s (or the Company Subsidiaries&#146;) assets that could have
a material effect on the Company&#146;s financial statements. The Company is not aware of any deficiencies in the design or operation of the internal control over financial reporting. Since January&nbsp;1, 2014, the Company has not identified and
has not been advised by the Company&#146;s auditors of any fraud or allegation of fraud, whether or not material, that involves management or other employees of the Company who have a role in the Company&#146;s or any of its Subsidiaries internal
controls over financial reporting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) The Company and the Company Subsidiaries do not have any liabilities or obligations of any
nature (whether absolute, contingent, accrued or otherwise) that would be required to be disclosed on balance sheet prepared in accordance with GAAP, except for those liabilities and obligations (i)&nbsp;reflected or reserved against in the last
balance sheet contained in the Unaudited Financial Statements, (ii)&nbsp;incurred since the Balance Sheet Date in the ordinary course of business consistent with past practice, (iii)&nbsp;incurred in accordance with the transactions contemplated by
this Agreement, (iv)&nbsp;that are executory obligations under Contracts, or (v)&nbsp;that, individually or in the aggregate, would not reasonably be expected to be material to the Company and the Company Subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6. <U>Absence of Certain Changes or Events</U>. Since the Balance Sheet Date through the date of this Agreement, (a)&nbsp;there
has not been any event, change, condition, occurrence or effect, that, individually or in the aggregate, has had or would reasonably be expected to have a Company Material Adverse Effect and (b)&nbsp;the Company and the Company Subsidiaries have
conducted their businesses in all material respects in the ordinary course of business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7. <U>Legal Proceedings</U>. There
are no Proceedings pending, or to the Knowledge of the Company, threatened against the Company or any of the Company Subsidiaries or any of their respective assets, rights or properties or any of the officers or directors of the Company or any of
the Company Subsidiaries, except, in each case, for those Proceedings that, individually or in the aggregate, would not reasonably be expected to result in material liability to the Company and the Company Subsidiaries, taken as a whole, or prevent,
materially delay or materially impair the Company&#146;s ability to consummate the transactions contemplated by this Agreement. Neither the Company nor any of the Company Subsidiaries nor any of their respective properties, rights or assets is or
are subject to any Order, except for those Orders that, individually or in the aggregate, would not reasonably be expected to (a)&nbsp;result in material liability to the Company and the Company Subsidiaries, taken as a whole, (b)&nbsp;impose
material restrictions or limitations on the business or operations of the Company or any Company Subsidiary or (c)&nbsp;prevent, materially delay or materially impair the Company&#146;s ability to consummate the transactions contemplated by this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.8. <U>Compliance with Laws; Permits</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The Company and the Company Subsidiaries are, and since January&nbsp;1, 2014 have been, in compliance with all (and have not violated any)
applicable Laws and Orders, except for any failure to comply or violation that, individually or in the aggregate, would not reasonably be expected to (a)&nbsp;result in material liability to the Company and the Company Subsidiaries, taken as a
whole, (b)&nbsp;impose material restrictions or limitations on the business or operations of the Company or any Company Subsidiary or (c)&nbsp;prevent, materially delay or materially impair the Company&#146;s ability to consummate the transactions
contemplated by this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Since January&nbsp;1, 2014 through the date of this Agreement, neither the Company nor any Company
Subsidiary has received any written notice, subpoena, written demand, or written inquiry from a Governmental Entity alleging <FONT STYLE="white-space:nowrap">non-compliance</FONT> with or violation of any Law, Order or Permit. To the Knowledge of
the Company, (i)&nbsp;no investigation (whether civil, criminal, administrative, investigative, formal or informal) by any Governmental Entity with respect to the Company or any Company Subsidiary is pending or threatened, nor (ii)&nbsp;has any
Governmental Entity notified the Company in writing of an intention to conduct the same. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) The Company and each of the Company Subsidiaries hold and are in compliance with, and since
January&nbsp;1, 2014 have held and have been in compliance with, all Permits necessary for the lawful conduct of their business and the ownership and use of their properties and assets and each of such Permits is valid and in full force and effect,
except where the failure to so hold or be in compliance with such Permit, individually or in the aggregate, would not reasonably be expected to (a)&nbsp;result in material liability to the Company and the Company Subsidiaries, taken as a whole,
(b)&nbsp;impose material restrictions or limitations on the business or operations of the Company or any Company Subsidiary or (c)&nbsp;prevent, materially delay or materially impair the Company&#146;s ability to consummate the transactions
contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.9. <U>Company Material Contracts</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Except as set forth in <U>Section</U><U></U><U>&nbsp;3.9(a)</U> of the Company Disclosure Letter, neither the Company nor any of the
Company Subsidiaries is, as of the date of this Agreement, a party to or bound by any Contract in effect as of the date of this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;(A) with a customer or distributor that involved individual or aggregate payments or consideration to the Company or
the Company Subsidiaries of more than $400,000 in the <FONT STYLE="white-space:nowrap">12-month</FONT> period ending on December&nbsp;31, 2016 from such customer and its Affiliates or (B)&nbsp;with a supplier that involved individual or aggregate
payments or consideration by the Company or the Company Subsidiaries to such supplier and its Affiliates of more than $400,000 in the <FONT STYLE="white-space:nowrap">12-month</FONT> period ending on December&nbsp;31, 2016; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;(A) that limits in any material respect the freedom of the Company or any Company Subsidiary to compete in any line
of business, area or geographic region, or with any Person, including any Contract that requires the Company and any Company Subsidiary to work exclusively with any Person in any area or geographic region, or which by its terms would so limit the
freedom of Parent or any of its Subsidiaries after the Effective Time, (B)&nbsp;that provides for &#147;most favored nation&#148; rights with respect to pricing (or other terms) to another Person or (C)&nbsp;that provides for exclusive or preferred
purchasing arrangements or other provisions obligating the Company or Company Subsidiary to obtain its requirements for, or a minimum quantity of, certain products exclusively from any Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) that relates to any joint venture, legal partnership, limited liability or other similar agreement or arrangements
relating to the formation, creation, operation, management or control of any joint venture or legal partnership, in each case in which Company or any Company Subsidiary will be a party (other than with or among wholly-owned Company Subsidiaries);
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) that (A)&nbsp;is a credit agreement, loan agreement, indenture, security
agreement, guarantee, note, mortgage or other Contract providing for or securing Indebtedness (or guaranteeing the Indebtedness of another Person), (B)&nbsp;(x) grants a Lien (other than a Permitted Lien) or (y)&nbsp;restricts the granting of Liens
on any property or asset that is material to the Company and the Company Subsidiaries, taken as a whole, (C)&nbsp;provides for or relates to any interest, currency or hedging, derivatives or similar Contracts or (D)&nbsp;restricts payment of
dividends or any distributions in respect of the equity interests of the Company or any of the Company Subsidiaries, <U>provided</U>, that clause (B)(y) shall be disregarded for purposes of <U>Section</U><U></U><U>&nbsp;5.1</U>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) that relates to, involves or provides for the settlement of any current or former claim (A)&nbsp;which Contract materially
restricts or imposes material obligations after the date of this Agreement upon the Company and the Company Subsidiaries, taken as a whole, or (B)&nbsp;which Contract would require the Company or the Company Subsidiaries to pay consideration of more
than $50,000 after the date of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) that is between (A)&nbsp;the Company or any of the Company
Subsidiaries, on the one hand, and (B)&nbsp;any of directors or officers of the Company or the Company Subsidiaries (other than any compensatory arrangements, indemnification agreements and related Contracts with such officers) or holders of Company
Capital Stock (or any Affiliates of such holders or any employees, officers or directors thereof) (other than restricted stock purchase agreements and similar Contracts executed substantially on the Company&#146;s standard forms), on the other hand;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) that grants any rights of first refusal, rights of first offer or other similar rights to any Person with respect
to any material asset of the Company and the Company Subsidiaries, taken as a whole, or that contains a put, call or similar right pursuant to which the Company or any Company Subsidiary could be required to purchase or sell, as applicable, any
equity interests of any Person; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) that is for the acquisition or disposition (by merger, stock purchase or
otherwise), of equity interests of any Person, pursuant to which the Company or any Company Subsidiary has continuing &#147;earn out&#148;, indemnification or other contingent obligations outstanding; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) that obligates as of the date hereof the Company of any of the Company Subsidiaries to make any capital expenditure or
investment not contemplated by the Capital Expenditure Budget in excess of&nbsp; $200,000; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) that requires the Company
or any of the Company Subsidiaries to provide any funds to or make any investment in (in each case, in the form of a loan, capital contribution or similar transaction) any Person (other than Company Subsidiaries); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi) under which the Company or any Company Subsidiary is granted any license, option or other right or immunity (including a
covenant not to be sued or right to enforce or prosecute any patents) with respect to any Intellectual Property of a third party, which Contract is material to the Company and the Company Subsidiaries, taken as a whole any Contract, but excluding
licenses for commercially available, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf</FONT></FONT> software (including software used by third parties to provide services through software as a service (SaaS)
arrangements); or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii) under which (A)&nbsp;the Company or the Company Subsidiaries leases from
any other Person any equipment or other tangible personal property providing for annual payments by the Company or the Company Subsidiaries in excess of&nbsp; $200,000 or (B)&nbsp;the Company or the Company Subsidiaries leases or sublease any real
property to any other Person; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiii) except to the extent such Contract is described in clauses (i)&nbsp;through (xii)
above (including any Contracts with customers, distributors or suppliers of the Company or the Company Subsidiaries), that calls for aggregate payments by, or other consideration from (or aggregate payments, or other consideration, to) the Company
or the Company Subsidiaries of more than $200,000. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) The Contracts required to be listed in <U>Section</U><U></U><U>&nbsp;3.9(a)</U> of
the Company Disclosure Letter are together referred to herein as the &#147;<U>Material Contracts</U>.&#148; The Company has made available to Parent true, correct and complete copies of each Material Contract, including any schedules, exhibits and
amendments thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;(i) Each Material Contract is valid and binding on the Company or a Company Subsidiary and is in full force
and effect, and, to the Knowledge of the Company, is valid and binding on the other parties thereto, subject to the Enforceability Limitations, in each case other than any Material Contract that expires or is terminated by the Company in accordance
with its terms following the date of this Agreement, and (ii)&nbsp;no event or condition exists which constitutes or, after notice or lapse of time or both, would constitute a breach or default on the part of the Company or any Company Subsidiary
under any Material Contract or, to the Knowledge of the Company, any other party thereto, except, in each case of clauses (i)&nbsp;through (ii), as has not had and would not reasonably be expected to have a Company Material Adverse Effect. As of the
date hereof, neither the Company nor any Company Subsidiary is or has been in a material dispute with a counterparty to a Material Contract or have received written notice from any other party to a Material Contract that such other party intends to
terminate or fail to renew any such Material Contract. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10. <U>Company Benefit Plans</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Section</U><U></U><U>&nbsp;3.10(a)</U> of the Company Disclosure Letter contains a true and complete list of all material Company
Benefit Plans; <U>provided</U>, that, with respect to any <FONT STYLE="white-space:nowrap">(i)&nbsp;at-will</FONT> employment or services agreement providing no (A)&nbsp;requirement for a termination notice period, (B)&nbsp;severance or other
post-termination payments or benefits (other than benefits continuation coverage required by law) or (C)&nbsp;change in control related payments or benefits, only forms of such agreements will be scheduled, and (ii)&nbsp;Company Option and other
equity award agreements, only forms of such agreements shall be scheduled (<U>provided</U> that a separate schedule providing any material terms, other than milestone or performance-based vesting conditions, that are not including in such forms is
provided to the Buyer). Any form scheduled pursuant to the immediately prior sentence is substantially the same as, and contains all material </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
terms of, any agreement such form represents. The Company has previously made available to Buyer, as applicable, current, accurate, true and complete copies of: (i)&nbsp;each material Company
Benefit Plan (or, to the extent no such copy exists, an accurate description thereof); (ii) each trust agreement, administrative agreement, insurance policy or other funding Contract related to each such Company Benefit Plan; (iii)&nbsp;the most
recent financial statements and the three most recent Forms 5500 with all attachments required to have been filed with respect to each such Company Benefit Plan; (iv)&nbsp;the most recently received IRS determination letters or opinion letters with
respect to any such Company Benefit Plans that is intended to qualify under Section&nbsp;401(a) of the Code, and any pending request for such letter; and (v)&nbsp;the most recent summary plan description for each such Company Benefit Plan, including
any summary of material modifications required under ERISA. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Each Company Benefit Plan has been established, operated and administered
in all material respects in compliance and in accordance with its terms and applicable Laws, including, but not limited to, ERISA, the Code and in each case the regulations thereunder. Each Company Benefit Plan that is intended to be qualified
within the meaning of Section&nbsp;401(a) of the Code is so qualified and has received a favorable determination letter as to its qualification, or if such Company Benefit Plan is a prototype plan, the opinion or notification letter for each such
Company Benefit Plan, and nothing has occurred that could reasonably be expected to cause the loss of such qualification. There are no material actions, suits or claims (other than routine claims for benefits in the normal course), investigations,
audits, inquiries or proceedings pending or, to the Knowledge of the Company, threatened by the IRS or any other Governmental Entity with respect to any Company Benefit Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) No event has occurred and to the Knowledge of the Company, no condition exists that would subject the Company, either directly or
indirectly by reason of its affiliation with any other member of their &#147;controlled group&#148; (defined as any organization which is a member of a controlled group of organizations within the meaning of Sections 414(b), (c), (m) or (o)&nbsp;of
the Code), to any material Tax, fine, lien, penalty or other liability imposed by ERISA, the Code or other applicable Laws relating to any employee benefit plan (as defined in Section&nbsp;3(3) of ERISA). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) No Company Benefit Plan is, and neither the Company nor any Company Subsidiary currently, or has ever, maintained, contributed to, been
required to contribute to or otherwise had any liability or obligations (contingent or otherwise) with respect to (i)&nbsp;any &#147;employee pension plan,&#148; as defined in Section&nbsp;3(2) of ERISA, that is subject to Title IV of ERISA or
Section&nbsp;412 or Section&nbsp;4971 of the Code, (ii)&nbsp;any &#147;multiemployer plan&#148; (as defined in ERISA Section&nbsp;3(37)), or (iii)&nbsp;a &#147;nonqualified deferred compensation plan&#148; within the meaning of Section&nbsp;409A of
the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) No Company Benefit Plan provides for medical or welfare benefits (through insurance or otherwise), or for the continuation
of such benefits or coverage, in any case, after retirement or other termination of employment, except as may be required by Part 6 of Subtitle B of Title I of ERISA and Section&nbsp;4980B of the Code or similar state or foreign Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) Except as set forth in <U>Section</U><U></U><U>&nbsp;3.10(</U><U>f)</U> of the Company
Disclosure Letter, neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated by this Agreement (either alone or in conjunction with any other event) will, or could reasonably be expected to result in
(i)&nbsp;any payment (including severance, unemployment compensation, forgiveness of Indebtedness or otherwise) becoming due to any current or former Company Employee under any Company Benefit Plan or otherwise, (ii)&nbsp;the acceleration of the
time of payment or vesting, or increase the amount of compensation or benefits otherwise payable or due to any current or former Company Employee, (iii)&nbsp;an obligation to fund or otherwise set aside assets to secure to any extent any of the
obligations under any Company Benefit Plan or (iv)&nbsp;limiting or restricting the right to amend, terminate or transfer the assets of any Company Benefit Plan on or following the Effective Time. No amount paid or payable as a result of the
execution and delivery of this Agreement and the consummation of the transactions contemplated by this Agreement (either alone or in conjunction with any other event) will result in any &#147;excess parachute payment&#148; (within the meaning of
Section&nbsp;280G of the Code). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) Each Company Option has been granted with a per share exercise price at least equal to the fair
market value of the underlying equity on the date of grant, and have not otherwise been subject to &#147;modification&#148; or &#147;extension&#148; within the meaning of Section&nbsp;409A of the Code and associated Treasury Department guidance.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) No Company Benefit Plan is maintained outside the jurisdiction of the United States, or covers any employee residing or working
outside of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11. <U>Labor Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) There are, and since January&nbsp;1, 2014 have been, no effort being made or threatened by or on behalf of any labor union, works council,
employee committee or representative or other labor organization to authorize representation of any employees of the Company or any Company Subsidiary by any labor organization. Since January&nbsp;1, 2014 no petition has been filed, nor has any
Proceeding been instituted by any employee of the Company or any Company Subsidiary, group of employees of the Company or any Company Subsidiary, or labor organization with any labor relations board or commission seeking recognition of a collective
bargaining or similar representative. Neither the Company nor any Company Subsidiary is a party to or otherwise bound by any collective bargaining agreement or other contract or agreement with any labor organization or other representative of any
employees of the Company or any Company Subsidiary, nor is any such contract or agreement presently being negotiated. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Neither the
Company nor any Company Subsidiary has closed any plant or facility, effectuated any layoffs of employees or implemented any early retirement, separation or window program within the past three years, nor has the Company or any Company Subsidiary
planned or announced any such action or program for the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.12. <U>Taxes</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The Company and the Company Subsidiaries have timely filed (or caused to be timely filed) all income and other material Tax Returns
required to be filed by them, and all such Tax Returns are true, correct and complete in all material respects. The Company and the Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Subsidiaries have paid (or caused to be paid) all income and other material Taxes due and payable by them and have withheld and paid all material Taxes that the Company or any of the Company
Subsidiaries are obligated to withhold from amounts owing to any employee, former employee, independent contractor, shareholder, creditor or any other Person. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) No material deficiency for any Tax has been asserted or assessed against the Company or any of the Company Subsidiaries by a Tax authority
in writing, other than any deficiency that has been fully paid, settled or withdrawn. Neither the Company nor any Company Subsidiary has waived any statute of limitations or agreed to any extension of time with respect to a material Tax assessment
or deficiency. There are no Liens for Taxes on the assets of the Company or any Company Subsidiary other than Permitted Liens. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) No
audit, examination, investigation or other proceeding in respect of any material Taxes or any income or other material Tax Return of the Company or any of the Company Subsidiaries is currently pending or threatened in writing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) Neither the Company nor any of the Company Subsidiaries (i)&nbsp;is or has been a member of a group (other than a group which includes
only the Company and/or the Company Subsidiaries) filing a consolidated, combined, affiliated, unitary or similar income Tax Return or (ii)&nbsp;has any liability for Taxes of any Person (other than the Company or any Company Subsidiary) arising
from the application of Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any similar provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Law), as a transferee or successor, or otherwise
by operation of Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) Neither the Company nor any of the Company Subsidiaries is a party to or bound by or has any obligation under
any Tax allocation, sharing, indemnity, reimbursement or similar agreement or arrangement (other than any customary Tax indemnification provisions in ordinary course commercial agreements the primary subject matter of which is not Tax matters). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) No written claim has been made by any Tax authority in a jurisdiction where the Company or any of the Company Subsidiaries has not filed a
Tax Return that it is or may be subject to Tax by, or required to file Tax Returns in, such jurisdiction, other than any such claims that have been fully resolved. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) None of the Company or any of the Company Subsidiaries has been either a &#147;distributing corporation&#148; or a &#147;controlled
corporation&#148; in a distribution in which the parties to such distribution treated the distribution as one to which Section&nbsp;355 of the Code is applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) Neither the Company nor any of the Company Subsidiaries has participated in a &#147;listed transaction&#148; within the meaning of
Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.6011-4(b)</FONT> (or any similar provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Law). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Neither the Company nor any of the Company Subsidiaries will be required to include a material item of income (or exclude a material item
of deduction) in any taxable period (or portion thereof) beginning after the Closing Date as a result of (i)&nbsp;a change in or incorrect method of accounting occurring prior to the Closing Date, (ii)&nbsp;an installment sale or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
open transaction arising in a taxable period (or portion thereof) ending on or before the Closing Date, (iii)&nbsp;a prepaid amount received, or paid, prior to the Closing Date, (iv)&nbsp;a
&#147;closing agreement&#148; as described in Section&nbsp;7121 of the Code (or any similar provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Law) executed on or prior to the Closing Date, (v)&nbsp;any intercompany
transactions or any excess loss account described in Treasury Regulations under Section&nbsp;1502 of the Code (or any similar provision of state, local or foreign Law) with respect to a transaction occurring on or prior to the Closing Date or
(vi)&nbsp;an election under Section&nbsp;108(i) of the Code (or any similar provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Law) made on or prior to the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.13. <U>Intellectual Property</U>.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP><U>Section</U><U></U><U>&nbsp;3.13</U>
of the Company Disclosure Letter contains a complete and correct list, as of the date of this Agreement, of all current or previously registered Intellectual Property and all pending applications therefor owned or exclusively licensed by Company or
a Company Subsidiary. To the Knowledge of the Company, all unexpired registered Intellectual Property is valid and enforceable. As of the date of this Agreement, all unexpired registered Intellectual Property and pending applications are not subject
to any pending or, to the Knowledge of the Company, threatened claim challenging their validity or enforceability. To the Knowledge of the Company, the Company or a Company Subsidiary is the sole owner of the items listed above, free and clear of
all Liens and either the Company or a Company Subsidiary owns, is licensed, can acquire on reasonable terms or otherwise possesses the right to use, all Intellectual Property used in their respective businesses as currently or previously conducted.
Except as set forth on <U>Section</U><U></U><U>&nbsp;3.13</U> of the Company Disclosure Letter, (i)&nbsp;as of the date of this Agreement, there are no claims or other Proceedings pending or threatened in writing against the Company or any Company
Subsidiary by any Person alleging that the conduct of the businesses of the Company and the Company Subsidiaries as currently or previously conducted would infringe upon any Intellectual Property right of any Person in the jurisdictions in which the
Company and the Company Subsidiaries have operations, (ii)&nbsp;to the Knowledge of the Company, the Company and the Company Subsidiaries are not committing and have not committed any such infringement; and (iii)&nbsp;the Company and the Company
Subsidiaries take reasonable efforts to protect their trade secrets. As of the date hereof, neither the Company nor any of the Company Subsidiaries has made any claim of a violation or infringement by others of its rights to or in connection with
the Intellectual Property used in their respective businesses. To the Knowledge of the Company, no other party is infringing, misappropriating, diluting or otherwise violating the Company&#146;s Intellectual Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.14. <U>Environmental Matters</U>. (a) There are no Materials of Environmental Concern present at or affecting any real property
currently or formerly owned, leased or operated by the Company or the Company Subsidiaries or, to the Knowledge of the Company, any other real property, that in each case would reasonably be expected to result in a material liability to the Company
or any Company Subsidiary, taken as a whole, (b)&nbsp;neither the Company nor the Company Subsidiaries has caused any condition at any location that has resulted in or could reasonably be expected to result in a material liability or other material
obligation of the Company or any Company Subsidiary, taken as a whole (i)&nbsp;under any applicable Laws protecting the environment, quality of the ambient air, soil, surface water or groundwater, or natural resources or protecting human health and
safety as relates to exposure to Material of Environmental Concern (&#147;<U>Environmental Laws</U>&#148;) or (ii)&nbsp;regarding any Materials of Environmental Concern and (c)&nbsp;neither the Company nor any of the Company Subsidiaries has
expressly assumed or retained, by contract or operation of law, any material liabilities of another Person arising under any Environmental Laws or concerning any Materials of Environmental Concern. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.15. <U>Real Property</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Section</U><U></U><U>&nbsp;3.15(a)</U> of the Company Disclosure Letter identifies all leases, subleases, licenses and other occupancy
agreements in effect as of the date hereof pursuant to which the Company or a Subsidiary occupies real property (the &#147;<U>Leases</U>&#148;). Except as, individually or in the aggregate, has not had and would not reasonably be expected to have a
Company Material Adverse Effect: (i)&nbsp;each Lease is valid, in full force and effect and enforceable against the Company or Company Subsidiary that is party thereto and (ii)&nbsp;the Company and the Company Subsidiaries are not in default (and
there is no event or condition that after notice or lapse of time or both would constitute a default by the Company or any Company Subsidiary) under any Lease and, to the Knowledge of the Company, there is no default (or event or condition that
after notice or lapse of time or both would constitute a default) by any other party thereto under any Lease. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Neither the Company nor
any Company Subsidiaries own any real property or interests in real property or any options to acquire such real property or interests therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.16. <U>Insurance</U>. <U>Section</U><U></U><U>&nbsp;3.16</U> of the Company Disclosure Letter sets forth a list (including name
of insurer, agent, coverage and expiration date) of all insurance policies in force on the date hereof with respect to the business and assets of the Company and the Company Subsidiaries. The Company and the Company Subsidiaries are in material
compliance with their insurance policies and are not in material breach or default under any of the terms thereof. Each such policy is outstanding and in full force and effect and no insurer has refused, denied or disputed coverage of any
outstanding claim made thereunder. All premiums and other payments due under any such policy have been paid, and all claims thereunder have been filed in due and timely fashion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.17. <U>Certain Regulatory Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;(i) Each of the Company and each Company Subsidiary holds, and is operating in compliance in all material respects with, all Permits
of the U.S. Food and Drug Administration (the &#147;<U>FDA</U>&#148;) and comparable foreign Governmental Entities required for the conduct of its respective business as currently conducted (collectively, the &#147;<U>FDA Permits</U>&#148;),
including, but not limited to, <FONT STYLE="white-space:nowrap">pre-market</FONT> notifications under section 510(k) of the Federal Food, Drug and Cosmetic Act (21 U.S.C. &#167; 360(k)) (&#147;<U>510(k)&#146;s </U>&#148;) and <FONT
STYLE="white-space:nowrap">pre-market</FONT> approval applications approved in accordance with 21 U.S.C. &#167; 360(e) (&#147;<U>PMA&#146;s</U>&#148;), and all such FDA Permits are in full force and effect; (ii)&nbsp;all of the 510(k)&#146;s and
PMA&#146;s, or change the marketing classification or labeling of any such products for product of the Company and the Company Subsidiaries are exclusively owned by the Company or one of the Company Subsidiaries, and the FDA has not threatened in
writing to suspend or revoke any such 510(k)&#146;s or PMA&#146;s and (iii)&nbsp;the manufacture, distribution, and marketing of the Company&#146;s products (including components thereof) is in material compliance with all FDA Permits. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Since January&nbsp;1, 2014, each of the Company and each Company Subsidiary has operated and
currently is in compliance in all material respects with applicable (i)&nbsp;Laws administered or enforced by the FDA; (ii)&nbsp;Laws relating to the Medicare and Medicaid programs, any other federal healthcare programs, any state healthcare or
health insurance programs; (iii)&nbsp;Laws relating to healthcare fraud and abuse, including, without limitation, the federal Anti-Kickback Statute (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7b(b)),</FONT> the federal False Claims Act
(31 U.S.C. &#167;&#167; 3729 et seq.), the federal Stark Law (42 U.S.C. &#167; 1395nn), the federal False Statements Statute (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7b(a)),</FONT> the Exclusion Laws (42 U.S.C. &#167; <FONT
STYLE="white-space:nowrap">1320a-7),</FONT> the Beneficiary Inducement Statute (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7a(a)(5)),</FONT> and the Civil Monetary Penalties Law (42 U.S.C. &#167;
<FONT STYLE="white-space:nowrap">1320a-7a);</FONT> (iv) Laws relating to billing or claims for reimbursement submitted to any government or third-party payor; (v)&nbsp;any other applicable Laws relating to fraudulent, abusive or unlawful practices
connected in any way with the provision or marketing of healthcare items or services; (vi)&nbsp;federal Physician Payment Sunshine Act (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7h)</FONT> and similar state gift and disclosure laws;
and (vii)&nbsp;Laws relating to health information privacy, including, but not limited to, the Health Insurance Portability and Accountability Act of 1996 and the Health Information Technology for Economic and Clinical Health Act of 2009. To the
Knowledge of the Company, since January&nbsp;1, 2014, there has been no material false or misleading information or material omission in any applications, submissions, or reports submitted by the Company to any Governmental Entity, including the
FDA, in violation in any material respect of any applicable Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Since January&nbsp;1, 2014, neither the Company nor any Company
Subsidiary has received any written notice from the FDA alleging that any operation or activity of the Company or any Company Subsidiary is in material violation of any applicable Law, nor received any &#147;warning letters,&#148; &#147;untitled
letters,&#148; or similar communications from the FDA or comparable Governmental Entity. Since January&nbsp;1, 2014, there have been no recalls, detentions, withdrawals, seizures, field notifications or corrections, field alerts, or termination or
suspension of manufacturing requested or, to the Knowledge of the Company&#146;s, threatened relating to the Company or any Company Subsidiary. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) The clinical, <FONT STYLE="white-space:nowrap">pre-clinical</FONT> and other studies and tests conducted by, or on behalf of or sponsored
by the Company or any Company Subsidiary and submitted to regulatory authorities to support regulatory clearance or approval of Company product were since January&nbsp;1, 2014 and, if still pending, are being conducted in all material respect in
accordance with applicable Laws, including, but not limited to, the Federal Food, Drug and Cosmetic Act and its applicable implementing regulations at 21 C.F.R. Parts 50, 54, 56, 58 and 812. Since January&nbsp;1, 2014, no investigational device
exemption filed by or on behalf of the Company or any Company Subsidiary with the FDA has been terminated or suspended by the FDA, and the FDA has not commenced, or threatened to initiate, any action to place a clinical hold order on, or otherwise
terminate or suspend, any proposed or ongoing clinical investigation conducted or proposed to be conducted by or on behalf of the Company or any Company Subsidiary. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) Since January&nbsp;1, 2014, neither the Company nor any Company Subsidiary has received any written notice from the FDA of any pending or
threatened investigation in respect of the Company, any Company Subsidiary or any of the Company directors, officers, and employees, or any products of the Company or any Company Subsidiary, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
pursuant to the FDA&#146;s &#147;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#148; Final Policy set forth in 56 Fed. Reg. 46191 (September 10, 1991) and any
amendments thereto. None of the Company, the Company Subsidiaries nor, to the Knowledge of the Company, any of their respective officers, employees or agents has been convicted of any crime or engaged in any conduct that could result in a material
debarment or exclusion under 21 U.S.C. Section&nbsp;335a. Since January&nbsp;1, 2014, neither the Company nor any Company Subsidiary has received any written notice of any pending or threatened claims, actions, proceedings or investigations that
would reasonably be expected to result in such a material debarment or exclusion against the Company, any of the Company Subsidiaries or any of their respective officers, employees or agents. Neither the Company nor any Company Subsidiary
(i)&nbsp;is a party to a Corporate Integrity Agreement with the U.S. Department of Health and Human Services Office of Inspector General, or (ii)&nbsp;has had any reporting obligations pursuant to any settlement, deferred prosecution, consent
decree, or any other agreement entered into with any Governmental Entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.18. <U>Inventory</U>. All material inventory of
raw materials, components, and final finished products are in good and usable condition, has been manufactured and stored in accordance with applicable good manufacturing practices in all material respects and can reasonably be anticipated to be
used and consumed in the ordinary course of business consistent with past practice, except for obsolete, damaged, defective or slow-moving items that have been or will be, as applicable, written off or written down to fair market value and, in each
case, for which adequate reserves in accordance with GAAP have been established to the extent required by GAAP. The Company has accurate records of the location of all such material inventory and the expiration dates for all such material inventory,
if applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.19. <U>Product Liability</U>. There are no (a)&nbsp;outstanding or, to the Knowledge of the Company,
threatened, claims for or based upon breach of product or service warranty, indemnity or guaranty or similar claim, strict liability in tort, negligent design of product, negligent provision of services, failure to warn or any other allegation of
liability, including or arising from the materials, design, testing, manufacture, packaging, labeling (including instructions for use), or sale of its Products or from the provision of services, in each case other than complaints by customers in the
ordinary course of business which have not resulted in any Proceedings or (b)&nbsp;to the Knowledge of the Company, design defects, failures to provide adequate warning, or manufacturing deficiencies that would provide a reasonable basis for any
product liability suit or similar claim or suit against the Company or any Company Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.20. <U>Transactions with
Affiliates</U>. Neither the Company, nor any of the Company Subsidiaries, is party to any Contract with any (i)&nbsp;officer or director of the Company or any Company Subsidiaries, other than as directly related to such person&#146;s employment or
service with the Company or any Company Subsidiary, (ii)&nbsp;Person that is the beneficial owner of five percent (5%) or more of the outstanding Company Capital Stock or (iii)&nbsp;Affiliate or family member of any such officer, director or
stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.21. <U>Stockholder Vote Required</U>. The Company Stockholder Approval is the only vote of holders of any
class or series of securities of the Company necessary to adopt this Agreement or to approve the Merger and the other transactions contemplated hereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.22. <U>Brokers</U>. Other than J.P. Morgan, neither the Company nor any of the
Company Subsidiaries has engaged any financial advisor, broker or finder or incurred any liability for any financial advisory fee, broker&#146;s fee, commission or finder&#146;s fee in connection with any of the transactions contemplated hereby.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.23. <U>No Other Representations or Warranties</U>. Except for the representations and warranties of Parent, Buyer, and
Merger Sub contained in <U>Article IV</U>, the Company acknowledges that neither Parent, Buyer, Merger Sub, nor any Person acting on their behalf makes any other express or any implied representations or warranties whatsoever and specifically (but
without limiting the generality of the foregoing) that neither Parent, Buyer, Merger Sub, nor any Person acting on their behalf makes any representation or warranty with respect to (i)&nbsp;Parent or any of its Affiliates, any of their businesses,
operations, assets, liabilities, condition (financial or otherwise) or prospects or any other matter relating to Parent or any of its Affiliates or (ii)&nbsp;any documentation, forecasts, budgets, projections, estimates or other information provided
by Parent or any Person acting on its behalf to the Company, any Affiliate of the Company or any Person acting on any of their behalf. The Company has not relied on any such information or any representation or warranty not set forth in <U>Article
IV</U>. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>REPRESENTATIONS AND WARRANTIES OF </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>PARENT, BUYER, AND MERGER SUB </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise disclosed in the corresponding section of the letter (the &#147;<U>Parent Disclosure Letter</U>&#148;) delivered to the
Company by Parent at the time of the execution of this Agreement (it being agreed that disclosure of any item in any section or subsection of the Parent Disclosure Letter shall be deemed disclosure with respect to any other section or subsection to
which the relevance of such item is reasonably apparent) or as disclosed in any forms, reports, schedules, statements and documents filed or furnished by Parent with or to the SEC on or after January&nbsp;1, 2016 and prior to the date of this
Agreement (excluding any risk factor disclosures contained under the heading &#147;Risk Factors&#148; and any disclosure of risks or other matters included in any &#147;forward-looking statements&#148; disclaimer or other statements that are
cautionary, predictive or forward-looking in nature), Parent, Buyer and Merger Sub represent and warrant to the Company as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1. <U>Organization and Corporate Power</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Parent is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Delaware, Buyer is a
private limited company duly incorporated and validly existing under the Laws of Ireland and Merger Sub is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Delaware and each of Parent, Buyer and
Merger Sub have all requisite corporate power and authority to own, lease and operate its properties and assets and to carry on its business as now being conducted, except where the failure to have such power or authority, individually or in the
aggregate, has not had and would not reasonably be expected to have a Parent Material Adverse Effect. Each of Parent and Merger Sub is duly qualified or licensed to do business and is in good standing in each jurisdiction in which the nature of its
business or the ownership, leasing or operation of its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
properties makes such qualification or licensing necessary, except for those jurisdictions in which the failure to be so qualified or licensed or to be in good standing, individually or in the
aggregate, has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Parent has made available to the Company copies of the Constituent Documents of Parent, Buyer and Merger Sub in effect on the date of this
Agreement. Each of Parent, Buyer and Merger Sub is not in violation of any provision of its Constituent Documents, except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse
Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Merger Sub was formed solely for the purposes of engaging in the transactions contemplated by this Agreement and Merger Sub
has not carried on any business or conducted any operations other than the execution of this Agreement, the performance of its obligations hereunder and matters ancillary thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2. <U>Authority</U>. Each of Parent, Buyer and Merger Sub has all requisite power and authority to execute and deliver this
Agreement, to perform its obligations under this Agreement and to consummate the Merger and the other transactions contemplated hereby. The execution, delivery and performance by each of Parent, Buyer and Merger Sub of this Agreement and the
consummation by Parent, Buyer and Merger Sub of the transactions contemplated hereby have been duly authorized by all necessary corporate action on the part of Parent, Buyer and Merger Sub. Each of Parent, Buyer and Merger Sub has duly executed and
delivered this Agreement and, assuming the due authorization, execution and delivery by the Company of this Agreement, this Agreement constitutes Parent&#146;s, Buyer&#146;s and Merger Sub&#146;s legal, valid and binding obligation, enforceable
against it in accordance with its terms, except as limited by the Enforceability Limitations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3. <U>Consents and
Approvals; No Conflicts</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) No consent, approval, clearance, permit or authorization of, or registration or filing with, or notice
to, any Governmental Entity is required to be made or obtained by Parent, Buyer or any Affiliate thereof in connection with the execution or delivery of this Agreement or the consummation of the transactions contemplated by this Agreement, except
for (i)&nbsp;compliance by Parent with the HSR Act and (ii)&nbsp;such other consents, approvals, clearances, permits, authorizations, registrations, filings or notices that, individually or in the aggregate, have not had and would not reasonably be
expected to have a Parent Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) The execution, delivery and performance of this Agreement by each of Parent, Buyer
and Merger Sub does not and the consummation by each of Parent, Buyer, and Merger Sub of the transactions contemplated hereby will not (i)&nbsp;conflict with or violate any provision of the Constituent Documents of Parent, Buyer, or Merger Sub, or
(ii)&nbsp;assuming the filings, consents, approvals and waiting periods referred to in <U>Section</U><U></U><U>&nbsp;4.3(a)</U> are duly made, obtained or satisfied (A)&nbsp;violate any Law or Order, in either case, applicable to Parent or any
Affiliate thereof or any of their respective properties or assets or (B)&nbsp;violate, conflict with, result in the loss of any benefit under, require a payment or incur a penalty under, constitute a default
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(or an event which, with notice or lapse of time, or both, would constitute a default) under, result in the termination of or a right of termination or cancellation under, accelerate the
performance required by, or result in the creation of any Lien upon any of the respective properties or assets of Parent or any Affiliate thereof under, any Contract to which Parent, Buyer or any Affiliate thereof is a party, or by which they or any
of their respective properties or assets may be bound or affected, except, in the case of the foregoing clause (ii), for such matters as, individually or in the aggregate, have not had and would not reasonably be expected to have, individually or in
the aggregate, a Parent Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4. <U>Legal Proceedings</U>. There are no Proceedings pending, or to the
Knowledge of Parent, threatened against Parent, Buyer or any Affiliate thereof or any of their respective assets, rights or properties or any of the officers or directors of Parent, Buyer or any Affiliate thereof, except, in each case, for those
that, individually or in the aggregate, have not had and would not reasonably be expected to have a Parent Material Adverse Effect. Neither Parent, Buyer nor any Affiliate thereof nor any of their respective properties, rights or assets is or are
subject to any Order, except for those that, individually or in the aggregate, have not had and would not reasonably be expected to have a Parent Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5. <U>Brokers</U>. Except for Guggenheim Securities, LLC, no broker, finder or investment banker will be entitled to any
brokerage, finder&#146;s or other fee or commission in connection with the transactions contemplated by this Agreement based upon arrangements made by or on behalf of Parent, Buyer or any Affiliate thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6. <U>Availability of Funds</U>. Parent and Buyer currently have access to sufficient available funds in cash or cash
equivalents, and will at the Closing have sufficient available funds, in cash, to make the payments required to be made by Buyer on the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7. <U>Absence of Parent Material Adverse Effect</U>. Since July&nbsp;2, 2017, through the date of this Agreement, there has not
been any event, change, condition, occurrence or effect that, individually or in the aggregate, has had or would reasonably be expected to have a Parent Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8. <U>No Other Representations or Warranties</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Parent, Buyer and Merger Sub acknowledge that: (a)&nbsp;except for the specific representations and warranties made by the Company in
<U>Article III</U>, it is not relying upon any representation or warranty of the Company, the Company Subsidiaries or any of their respective representatives, members, managers, employees, officers, directors, stockholders or Affiliates, nor upon
the accuracy of any projections, estimates, presentations, predictions, statements, information (including financial information) or other materials made available or given to Parent, Buyer, Merger Sub or their Affiliates or Representatives;
(b)&nbsp;it has had access to the Company and the Company Subsidiaries&#146; books and records, contracts, agreements and documents, and employees, agents and Representatives; and (c)&nbsp;Parent, Buyer, and Merger Sub have had an opportunity to
seek accounting, legal and other advice or information in connection with its entry into this Agreement and the other documents referred to herein relating to the consummation of the transactions contemplated hereby and thereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Parent, Buyer and Merger Sub acknowledges and agrees that except for the representations and
warranties of the Company set forth in <U>Article III</U>, none of the Company, the Company Subsidiaries or any of their respective Representatives, members, managers, employees, officers, directors, stockholder or Affiliates (or Representatives of
such Affiliates), has made, and shall not be deemed to have made, any other express or any implied representations or warranties whatsoever and specifically (but without limiting the generality of the foregoing) that, except for the representations
and warranties of the Company set forth in <U>Article III</U>, neither the Company, the Company Subsidiaries, nor any Person acting on their behalf had made any representation or warranty with respect to (i)&nbsp;the Company, or any of its
Affiliates, any of their businesses, operations, assets, liabilities, condition (financial or otherwise) or prospects or any other matter relating to the Company, or any of its Affiliates or (ii)&nbsp;any projections, estimates, presentations,
predictions, statements, information (including financial information) or other materials (written or oral) made available to Parent, Buyer, Merger Sub or their Affiliates or Representatives, including due diligence or &#147;data room&#148;
materials, or in any presentation concerning the business of the Company and Company Subsidiaries in connection with the transactions contemplated hereby or otherwise, and no statement contained in any of such materials or made in any such
presentation shall be deemed a representation or warranty hereunder. Parent, Buyer, Merger Sub and their Affiliates or Representatives have not relied on any such projections, estimates, presentations, predictions, statements, information (including
financial information) or other materials in executing, delivering and performing this Agreement and the transactions contemplated hereby, and none of the Company, the Company Subsidiaries or any of their respective Representatives, members,
managers, employees, officers, directors, stockholder or Affiliates (or Representatives of such Affiliates) shall have or be subject to any liability to Parent, Buyer, Merger Sub, their Affiliates or Representatives or any other Person resulting
from such projections, estimates, presentations, predictions, statements, information (including financial information) or other materials (or omissions related thereto) or any reliance thereon by Parent, Buyer, Merger Sub, their Affiliates or
Representatives or any other Person. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>COVENANTS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1. <U>Company Conduct of Business Prior to the Effective Time</U>. Except (i)&nbsp;as set forth in
<U>Section</U><U></U><U>&nbsp;5.1</U> of the Company Disclosure Letter, (ii)&nbsp;as expressly contemplated by this Agreement, (iii)&nbsp;as required by applicable Law or (iv)&nbsp;with the prior written consent of Parent (such consent not to be
unreasonably withheld, conditioned or delayed, <U>provided</U> that if Parent does not respond to any request within five Business Days, such consent is deemed to be given), during the period from the date of this Agreement to the Effective Time
(A)&nbsp;the Company shall, and shall cause the Company Subsidiaries to: (1)&nbsp;conduct its business in the ordinary course consistent with past practice and (2)&nbsp;use commercially reasonable efforts to maintain and preserve its present
business organization, maintain in effect all Contracts and Permits as necessary to operate their businesses, keep available the services of officers and key employees and maintain relationships with customers, suppliers and others having material
business relationships with it and (B)&nbsp;in furtherance of, and without limiting the generality of the foregoing, the Company shall not, and shall cause the Company Subsidiaries to not: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;(A) amend or otherwise change the Company&#146;s Constituent Documents and (B)&nbsp;with respect to any Company Subsidiaries, amend
or otherwise change their Constituent Documents in any material respect; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) adjust, split, combine or reclassify any capital stock or other equity interest in the
Company or any Company Subsidiary or enter into any agreement or plan to effect a merger, consolidation, share exchange, reorganization, dissolution or liquidation; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) issue, grant, sell, dispose of, redeem or repurchase any equity securities or equity-based award in the Company or any Company
Subsidiaries, or securities convertible into, or exchangeable or exercisable for, any such equity securities or awards, or any rights of any kind to acquire any such equity securities or such convertible or exchangeable securities, other than
(i)&nbsp;the issuance of shares of Company Common Stock upon the exercise of Company Options outstanding as of the date hereof in accordance with their terms, (ii)&nbsp;the issuance of shares of Company Common Stock upon the conversion of shares
Company Preferred Stock outstanding as of the date hereof in accordance with their terms, and (iii)&nbsp;the repurchase of Company Common Stock pursuant to Company repurchase rights arising upon termination of service of a Company Employee; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) declare, set aside, make or pay any <FONT STYLE="white-space:nowrap">non-cash</FONT> dividend or other
<FONT STYLE="white-space:nowrap">non-cash</FONT> distribution, with respect to any of Company Capital Stock or other shares of capital stock or equity interests (except for any dividend or distribution by a wholly-owned Company Subsidiary to the
Company or another wholly-owned Company Subsidiary); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) sell, license, transfer, or otherwise dispose of (whether by merger,
consolidation or sale of stock or assets or otherwise), any capital stock of any Company Subsidiaries, businesses, material assets or material rights (including Intellectual Property) of the Company or the Company Subsidiaries, in each case other
than dispositions of inventory, equipment and other assets in the ordinary course of business consistent with past practice and the incurrence of Liens on property of the Company and the Company Subsidiaries; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) acquire (whether by merger, consolidation or acquisition of stock or assets or otherwise) any corporation, partnership or other entity or
any business or material assets in each case other than purchases of supplies, equipment and other assets in the ordinary course of business consistent with past practice and other than any capital expenditures contemplated by clause (i)&nbsp;below;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;(A) incur, assume, refinance or guarantee any Indebtedness or issue any debt securities, or assume or guarantee any Indebtedness
of any person other than ordinary course trade payables, credit card obligations, and Indebtedness incurred from to time under the Credit Facilities, in each case in the ordinary course of business consistent with past practice or (B)&nbsp;enter
into (or terminate) any swap or hedging transaction or other derivative agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) make any loans or capital contributions to, or
investments in, any other Person, other than to any Company Subsidiary; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) except for expenditures contemplated by and consistent with
the capital expenditure budgets set forth on <U>Section</U><U></U><U>&nbsp;5.1(i)</U> of the Company Disclosure Letter (the &#147;<U>Capital Expenditure Budget</U>&#148;), make, or commit to make, or otherwise authorize any capital expenditures in
excess of $200,000 in the aggregate; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) other than as required by Law or by Company Benefit Plans existing on the date hereof
(A)&nbsp;except in the ordinary course of business consistent with past practice for employees of the Company or its Subsidiaries who have an annual base salary below $175,000 (&#147;<U><FONT STYLE="white-space:nowrap">Non-Management</FONT>
Employees</U>&#148;), increase the compensation of, or benefits payable or to become payable or provided to, any Company Employee, (B)&nbsp;adopt, enter into, amend or terminate any Company Benefit Plan (or any plan, arrangement, agreement, program
or policy that would be a Company Benefit Plan if it were in existence as of the date of this Agreement), (C) hire or terminate (other than for cause) the employment of any employee other than <FONT STYLE="white-space:nowrap">Non-Management</FONT>
Employees, (D)&nbsp;loan or advance any money or other property to any Company Employee, other than routine advances for business expenses in the ordinary course of business consistent with past practice, (E)&nbsp;grant any cash bonus or any cash
incentive compensation outside the ordinary course of business consistent with past practice, (F)&nbsp;grant any severance, termination pay, retention, or change in control benefits to any current or former Company Employee, other than any
termination pay or severance granted in the ordinary course of business consistent with past practice or (G)&nbsp;grant any equity or equity-based compensation; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k) except in the ordinary course of business consistent with past practice or with respect to the payoff of the Credit Facilities, enter
into, amend in any respect, waive compliance with any rights with respect to, or cancel, fail to renew or terminate any Material Contract or Contract which if entered into prior to the date hereof would be a Material Contract, <U>provided</U>, that
if any action is of a nature contemplated and permitted by another subsection of this <U>Section</U><U></U><U>&nbsp;5.1</U>, the Company shall not require a separate consent pursuant to this <U>subsection (k);</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(l) enter into any Contract involving or providing for the settlement of any claims or threatened claim (or series of related claims): (A)
which Contract materially restricts or imposes material <FONT STYLE="white-space:nowrap">non-monetary</FONT> obligations on the Company or any Company Subsidiary or (B)&nbsp;which Contract involves payments by the Company or any Company Subsidiaries
after the date hereof in excess of $100,000 (excluding any amounts that may be paid under existing insurance policies); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;(i)
announce, implement or effect any reduction in force, layoff or other program resulting in the termination of Company Employees, in each case, that would trigger the WARN Act or (ii)&nbsp;recognize any union or other labor organization as the
representative of any Company Employees or enter into any collective bargaining agreement with any union or other labor organization; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(n)
make any changes in its methods, practices or policies of financial accounting, except as may be required under Law, rule, regulation or U.S. GAAP; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;(i) make, change or revoke any material Tax election, (ii)&nbsp;file any amended material Tax Returns, (iii)&nbsp;settle or
compromise any material Tax liability of the Company or any Company Subsidiary, (iv)&nbsp;agree to an extension or waiver of the statute of limitations with respect to the assessment or determination of Taxes of the Company or any Company
Subsidiaries, (v)&nbsp;enter into any closing agreement with respect to any material Tax or surrender any right to claim a material Tax refund, or (vi)&nbsp;make any material changes in its methods, practices or policies of Tax accounting; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(p) agree, resolve or commit to take any of the actions prohibited by this
<U>Section</U><U></U><U>&nbsp;5.1</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Nothing contained in this Agreement is intended to give Parent, directly or indirectly, the right
to control or direct the Company&#146;s or the Company Subsidiaries&#146; operations prior to the Effective Time. Prior to the Effective Time, the Company shall exercise, consistent with the terms and conditions of this Agreement, complete control
and supervision over its and the Company Subsidiaries&#146; respective operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2. <U>Access to Information</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) From the date of this Agreement through the earlier of the Effective Time and the termination of this Agreement, the Company shall afford
to Parent and its Affiliates (and its and their Representatives), upon reasonable notice by Parent, reasonable access during normal business hours to its and the Company Subsidiaries&#146; properties, books and records, and to its and the Company
Subsidiaries&#146; officers, employees, accountants, counsel and other Representatives and the Company shall make available to Parent all information concerning its business, properties and personnel as Parent may reasonably request; <U>provided</U>
that the Company shall not be required to provide such access or furnish such information if the Company in good faith reasonably believes that doing so would reasonably be expected to (i)&nbsp;breach or violate any applicable Law relating to the
exchange of information, (ii)&nbsp;result in the loss of attorney-client privilege or attorney work product privilege or (iii)&nbsp;violate any confidentiality obligation with respect to such information; <U>provided</U>, <U>further</U>, that the
Parties agree to collaborate in good faith to make alternative arrangements to allow for such access or disclosure in a manner that does not result in the events set out in clauses (i), (ii) or (iii)&nbsp;above. No investigation by Parent or its
Representatives shall constitute a waiver of or otherwise affect the representations, warranties, covenants or agreements of the Company set forth herein. Any access to any Company properties shall be subject to the Company&#146;s reasonable
security measures and the applicable requirements of the Leases and shall not include the right to perform any &#147;invasive&#148; testing or soil, air or groundwater sampling, including, without limitation, any Phase I or Phase II environmental
assessments. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) All information furnished by a Party or any of its Representatives to another Party or its Representatives pursuant to
this Agreement (including <U>Section</U><U></U><U>&nbsp;5.2(a)</U>) shall be subject to the provisions of the Confidentiality Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3. <U>Reasonable Best Efforts</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The Company and Parent agree to make (or cause to be made) an appropriate filing of a Notification and Report Form pursuant to the HSR Act
on the date of this Agreement or within one Business Day following the date hereof (pursuant to which Parent and the Company shall request early termination of the applicable waiting period under the HSR Act). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Subject to the terms and conditions of this Agreement, each of Parent, Buyer, Merger Sub and
the Company shall use their reasonable best efforts to take, or cause to be taken, all actions necessary, proper or advisable to (i)&nbsp;consummate the transactions contemplated hereby and to cause the conditions set forth in <U>Article VI</U> to
be satisfied as promptly as practicable (and in any event prior to the Outside Date); (ii) prepare as promptly as practicable all necessary applications, notices, filings, requests and other documents to be made or filed by such Party (and cooperate
with the other Parties with respect to any applications, notices, filings, requests and other documents to be made or filed by the other Parties) in connection with the transactions contemplated by this Agreement; and (iii)&nbsp;obtain as promptly
as practicable all consents, approvals, clearances, permits, authorizations, registrations, filings or notices from any Governmental Entity (or other Person) which is required to be obtained in connection with the transactions contemplated by this
Agreement. For the avoidance of doubt, Parent and its Subsidiaries and the Company and the Company Subsidiaries shall not be required (and without the prior consent of Parent, the Company and its Subsidiaries shall not), take any action with respect
to any order or any applicable Law or in order to obtain any approval, consent or clearance which is not conditioned upon the consummation of the Merger. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Subject to the other provisions of this Agreement, including those set forth elsewhere in this <U>Section</U><U></U><U>&nbsp;5.3</U>, each
of the Company, on the one hand, and Parent, Buyer and Merger Sub, on the other hand, shall (i)&nbsp;to the extent permitted by applicable Law, promptly inform the other Party in writing of any substantive communication (oral and written) received
by such party from, or given by such Party to, any Governmental Entity with respect to any applications, notices, filings or requests made (or any consents, approvals or clearances sought to be obtained) in connection with the transaction
contemplated by this Agreement (including keeping the other Parties apprised, on a current basis of the status thereof); (ii) to the extent permitted by applicable Law, promptly inform the other Party in writing of any substantive communication
(oral and written) received by such Party from, or given by such Party to, any Person that is not a Governmental Entity in connection with any Proceeding (or threatened Proceeding) by such Person regarding or arising out of this Agreement or the
transactions contemplated by this Agreement; (iii)&nbsp;consult with the other Parties (subject to applicable Law relating to the exchange of information) in connection with any analyses, appearances, presentations, memoranda, briefs, arguments,
opinions and proposals made or submitted by or on behalf of any Party relating to any applications, notices, filings or requests made (or any consents, approvals or clearances sought to be obtained) in connection with the transaction contemplated by
this Agreement; (iv)&nbsp;use reasonable best efforts to furnish to the other Party and, upon request, to any Governmental Entities such information and assistance as may be reasonably requested in connection with the foregoing, including by
responding promptly to and using reasonable best efforts to comply fully with any request for additional information or documents under any applicable Law; and (v)&nbsp;not independently participate in any meeting (including telephonic meetings)
with any Governmental Entity in connection with the foregoing without giving the other Party sufficient prior notice of the meeting (including telephonic meetings) and, to the extent permitted by such Governmental Entity, the opportunity to attend
and/or participate in such meeting (including telephonic meetings). Notwithstanding anything in this <U>Section</U><U></U><U>&nbsp;5.3</U> to the contrary, materials provided by or on behalf of Parent or Buyer to the Company or its counsel or the
Company to Parent or its counsel may be redacted to the extent necessary (a)&nbsp;to remove references concerning Parent&#146;s, Buyer&#146;s or the Company&#146;s valuation analyses with respect to the Company and the Company Subsidiaries,
(b)&nbsp;as necessary to comply with Contracts in effect on the date hereof, (c)&nbsp;to address reasonable concerns regarding attorney-client privilege or (d)&nbsp;to remove personal, proprietary and other confidential business information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) Without limiting the generality of anything contained in this
<U>Section</U><U></U><U>&nbsp;5.3</U>, the Company shall use its reasonable best efforts to obtain any consents or approvals from any Persons (other than Governmental Entities) that are necessary or advisable in connection with the transactions
contemplated by this Agreement. In the event that the Company shall fail to obtain any such third-party consent, the Company shall use its reasonable best efforts, and shall take such actions as are reasonably requested by Parent and Buyer, to
minimize any adverse effect upon the Company and the Company Subsidiaries resulting, or which would reasonably be expected to result, after the Effective Time, from the failure to obtain such consent. Notwithstanding anything to the contrary in this
Agreement, in connection with obtaining any such approval or consent with respect to any transaction contemplated by this Agreement, (i)&nbsp;none of the Company or any Company Subsidiary shall be required to, or, without the prior written consent
of Parent, shall, pay or commit to pay to such Person whose approval or consent is being solicited any cash or other consideration, make any commitment or incur any liability or other obligation due to such person and (ii)&nbsp;none of Parent,
Buyer, Merger Sub or any of their Affiliates shall be required to pay or commit to pay to such person whose approval or consent is being solicited any cash or other consideration, make any commitment or incur any liability or other obligation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4. <U>Notification of Certain Matters</U>. Each Party shall give reasonably prompt written notice to the other Party, if to
such Party&#146;s Knowledge, (a)&nbsp;any representation or warranty made by it contained in this Agreement becomes untrue or inaccurate such that it would be reasonable to expect that the applicable closing conditions would be incapable of being
satisfied by the Outside Date or (b)&nbsp;it fails to comply with or satisfy in any material respect any covenant, condition or agreement to be complied with or satisfied by it under this Agreement; <U>provided</U> that (i)&nbsp;nothing in this
<U>Section</U><U></U><U>&nbsp;5.4</U> shall be deemed to affect, modify or condition the obligations of each party to effect the Closing and (ii)&nbsp;any breach of this <U>Section</U><U></U><U>&nbsp;5.4</U> shall be deemed excluded for purposes of
determining whether the conditions set forth in either <U>Section</U><U></U><U>&nbsp;6.2(b)</U> or <U>Section</U><U></U><U>&nbsp;6.3(b)</U> have been satisfied, for purposes of termination under <U>Section</U><U></U><U>&nbsp;7.1(d)</U>, and for
purposes of any indemnification pursuant to <U>Section</U><U></U><U>&nbsp;8.2</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5. <U>Publicity</U>. Promptly following
the execution of this Agreement, Parent and the Company shall issue a joint press release relating to the transactions contemplated by this Agreement, the text of which shall be mutually agreed by Parent and the Company. Following the issuance of
such joint press release, each of Parent and the Company shall consult with each other before issuing any press release or public statement with respect to this Agreement, the Merger or the other transactions contemplated hereby and shall not issue
any such press release or make any such public statement without the prior consent (not to be unreasonably withheld, delayed or conditioned) of the other Party; <U>provided</U> that a Party may, without obtaining the prior consent of the other party
(but after prior consultation, to the extent practicable in the circumstances), issue such press release or make such public statement as may upon the advice of outside counsel be required by applicable Law. Without limiting the foregoing, Parent
and the Company shall use reasonable efforts to cooperate to develop all public announcement materials and make appropriate management available at presentations related to the transactions contemplated by this Agreement as reasonably requested by
the other Party, and the Company shall consult with Parent regarding communications with customers, stockholders and employees related to the transactions contemplated hereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6. <U>Director</U><U></U><U>&nbsp;&amp; Officer Indemnification</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) For a period of six years after the Effective Time, Buyer will cause the Surviving Corporation to indemnify, defend and hold harmless, to
the same extent required by the certificate of incorporation and bylaws of the Company as in effect on the date of this Agreement and as permitted under applicable Law, all past and present directors and officers of the Company and any Company
Subsidiary (each, together with such person&#146;s heirs, executors or administrators, a &#147;<U>Company Indemnified Party</U>&#148;) against any liabilities, damages, costs or expenses (including reasonable attorneys&#146; fees and expenses)
incurred in connection with any Proceeding (whether asserted before or after the Effective Time) arising out of acts or omissions occurring at or prior to the Effective Time in connection with such Company Indemnified Party having served as a
director or officer of the Company or a Company Subsidiary or having served at the request of the Company as a director, officer or employee of any other corporation, limited liability company, partnership, joint venture, employee benefit plan,
trust or other business, and, to the same extent that such Company Indemnified Parties have the right to advancement of expenses from the Company as of the date of this Agreement, to provide advancement of expenses to any such Company Indemnified
Party, subject to receipt of an undertaking from such Company Indemnified Party to repay such advanced amounts if it is determined by a court of competent jurisdiction in a final judgment that such Company Indemnified Party was not entitled to
indemnification. Parent shall cause the Surviving Corporation (or any successor) to include and maintain in effect, for a period of six (6)&nbsp;years after the Effective Time, the provisions regarding indemnification and elimination of liability of
directors that are in the Company&#146;s Constituent Documents as in effect as of the date of this Agreement. Parent shall cause the Surviving Corporation to honor all indemnification agreements with any Company Indemnified Party in effect as of the
date of this Agreement only to the extent such indemnification agreements are set forth in <U>Section</U><U></U><U>&nbsp;5.6(a)</U> of the Company Disclosure Letter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) The Company shall, at or prior to the Closing, at the direction of the Buyer, purchase tail coverage under the Company&#146;s current
directors&#146; and officers&#146; liability insurance policy for the benefit of each Company Indemnified Party, which provides coverage for period of six (6)&nbsp;years after the Effective Time for acts or omissions occurring on or prior to the
Effective Time with terms and conditions which are not less advantageous to such Company Indemnified Parties than the terms and conditions of the existing directors&#146; and officers&#146; liability insurance policy of the Company. The expense of
such tail coverage shall be a Transaction Expense hereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) In the event that the Surviving Corporation or any of its successors or
assigns (i)&nbsp;consolidates with or merges into any other Person and is not the continuing or surviving corporation or entity of such consolidation or merger or (ii)&nbsp;transfers or conveys all or substantially all of its properties, rights and
other assets to any Person, then, in each such case to the extent so required, Parent shall cause proper provision to be made so that such successor or assign of the Surviving Corporation assumes the obligations set forth in this
<U>Section</U><U></U><U>&nbsp;5.6</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) The provisions of this <U>Section</U><U></U><U>&nbsp;5.6</U> are intended to be for the
benefit of, and will be enforceable by, the Company Indemnified Parties following the Closing and are in addition to, and not in substitution for, any other rights to indemnification, advancement or contribution that any such Person may have by Law,
Contract or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7. <U>Employee </U><U>Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Effective as of the Effective Time, Parent shall provide, or shall cause the Surviving Corporation to provide, to employees of the Company
or its Subsidiaries who continue to be employed by the Parent or the Surviving Corporation or any Subsidiary thereof (the &#147;<U>Continuing Employees</U>&#148;), until December&nbsp;31, 2018, (i) base salary and bonus opportunities (excluding
equity or equity-based compensation) that are no less favorable than those provided by the Company immediately prior to the Effective Time and (ii)&nbsp;employee benefits that are, in the aggregate, no less favorable than those made available
pursuant to employee benefit plans of Parent that are applicable to similarly situated employees of Parent and its affiliates, while such Continuing Employees remain employed by the Surviving Corporation or Parent. Parent will adopt and maintain a
retention plan for Continuing Employees on the terms set forth on <U>Section</U><U></U><U>&nbsp;5.7(a)</U> of the Company Disclosure Letter. Parent (x)&nbsp;will give, or cause the Surviving Corporation to give, each Continuing Employee credit for
the Continuing Employee&#146;s service with the Company or its Subsidiaries (as applicable) prior to the Effective Time for purposes of eligibility, vesting and entitlement to amount of vacation, sick leave and severance benefits (but not benefit
accrual under any defined benefit pension plan), to the same extent such service was recognized under a similar Company Benefit Plan, including with respect to providing matching contributions based on years of service under any 401(k) plan
maintained by the Parent, except in each case, to the extent such treatment would result in duplicative benefits and (y)&nbsp;will use commercially reasonable efforts to allow such Continuing Employees to participate in each plan providing welfare
benefits, including medical, life insurance, long-term disability insurance and long-term care insurance, without regard to preexisting-condition limitations, waiting periods, evidence of insurability or other exclusions or limitations not imposed
on the Continuing Employee by the corresponding Company Benefit Plans immediately prior to the Effective Time and will provide credit for any <FONT STYLE="white-space:nowrap">co-payments</FONT> and deductibles for purposes of satisfying any
applicable deductible, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> or similar requirements under any such plans that may apply after the Closing Date for the calendar year in which the Continuing
Employee begins participation in such plans of the Parent. All vacation accrued by Continuing Employees under the vacation policies of the Company or its subsidiaries or predecessors shall be carried over by Parent at Closing and, after Closing,
shall be governed by Parent&#146;s applicable vacation policies. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Nothing in this Agreement shall confer upon any Continuing Employee
any right to continue in the employ or service of Parent, the Surviving Corporation or any affiliate of Parent, or, subject to <U>Section</U><U></U><U>&nbsp;2.6</U>, shall interfere with or restrict in any way the rights of Parent, the Surviving
Corporation or any affiliate of Parent, which rights are hereby expressly reserved, to discharge or terminate the services of any Continuing Employee at any time for any reason whatsoever, with or without cause, except to the extent expressly
provided otherwise in a written agreement between Parent, the Surviving Corporation, the Company or any affiliate of Parent and the Continuing Employee or any severance, benefit or other applicable plan or program covering such Continuing Employee.
Notwithstanding any provision in this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement to the contrary, nothing in this <U>Section</U><U></U><U>&nbsp;5.7</U> shall (i)&nbsp;be deemed or construed to be an amendment or other modification of any Company Benefit Plan or
employee benefit plan of Parent, Buyer, or Merger Sub, (ii)&nbsp;create any third party rights in any Person or (iii)&nbsp;alter or limit the ability of the Surviving Corporation, Parent or any of their respective affiliates to amend, modify or
terminate any Company Benefit Plan or other employee benefit program, agreement or arrangement at any time assumed, established, sponsored or maintained by any of them. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Parent will cause the Surviving Corporation to honor the annual cash incentive awards applicable to such Continuing Employee for calendar
year 2017. The Surviving Corporation will pay to Continuing Employees such 2017 bonus in the ordinary course (and at the time ordinarily paid) based on actual results for the 2017 fiscal year, <U>provided</U>, that if any Continuing Employee is
involuntarily terminated by the Surviving Corporation without cause prior to the bonus payment date, a prorated portion of such bonus shall be paid to such terminated Continuing Employee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) The Company Board (or the appropriate committee thereof) shall adopt resolutions and take such corporate action as is reasonably necessary
to terminate any 401(k) plans maintained by the Company or any of its Subsidiaries (collectively, the &#147;<U>Company 401(k) Plans</U>&#148;), effective as of the day prior to the Closing Date. The Company shall provide Parent with a reasonable
opportunity to review and comment on such resolutions and any documents prepared in connection with such corporate actions prior to the adoption of such resolutions or taking of such actions. Following the Effective Time and as soon as practicable
following the termination of the Company 401(k) Plans, the assets thereof shall be distributed to the participants. Parent or the Surviving Corporation shall permit the Continuing Employees who are then actively employed to make rollover
contributions of &#147;eligible rollover distributions&#148; (within the meaning of Section&nbsp;401(a)(31) of the Code), including loans, in the form of cash, in an amount equal to the full account balance (including loans) distributed to such
Continuing Employees from the Company 401(k) Plans to Parent&#146;s or the Surviving Corporation&#146;s applicable 401(k) plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) The
Company shall provide Parent with a copy of any material written communications intended for broad-based and general distribution to any current or former employees of the Company or any of the Company Subsidiaries if such communications relate to
any of the transactions contemplated by this Agreement, and, to the extent practicable, shall provide Parent with a reasonable opportunity to review and comment on such communications prior to distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8. <U>280G Stockholder Vote</U>. Prior to the Closing, the Company shall: (i)&nbsp;use commercially reasonable efforts to
secure from each of the Persons who is a &#147;disqualified individual&#148; (as defined in Section&nbsp;280G(c) of the Code) and has received or would reasonably be expected to receive any payments, rights or benefits which, in the absence of
approval by the shareholders in a manner that complies with Section&nbsp;280G(5)(B) of the Code and Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.280G-1</FONT> (the &#147;<U>280G Shareholder Approval</U>&#148;), would be deemed
to constitute &#147;parachute payments&#148; under Section&nbsp;280G of the Code (the &#147;<U>Potential 280G Benefits</U>&#148;), a waiver of such Person&#146;s rights to some or all of such Potential 280G Benefits (the &#147;<U>Waived
Benefits</U>&#148;) so that all remaining Potential 280G Benefits applicable to such Person shall not be deemed to be &#147;parachute payments&#148; that would be <FONT STYLE="white-space:nowrap">non-deductible</FONT> under Section&nbsp;280G of </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Code; (ii)&nbsp;solicit the 280G Shareholder Approval of any Waived Benefits; (iii)&nbsp;prior to seeking any waiver or the 280G Shareholder Approval deliver to Buyer drafts of such 280G
Shareholder Approval related-documents and provide Buyer a reasonable opportunity to review and comment on all calculations, waivers, consents, disclosures and other documents prepared in connection with the actions described in this
<U>Section</U><U></U><U>&nbsp;5.8</U> (the Company&#146;s acceptance of Buyer&#146;s reasonable comments shall not be unreasonably withheld), and (iv)&nbsp;not pay the Waived Benefits for which the 280G Shareholder Approval was not obtained. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9. <U>Payoff of Credit </U><U>Facilities</U>. The Company shall arrange for customary payoff letters and instruments of
discharge to be delivered at Closing providing for the payoff, discharge and termination on the Closing Date of all then-outstanding indebtedness of, and commitments under, the Credit Facilities, and shall deliver prepayment and termination notices
in accordance with the terms of the Credit Facilities (<U>provided</U> that such prepayment and termination notices may be conditional on the occurrence of the Closing). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10. <U>Stockholder Consents</U>. Following the date that a written consent evidencing the Company Stockholder Approval is
delivered to Parent, the Company shall use its reasonable best efforts to obtain (and deliver to Parent) consents from each holder of shares of Company Capital Stock who did not execute such written consent evidencing the Company Stockholder
Approval, evidencing such holder&#146;s waiver of all appraisal rights under Section&nbsp;262 of the DGCL and such holder&#146;s approval of the provisions of <U>Section</U><U></U><U>&nbsp;9.12</U> (Stockholder Representative) as it relates to such
holder. The Company shall send such notices and information to the holders of Company Capital Stock as may be required under its Constituent Documents and applicable Law and shall provide drafts of such materials to Parent and Buyer with a
reasonable opportunity prior to the expected mailing or distribution date for Parent&#146;s and Buyer&#146;s review and comment and the Company&#146;s acceptance of reasonable comments from Parent or Buyer shall not be unreasonably withheld. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11. <U>Exclusivity</U>. On and after the date of this Agreement and through the Closing (or the earlier termination of this
Agreement), the Company and its Affiliates shall not, and the Company shall cause its directors, officers, employees, agents and other representatives to not, directly or indirectly (i)&nbsp;take any action to solicit, encourage, initiate or engage
in discussions or negotiations with, or provide any information to, or otherwise cooperate in any way with, any Person (other than Parent, Buyer, Merger Sub and their respective representatives) concerning any merger or recapitalization involving
the Company, sale of five percent or more of the capital stock of the Company or the Company Subsidiaries, or five percent or more of the assets of the Company and the Company Subsidiaries, taken as a whole (measured based on either book value or
fair market value), or similar transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12. <U>Debt Financing</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Prior to the Closing, the Company and Company Subsidiaries shall use their reasonable best efforts to provide all cooperation reasonably
requested in writing by Parent and Buyer in connection with Parent and/or Buyer arranging debt financing in connection with the transactions contemplated by this Agreement, which debt financing may be incurred before or following the Closing (the
&#147;<U>Debt Financing</U>&#148;), including all cooperation reasonably requested to enable Parent, Buyer and their Representatives to prepare financial statements, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
including pro forma financial statements, in compliance with applicable SEC requirements for use in a registered or unregistered offering of debt securities in connection with such Debt Financing
and to enable accountants of Parent and/or the Company to audit or review such financial statements, including, if requested by Parent, using reasonable best efforts to (x)&nbsp;provide a customary representation letter in such form as is reasonably
required by accountants of Parent and/or the Company, as applicable, with such facts and assumptions as reasonably determined by such accountants in order to make such certificate accurate, signed by the individual(s) responsible for the
Company&#146;s financial reporting, as prescribed by generally accepted auditing standards as promulgated by the Auditing Standards Divisions of the American Institute of Public Accountants in order to enable an independent public accountant to
render an opinion on such financial statements, (y)&nbsp;cause the auditor of the Company&#146;s financial statements to provide its consent to the inclusion of such report, without exception or qualification, with respect to the Audited Financial
Statements in any offering document of the Parent or Buyer or any report of the Parent or Buyer filed with the SEC, and (z)&nbsp;to provide to Parent and its underwriters, or the equivalent in an unregistered offering of securities, appropriate
comfort letters in accordance with the American Institute of Public Accountants&#146; professional standards and to participate in due diligence sessions customarily conducted in connection with the provision of comfort letters. In furtherance of
the foregoing, the Company shall use its reasonable best efforts to provide to Parent and Buyer the Company&#146;s unaudited consolidated balance sheet as of September&nbsp;30, 2017, and the related statements of income or operations for the three-
and nine-month periods ended September&nbsp;30, 2017 as soon as reasonably practicable following the end of the Company&#146;s third quarter of 2017 period but in no event later than October&nbsp;30, 2017. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) For the avoidance of doubt, nothing herein shall require the Company or any of the Company Subsidiaries to (A)&nbsp;waive or amend any
terms of this Agreement or pay or agree to pay any fees or reimburse any expenses in connection with the Debt Financing contemplated by<U> Section</U><U></U><U>&nbsp;5.12</U>, (B) enter into any definitive agreement, document or instrument with
respect to the Debt Financing contemplated by <U>Section</U><U></U><U>&nbsp;5.12</U>, (C) give any indemnities with respect to the Debt Financing contemplated by <U>Section</U><U></U><U>&nbsp;5.12</U> that are effective prior to the Effective Time,
(D)&nbsp;take any action with respect to the Debt Financing contemplated by <U>Section</U><U></U><U>&nbsp;5.12</U> that, in the good faith determination of the Company, would unreasonably interfere with the conduct of the business of the Company or
the Company Subsidiaries or create a risk of damage or destruction to any property or assets of the Company or any of the Company Subsidiaries, (E)&nbsp;provide any information the disclosure of which is prohibited or restricted under applicable
Laws or is legally privileged (<U>provided</U>, <U>further</U>, that the Parties agree to collaborate in good faith to make alternative arrangements to allow for such access or disclosure in a manner that does not result in a violation of Law or
loss of privilege), or (F)&nbsp;take any action that will conflict with or violate its organizational documents or any applicable Laws or would result in a violation or breach of, or default under, any Contract to which the Company or any of the
Company Subsidiaries is a party. Notwithstanding any other provision of this Agreement, nothing in this Agreement will require (A)&nbsp;any officer or Representative of the Company or any of the Company Subsidiaries to (x)&nbsp;execute or deliver
any definitive agreement, certificate, document, instrument or opinion in connection with the Debt Financing that would be effective prior to the Effective Time, or (y)&nbsp;take any other action pursuant to <U>Section</U><U></U><U>&nbsp;5.12(a)</U>
that could reasonably be expected to result in personal liability to such officer or Representative or that would be effective prior to the Effective Time, or (B)&nbsp;the members of the Company Board as of the date hereof to approve the Debt
Financing or any alternative financing or Contracts related thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) All <FONT STYLE="white-space:nowrap">non-public</FONT> or other confidential information
provided by the Company or any of its Representatives pursuant to this Agreement will be kept confidential in accordance with the Confidentiality Agreement, except that Parent, Buyer and Merger Sub will be permitted to disclose such information to
any Debt Financing sources and other financial institutions and investors that are or may become parties to the Debt Financing and to any underwriters, initial purchasers or placement agents in connection with the Debt Financing (and, in each case,
to their respective counsel and auditors) so long as such Persons (i)&nbsp;agree to be bound by the Confidentiality Agreement as if parties thereto, or (ii)&nbsp;are subject to other confidentiality undertakings reasonably satisfactory to the
Company and of which the Company is a beneficiary. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) If this Agreement is terminated, upon request by the Company, Parent and Buyer
shall promptly (and in any event within thirty (30)&nbsp;calendar days of invoice) reimburse the Company and the Company Subsidiaries for all <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and
expenses (including legal fees and expenses) incurred by the Company and/or any of the Company Subsidiaries in connection with providing the cooperation contemplated by <U>Section</U><U></U><U>&nbsp;5.12(a)</U> to the extent such expenses were in
excess of the expenses the Company and the Company Subsidiaries would have incurred in the absence of the cooperation obligations in <U>Section</U><U></U><U>&nbsp;5.12(a)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) Parent and Buyer shall indemnify and hold harmless the Company and the Company Subsidiaries, and each of their respective Representatives,
from and against any and all losses, damages, claims, interest, costs or expenses (including legal fees and expenses), awards, judgments, penalties and amounts paid in settlement suffered or incurred by any of them in connection with the Debt
Financing, including providing the support and cooperation contemplated by <U>Section</U><U></U><U>&nbsp;5.12(a)</U> and any information utilized in connection therewith (other than written information provided by or on behalf of the Company, the
Company Subsidiaries or any of their respective Representatives for use in connection with the Debt Financing). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) Parent, Buyer and
Merger Sub each acknowledge and agree that (i)&nbsp;the obtaining of (or failure to obtain) the Debt Financing or any other financing is not a condition to the Closing; (ii)&nbsp;the consummation of the transactions contemplated by this Agreement
shall not be delayed or postponed as a result of the obtaining of (or failure to obtain) the Debt Financing, and (iii)&nbsp;it shall continue to be obligated to consummate the transactions contemplated by this Agreement irrespective and
independently of the availability of the Debt Financing or any other financing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) Any breach of this
<U>Section</U><U></U><U>&nbsp;5.12</U> shall be deemed excluded for purposes of determining whether the conditions set forth in either <U>Section</U><U></U><U>&nbsp;6.2(b)</U> or <U>Section</U><U></U><U>&nbsp;6.3(b)</U> have been satisfied, for
purposes of termination under <U>Section</U><U></U><U>&nbsp;7.1(d)</U>, and for purposes of any indemnification pursuant to <U>Section</U><U></U><U>&nbsp;8.2</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13. <U>Tax Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) For any <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period or Straddle Period of the Company or any of the Company
Subsidiaries, Buyer shall timely prepare or cause to be prepared and shall file or cause to be filed with the appropriate taxing authorities all Tax Returns required to be filed; <U>provided</U> that Buyer shall permit the Stockholder Representative
to review and comment on each such Tax Return prior to the filing thereof, and Buyer shall not file any such Tax Return without the prior written approval of the Stockholder Representative, which approval shall not be unreasonably withheld or
delayed. Buyer shall pay all Taxes due with respect to such Tax Returns described in the preceding sentence; <U>provided</U> that any such amounts shall be released to Buyer from the Indemnity Escrow Funds to the extent required under
<U>Section</U><U></U><U>&nbsp;8.2(a)(iii)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) In the case of any Straddle Period, the amount of Taxes allocable to the portion of
the Straddle Period ending on the Closing Date shall be deemed to be: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) In the case of Taxes imposed on a periodic
basis (such as real or personal property Taxes), the amount of such Taxes for the entire period (or, in the case of such Taxes determined on an arrears basis, the amount of such Taxes for the immediately preceding period) multiplied by a fraction,
the numerator of which is the number of calendar days in the Straddle Period ending on and including the Closing Date and the denominator of which is the number of calendar days in the entire relevant Straddle Period; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) In the case of Taxes not described in (i)&nbsp;above (such as Taxes that are based upon or related to income or receipts,
based upon occupancy or imposed in connection with any sale or other transfer or assignment of property (real or personal, tangible or intangible)), the amount of any such Taxes shall be determined as if such Tax period ended as of the close of
business on the Closing Date, except that exemptions, allowances or deductions that are calculated on an annual basis (including depreciation and amortization deductions), other than with respect to property placed in service after the Closing,
shall be allocated on a per diem basis. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) To the extent permitted under applicable Law, the taxable year of the Company that includes
the Closing Date shall close, and in any event shall be treated as Closing, at the end of the day on the Closing Date for all income Tax purposes, and all income Tax Returns shall be filed consistently with the foregoing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) In the event that Parent delivers a Deferral Notice pursuant to <U>Section</U><U></U><U>&nbsp;1.2(b)</U>, any deductions arising from the
payment of the Closing Date Aggregate Option Payment Amount, any other compensatory payments arising from the transactions contemplated by this Agreement and the payment of Transaction Expenses, in each case made at or substantially contemporaneous
with the Closing, shall be treated as having been paid on the Satisfaction Date for purposes of calculating the Buyer Indemnified Parties&#146; right to indemnification for Taxes pursuant to this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) Parent, Buyer, the Company, each of the Company Subsidiaries and the Stockholder Representative shall reasonably cooperate, and shall
cause their respective Affiliates, officers, employees, agents, auditors and other representatives to reasonably cooperate, in preparing and filing all Tax Returns and in resolving all disputes and audits with
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respect to all periods relating to Taxes, including by maintaining and making available to each other all records necessary in connection with Taxes and making employees available on a mutually
convenient basis to provide additional information or explanation of any material provided hereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) Without the prior written
consent of the Stockholder Representative (which consent shall not be unreasonably withheld, conditioned or delayed), Buyer shall cause the Company and the Company Subsidiaries not to (i)&nbsp;make, change or rescind any Tax election with respect to
any <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period, (ii)&nbsp;amend any Tax Return with respect to any <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period, (iii)&nbsp;file any Tax Return with respect to a <FONT
STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period in a jurisdiction in which the Company did not file previously (unless Buyer reasonably determines that such filing is necessary based on a change in circumstances occurring after the taxable
period in respect of any previously filed Tax Return), (iv) engage in any voluntary disclosure or similar process with any taxing authority with respect to any <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period, (v)&nbsp;extend the
statute of limitations with respect to any Tax with respect to any <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period, or (vi)&nbsp;take any other action with respect to any <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period,
in each case that would reasonably be expected to have the effect of increasing the liability of the former holders of Company Capital Stock or Company Options for Taxes pursuant to <U>Article VIII</U> of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) <U>Tax Claims</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) With respect to any claim for indemnification for a breach of a representation or warranty contained in
<U>Section</U><U></U><U>&nbsp;3.12</U> or a covenant contained in <U>Section</U><U></U><U>&nbsp;5.1(o)</U> or under <U>Section</U><U></U><U>&nbsp;8.2(a)(iii)</U> (a &#147;<U>Tax Claim</U>&#148;) relating to a
<FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period, the Stockholder Representative shall, solely at the cost and expense of the holders of shares of Company Capital Stock, control all proceedings and may make all decisions taken in
connection with such Tax Claim and, without limiting the foregoing, may in its sole discretion pursue or forego any and all administrative appeals, proceedings, hearings and conferences with any taxing authority with respect thereto, and may, in its
sole discretion, either pay the Tax claimed or contest the Tax Claim in any permissible manner; <U>provided</U>, <U>however</U>, that the Stockholder Representative must first consult, in good faith with Buyer before taking any action with respect
to the conduct of such Tax Claim. Notwithstanding the foregoing, the Stockholder Representative shall not settle such Tax Claim without the prior written consent of Buyer, which consent shall not be unreasonably withheld, conditioned or delayed and
Buyer, and counsel of its own choosing, shall have the right to participate fully in all aspects of the prosecution or defense of such Tax Claim if it reasonably determines that such Tax Claim could have a material adverse impact on the Taxes of the
Company or any of the Company Subsidiaries in a Tax period or portion thereof beginning after the Closing Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)
Buyer shall control all proceedings taken in connection with any Tax Claim relating to Taxes of the Company or any of its Subsidiaries for a Straddle Period; <U>provided</U>, <U>however</U>, that Buyer shall not settle such Tax Claim without the
prior written consent of the Stockholder Representative, which consent shall not be unreasonably withheld, conditioned or delayed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14. <U>Directors</U>. The Company shall use reasonable best efforts to obtain the
resignation of all of the members of the board of directors of the Company (and of the board of directors or similar governing body for each Company Subsidiary), who are in office immediately prior to the Closing, which resignations shall be
effective at, and conditioned upon the occurrence of, the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15. <U>Buyer and Merger Sub Compliance</U>. Parent
shall cause Buyer and Merger Sub to comply with all of Buyer and/or Merger Sub&#146;s obligations under or relating to this Agreement. Merger Sub shall not engage in any business which is not in connection with the merger with and into the Company
pursuant to this Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CONDITIONS TO THE MERGER </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1. <U>Conditions </U><U>to Obligations of Each Party</U>. The respective obligations of each Party to consummate the Merger are
subject to the satisfaction of the following conditions (which may be waived, in whole or in part, to the extent permitted by Law, by the applicable Party): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Stockholder Approval</U>. The Company Stockholder Approval shall have been obtained. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>No Legal Restraints</U>. No Law or Order (whether temporary, preliminary or permanent) shall have been promulgated, enacted or issued
by any Governmental Entity of competent jurisdiction that prohibits or makes illegal the consummation of the Merger. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Regulatory
Approvals</U>. The waiting period (and any extensions thereof) under the HSR Act applicable to the Merger shall have expired or been terminated. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <U>Charter Amendment</U>. The Charter Amendment is effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2. <U>Conditions to Obligations of Parent, Buyer and Merger Sub to Effect the Merger</U>. The obligations of Parent, Buyer and
Merger Sub to consummate the Merger are subject to the satisfaction (or waiver by Parent) of the following conditions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)
<U>Representations and Warranties</U>. (i)&nbsp;The representations and warranties of the Company contained in <U>Section</U><U></U><U>&nbsp;3.1(a)</U> and <U>(b)</U>, <U>Section</U><U></U><U>&nbsp;3.3</U>, <U>Section</U><U></U><U>&nbsp;3.21</U> and
<U>Section</U><U></U><U>&nbsp;3.22</U> shall be true and correct in all respects as of the Closing Date as if made on and as of the Closing Date (or, in the case of representations and warranties that address matters only as of a particular date, as
of such date), (ii) the representations and warranties of the Company contained in <U>Section</U><U></U><U>&nbsp;3.2</U> shall be true and correct in all material respects as of the Closing Date as if made on and as of the Closing Date (or, in the
case of representations and warranties that address matters only as of a particular date, as of such date), excluding any inaccuracies which are fully accounted for in the calculation of the Fully Diluted Share Number at Closing, (iii)&nbsp;the
representations and warranties of the Company contained in <U>Section</U><U></U><U>&nbsp;3.6(a)</U> shall be true and correct in all respects as of the Closing Date as if made on and as of the Closing Date, and (iv)
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the other representations and warranties of the Company set forth in this Agreement shall be true and correct (in each case without giving effect to any materiality or Company Material Adverse
Effect qualifier therein), as of the date of this Agreement and as of the Closing Date as though made on or as of such date (or, in the case of representations and warranties that address matters only as of a particular date, as of such date),
except in the case of this clause (iv)&nbsp;where the failure of such representations and warranties to be so true and correct, individually or in the aggregate, has not had and would not reasonably be expected to have a Company Material Adverse
Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Covenants</U>. The Company shall have performed or complied in all material respects with all covenants and agreements
required by this Agreement to be performed or complied with by it prior to the Closing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>No Company Material Adverse Effect</U>.
Since the date of this Agreement, there shall not have occurred and be continuing any Company Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d)
<U>Officer&#146;s Certificate</U>. Parent and Buyer shall have received a certificate signed on behalf of the Company by an executive officer certifying that the conditions set forth in <U>Section</U><U></U><U>&nbsp;6.2(a)</U>,
<U>Section</U><U></U><U>&nbsp;6.2(b)</U> and <U>Section</U><U></U><U>&nbsp;6.2(c)</U> have been satisfied. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) <U>Other Deliverables</U>.
Parent and Buyer shall have received the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the Escrow Agreement duly executed by the Stockholder Representative and the
Escrow Agent; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the Paying Agent Agreement duly executed by the Stockholder Representative and the Paying Agent; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) a copy of executed payoff letters in respect of the Credit Facilities; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) a duly authorized and executed certificate from the Company, in a form reasonably satisfactory to Parent and Buyer, in accordance with
Treasury Regulations Sections <FONT STYLE="white-space:nowrap">1.1445-2(c)</FONT> and <FONT STYLE="white-space:nowrap">1.897-2(h)</FONT> certifying that the sale of the Company Capital Stock and other transactions contemplated by this Agreement are
exempt from withholding pursuant to Section&nbsp;1445 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3. <U>Conditions to Obligations of the Company to
Effect the Merger</U>. The obligation of the Company to consummate the Merger is subject to the satisfaction at or prior to the Closing of the following conditions (which may be waived in whole or in part by the Company): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Representations and Warranties</U>. The representations and warranties of Parent and Merger set forth in this Agreement shall be true
and correct (in each case without giving effect to any materiality or Parent Material Adverse Effect qualifier therein), as of the date of this Agreement and as of the Closing Date as though made on or as of such date (or, in the case of
representations and warranties that address matters only as of a particular date, as of such date), except where the failure of such representations and warranties to be true and correct, individually or in the aggregate, would not reasonably be
expected to have a Parent Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Covenants</U>. Parent, Buyer, and Merger Sub shall have performed or complied in all
material respects with all covenants and agreements required by this Agreement to be performed or complied with by each of them prior to the Closing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>No Parent Material Adverse Effect</U>. Since the date of this Agreement, there shall not have occurred and be continuing any Parent
Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <U>Officer&#146;s Certificate</U>. The Company shall have received a certificate signed on behalf of Parent
by an executive officer certifying that the conditions set forth in <U>Section</U><U></U><U>&nbsp;6.3(a)</U>, <U>Section</U><U></U><U>&nbsp;6.3(b) and Section</U><U></U><U>&nbsp;6.3(c)</U> have been satisfied. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) <U>Other Deliverables</U>. The Company shall have received the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the Escrow Agreement duly executed by the Buyer and the Escrow Agent; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the Paying Agent Agreement duly executed by Buyer and the Paying Agent. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TERMINATION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1. <U>Termination</U>. This Agreement may be terminated and the Merger may be abandoned at any time prior to the Closing (with
any termination by Parent also being an effective termination by Buyer and Merger Sub): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) By the mutual written consent of Parent and
the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) By either of Parent or the Company, by written notice to the other: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) if the Merger shall not have been consummated on or before November&nbsp;30, 2017 (the &#147;<U>Outside Date</U>&#148;);
<U>provided</U> that the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;7.1(b)(i)</U> shall not be available to any Party whose failure to perform in all material respects its obligations under this Agreement was a
primary cause of the failure of the Merger to have been consummated by the Outside Date; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) if any Governmental
Entity of competent jurisdiction shall have issued an Order permanently restraining, enjoining or otherwise prohibiting the Merger and such Order shall have become final and <FONT STYLE="white-space:nowrap">non-appealable;</FONT> <U>provided</U>
that the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;7.1(b)(ii)</U> shall not be available to any Party unless such Party shall have used its reasonable best efforts to oppose any such Order and to have such
Order vacated or made inapplicable to such Merger; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) by the Company, by written notice to Parent, if Parent, Buyer or Merger Sub shall have
breached any of its representations, warranties, covenants or agreements set forth in this Agreement, such that the conditions set forth in <U>Section</U><U></U><U>&nbsp;6.3(a)</U> or <U>Section</U><U></U><U>&nbsp;6.3(b)</U> would be incapable of
being satisfied by the Outside Date and, if such breach is curable, following notice of such breach by the Company to Parent such breach is not cured within thirty days (or the Business Day before the Outside Date, if earlier); <U>provided</U> that
the Company shall not have the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;7.1(c)</U> if the Company is in material breach of any of its covenants or agreements contained in this Agreement, which breach has not
been cured; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) by Parent, by written notice to the Company, if the Company shall have breached any of its representations, warranties,
covenants or agreements set forth in this Agreement such that the conditions set forth in <U>Section</U><U></U><U>&nbsp;6.2(a)</U> or <U>Section</U><U></U><U>&nbsp;6.2(b)</U> would be incapable of being satisfied by the Outside Date and, if such
breach is curable, following notice of such breach by the Company to Parent such breach is not cured within thirty days (or the Business Day before the Outside Date, if earlier); <U>provided</U> that Parent shall not have the right to terminate this
Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;7.1(d)</U> if Parent, Buyer or Merger Sub is in material breach of any of its covenants or agreements contained in this Agreement, which breach has not been cured; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) by Parent, by written notice to the Company, if written consents evidencing the Company Stockholder Approval are not delivered to Parent
within 24 hours following the time this Agreement is executed and delivered by the Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2. <U>Effect of
Termination</U>. In the event of the termination of this Agreement in accordance with <U>Section</U><U></U><U>&nbsp;7.1</U>, this Agreement shall forthwith become void and have no effect, and there shall not be any liability or obligation on the
part of any Party hereto (or any of its Representatives or Affiliates) to another Party, except that (i)&nbsp;the provisions of this <U>Section</U><U></U><U>&nbsp;7.2</U> and <U>Article IX</U> shall survive such termination and (ii)&nbsp;no such
termination shall relieve any Party from liability to any other Party for willful and material breach of this Agreement. For purposes of this Agreement, &#147;willful and material breach&#148; shall mean a material breach that is a consequence of an
action by the breaching Party (or failure to act by the breaching Party) with the Knowledge that the taking of such action (or failure to take such action) would, or would reasonably be expected to, cause a breach of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>INDEMNIFICATION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.1. <U>Survival</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The representations and warranties contained in this Agreement shall survive the Closing Date hereunder and continue in full force and
effect until the date that is fifteen months following the Closing Date, except that (i)&nbsp;the representations and warranties contained in <U>Section</U><U></U><U>&nbsp;3.1</U> (Organization and Corporate Power),
<U>Section</U><U></U><U>&nbsp;3.2</U> (Capitalization), <U>Section</U><U></U><U>&nbsp;3.3</U> (Authority), <U>Section</U><U></U><U>&nbsp;3.21</U> (Stockholder Vote Required), <U>Section</U><U></U><U>&nbsp;3.22</U> (Brokers),
<U>Section</U><U></U><U>&nbsp;4.1</U> (Organization and Corporate Power), <U>Section</U><U></U><U>&nbsp;4.2</U> (Authority) and <U>Section</U><U></U><U>&nbsp;4.5</U> (Brokers) (and any corresponding representations made in the closing certificate
provided pursuant to <U>Section</U><U></U><U>&nbsp;6.2(d)</U> or <U>Section</U><U></U><U>&nbsp;6.3(c)</U>) shall survive indefinitely, (ii)&nbsp;the representations and warranties contained in <U>Section</U><U></U><U>&nbsp;3.12</U> (Taxes) shall
survive until the date that is 60 days after the expiration of the applicable statute of limitations (after giving effect to any extensions or waivers), and (iii)&nbsp;the representations and warranties contained in
<U>Section</U><U></U><U>&nbsp;3.10</U> (Company Benefit Plans) and <U>Section</U><U></U><U>&nbsp;3.17</U> (Certain Regulatory Matters), shall survive until the date that is <FONT STYLE="white-space:nowrap">thirty-six</FONT> months following the
Closing Date. The representations and warranties set forth in clauses (i)&nbsp;and (ii) are the &#147;<U>Specified Representations</U>&#148;. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Each of the covenants and agreements contained herein that are to be performed following the Closing shall survive the Closing and
continue in full force and effect in accordance with their terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.2. <U>Indemnification</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) From and after the Closing, Parent, Buyer, the Surviving Corporation and their Affiliates and each of their respective officers,
directors, employees, agents and other Representatives (each, a &#147;<U>Buyer Indemnified Party</U>&#148;) shall be indemnified and held harmless from and against any and all Losses incurred or suffered by a Buyer Indemnified Party, arising out of,
or resulting from: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) any breach of or inaccuracy in any representation or warranty of Company as of the date of this
Agreement or as of the Closing Date as if made on and as of such date; <U>provided</U> that for purposes of determining both (x)&nbsp;the amount of any Losses and (y)&nbsp;whether there has been any such breach or inaccuracy, any qualifications as
to materiality or Company Material Adverse Effect or similar qualifiers shall be disregarded; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) any breach of or
failure by the Company to perform, or cause to be performed, any of the covenants or obligations contained in this Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;(A) any liability or obligation for Taxes of the Company or any Company Subsidiary, for any Tax period ending on or
before the Closing Date (&#147;<U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period</U>&#148;) or with respect to any Tax period that begins on or before and ends after the Closing Date (&#147;<U>Straddle Period</U>&#148;), for the
portion thereof ending on the Closing Date, in each case except to the extent such amounts have been included in (and resulted in a reduction to) the Final Purchase Price or (B)&nbsp;any liability or obligation (as a result of Treasury Regulations <FONT
STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> or otherwise) for Taxes of any Person (other than Company or any of the Company Subsidiaries) which is or has ever been affiliated with Company or any of the Company Subsidiaries or with whom
Company or any of the Company Subsidiaries otherwise joins or has ever joined (or is or has ever been required to join) in filing any consolidated, combined, unitary, aggregate or similar Tax Return, prior to the Closing Date except, in each case,
any Taxes taken into account as a Current Liability in calculating Net Working Capital, any Transaction Payroll Taxes and any transfer Taxes arising out of or resulting from the transactions contemplated by this Agreement; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) any Indebtedness of the Company or the Company Subsidiaries incurred,
assumed or otherwise arising prior to the Closing or any Transaction Expenses, in each case to the extent not taken into account in the calculation of the Estimated Purchase Price and the Final Purchase Price. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) The sole and exclusive remedy of the Buyer Indemnified Parties with respect to indemnification under
<U>Section</U><U></U><U>&nbsp;8.2(a)</U> of this Agreement shall be: (i)&nbsp;first, to the extent there are sufficient Indemnity Escrow Funds to satisfy such indemnification obligation, by release of Indemnity Escrow Funds to the applicable Buyer
Indemnified Parties in accordance with the procedures set forth in this Agreement and the Escrow Agreement and (ii)&nbsp;second, by reducing any Milestone Payment
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">dollar-for-dollar</FONT></FONT> by the amount of such indemnification obligation in accordance with <U>Section</U><U></U><U>&nbsp;8.4(b)</U>. Other than with respect to actual fraud
or with respect to matters for which the remedy of specific performance, injunctive relief or other <FONT STYLE="white-space:nowrap">non-monetary</FONT> equitable remedies are available, the sole and exclusive remedy of all parties from and after
the Closing with respect to any breach of this Agreement shall be limited to this <U>Article VIII</U>. The Buyer Indemnified Parties shall not be entitled to indemnification for any Losses that are in the nature of punitive or special damages
(except to the extent a Buyer Indemnified Party pays to any third party any such damages) and, in calculating the amount of any Losses, no methodology related to the &#147;diminution in value&#148; of the Company shall be used. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything herein to the contrary, the Buyer Indemnified Parties shall not be entitled to indemnification pursuant to
<U>Section</U><U></U><U>&nbsp;8.2(a)(i)</U> until (A)&nbsp;with respect to any given claim for Losses, such claim is individually in excess of $50,000 (the &#147;<U>Individual Basket Amount</U>&#148;) (it being understood that the Buyer Indemnified
Parties may recover for the full amount of such Losses once the claim exceeds such Individual Basket Amount), and (B)&nbsp;the aggregate Losses of the Buyer Indemnified Parties with respect to indemnification claims pursuant to
<U>Section</U><U></U><U>&nbsp;8.2(a)(i)</U> that individually exceed the Individual Basket Amount exceeds on a cumulative basis an amount equal to $3,000,000; <U>provided</U> that, in each case of clauses (A)&nbsp;and (B), the foregoing limitation
shall not apply with respect to breaches of or inaccuracies in the Specified Representations of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding anything
herein to the contrary, the Buyer Indemnified Parties shall not be entitled to any indemnification arising out of any Losses (i)&nbsp;for&nbsp;any Taxes arising in any taxable period (or portion thereof) beginning after the Closing Date attributable
to a breach of the representations in <U>Section</U><U></U><U>&nbsp;3.12</U> other than the representation in <U>Section</U><U></U><U>&nbsp;3.12(e)</U>, or <U>(i)</U>, (ii) based on the amount or availability of any Tax asset or attribute (e.g., any
net operating loss carryover or tax credit carryover) of the Company or its Subsidiaries, or the ability of Buyer or its Subsidiaries to utilize any such Tax asset or attribute for any taxable period commencing on or after the Closing or
(iii)&nbsp;for Taxes arising from actions of Buyer or its Affiliates on the Closing Date after the Closing outside the ordinary course of business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) From and after the Closing, Buyer shall indemnify each holder of shares of Company Capital
Stock (each, a &#147;<U>Seller Indemnified Party</U>&#148;) from and against any and all Losses incurred or suffered by such Seller Indemnified Party arising out of, resulting from, or relating to (A)&nbsp;any breach of or inaccuracy in any
representation or warranty of Parent, Buyer or Merger Sub as of the date of this Agreement or as of the Closing Date as if made on and as of such date; <U>provided</U> that for purposes of determining both (i)&nbsp;the amount of any Losses and
(ii)&nbsp;whether there has been any such breach or inaccuracy, any qualifications as to materiality or Parent Material Adverse Effect or similar qualifiers shall be disregarded and (B)&nbsp;any breach of or failure by Parent, Buyer or Merger Sub to
perform, or cause to be performed, any of the covenants or obligations contained in this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) The Buyer shall use commercially
reasonable efforts to mitigate any Losses claimed under this <U>Article VIII</U> upon Buyer becoming aware of such Losses. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) The amount
of any and all Losses for which indemnification is provided pursuant to this <U>Article VIII</U> will be net of any reduction in taxes actually realized (determined on a &#147;with or without&#148; basis) by a Buyer Indemnified Party (as determined
in its reasonable discretion exercised in good faith) by reason of payment of such obligation or liability (taking into account any tax cost or reduction in such tax benefits by reason of receipt of the indemnification payment) and any amounts of
any insurance proceeds, other indemnification payments, contribution payments or reimbursements actually received (net of any deductibles and the costs and expenses incurred in obtaining such proceeds, payments or reimbursements) by the Buyer
Indemnified Party with respect to such Losses or any of the circumstances giving rise thereto, which the Buyers shall use commercially reasonable efforts to seek. For the avoidance of doubt, if the Buyer is entitled to claims or payments in respect
of the same factual circumstances under more than one provision of this Agreement, it will only be entitled to recover indemnification for any specific Loss once under the provisions of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.3. <U>Procedure for Indemnification</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Any Buyer Indemnified Party or Seller Indemnified Party seeking indemnification under <U>Section</U><U></U><U>&nbsp;8.2</U> (an
&#147;<U>Indemnified Party</U>&#148;) shall, in the case of a Buyer Indemnified Party, promptly notify in writing the Stockholder Representative and, in the case of a Seller Indemnified Party, promptly notify in writing the Buyer (any such notice, a
&#147;<U>Notice of Claim</U>&#148;); <U>provided</U>, <U>however</U>, that no delay on the part of any Indemnified Party in providing such notice shall adversely affect the rights of the Indemnified Party under <U>Section</U><U></U><U>&nbsp;8.2</U>.
The Notice of Claim shall set forth in reasonable detail (i)&nbsp;the date and nature and basis of such claim and (ii)&nbsp;a good faith estimate of the amount of such claim. The Indemnified Party shall provide any information reasonably requested
by the Stockholder Representative or the Buyer, as the case may be, in relation to such claim. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) If a claim for indemnification is with
respect to a Proceeding by a third-party against an Indemnified Party, the Stockholder Representative, in the case of a claim by a Buyer Indemnified Party and Buyer, in the case of a claim by a Seller Indemnified Party (the Stockholder
Representative or Buyer, as applicable, the &#147;<U>Indemnifying Party</U>&#148;), shall be entitled (but not obligated) to defend the Indemnified Party against such Proceeding with counsel selected by the Indemnifying Party (subject to the
reasonable approval of the Indemnified Party) at the Indemnifying Party&#146;s sole cost and expense; <U>provided</U> <U>however</U> that prior to assuming such control of the Proceeding, the Indemnifying Party acknowledges in writing that it is
obligated to indemnify the Indemnified Party with respect to such Proceeding to the extent provided for in, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and subject to the limitations of, this <U>Article VIII</U>. The Indemnifying Party shall not consent to the entry of any judgment or enter into any settlement with respect to such Proceeding
without the prior written consent of the Indemnified Party (not to be unreasonably withheld, conditioned or delayed), unless the judgment or proposed settlement (i)&nbsp;involves only the payment of money damages against which the Indemnified Party
is indemnified in full by release of Indemnity Escrow Funds at the time of such settlement, (ii)&nbsp;releases the Indemnified Party and its Affiliates from all liability or obligation in connection with such Proceeding, (iii)&nbsp;does not impose
an injunction or other equitable relief upon the Indemnified Party or its Affiliates and (iv)&nbsp;does not involve a finding or admission of any violation of applicable Law or other wrongdoing by the Indemnified Party or its Affiliates. If the
Indemnifying Party elects to assume the defense of such a Proceeding, the Indemnified Party shall, at the Indemnifying Party&#146;s sole cost and expense, cooperate in all reasonable respects with the Indemnifying Party and its attorneys in such
defense. In any such Proceeding, the Indemnified Party shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at its own expense unless representation of both the Indemnified Party and the Indemnifying
Party by the same counsel would represent a conflict of interest for such counsel under applicable standards of professional conduct for attorneys, in which case the Indemnifying Party will pay (including through release of Indemnity Escrow Funds to
make such payments) the reasonable fees and expenses of such counsel. This <U>Section</U><U></U><U>&nbsp;8.3(b)</U> shall not apply to any Tax Claim, which shall be governed by <U>Section</U><U></U><U>&nbsp;5.13</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.4. <U>Release of Funds from Escrow and Offset of Milestone Payments</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Any indemnification payment that a Buyer Indemnified Party is entitled to pursuant to this <U>Article VIII</U> shall be paid, to the
extent there are sufficient Indemnity Escrow Funds, by release of Indemnity Escrow Funds to such Buyer Indemnified Party by the Escrow Agent within five Business Days after the date notice of such proposed release is given to both the Stockholder
Representative and the Escrow Agent, except if the Stockholder Representative delivers a written objection to Buyer (with a copy to the Escrow Agent) objecting to such release, in which case Indemnity Escrow Funds shall only be released upon the
final resolution of such objection (either pursuant to agreement between Buyer and the Stockholder Representatives or by an Order from a court of competent jurisdiction ordering the release of such funds by the Escrow Agent). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) On the date that is 15 months after the Closing Date, the Escrow Agent shall release the remaining Indemnity Escrow Funds (to the extent
not utilized to pay for any indemnification claims hereunder) for disbursement to the former holders of Company Capital Stock, Company Warrants and Company Options as set forth below, except that the Escrow Agent shall retain all or a portion of the
Indemnity Escrow Funds then held by the Escrow Agent in an amount reasonably necessary to satisfy the outstanding claims for indemnification under this <U>Article VIII</U> asserted prior to the such date but not yet resolved (&#147;<U>Unresolved
Claims</U>&#148;). If there are any remaining Indemnity Escrow Funds after satisfaction of all indemnity claims (including Unresolved Claims) under this <U>Article VIII</U>, Buyer and the Stockholder Representative shall jointly instruct the Escrow
Agent to release (1)&nbsp;to the Paying Agent an amount equal to the Indemnity Escrow Release Per Share Payment owed, with respect to all shares of Company Capital Stock and Company Warrants, to the former holders of shares of Company Capital Stock
and Company Warrants and (2)&nbsp;to the Company an amount equal to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the aggregate Indemnity Escrow Release Per Share Payment owed, with respect to all Company Options, to the former holders of Company Options. The Paying Agent shall promptly disburse the funds
received pursuant to this <U>Section</U><U></U><U>&nbsp;8.4(b)</U> to the former holders of Company Capital Stock and Company Warrants and the Company shall promptly disburse, through the Company&#146;s payroll (or by check for any holder who is not
a current employee of the Company), the funds received pursuant to this <U>Section</U><U></U><U>&nbsp;8.4(b)</U> to the former holders of Company Options, in each case in accordance with <U>Article II</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) In the event there are any claims for indemnification by a Buyer Indemnified Party that are for an amount greater than the then-remaining
Indemnity Escrow Funds (such claims, &#147;<U>Offset Claims</U>&#148; and the aggregate amount of such Offset Claims minus the then-remaining Indemnity Escrow Funds, the &#147;<U>Aggregate Offset Amount</U>&#148;), if any Milestone Payment would
otherwise become due following the time such Offset Claims have been made, such Milestone Payment shall be reduced <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">dollar-for-dollar</FONT></FONT> by the Aggregate Offset Amount and
if the Aggregate Offset Amount is greater than such Milestone Payment, any further Milestone Payments that would otherwise become due following such time shall also be reduced
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">dollar-for-dollar</FONT></FONT> until and to the extent the Milestone Payments that would otherwise have become due have been reduced, in the aggregate, by amount equal to the
Aggregate Offset Amount. In the event all Offset Claims are finally resolved (either pursuant to agreement between Parent and the Stockholder Representatives or by a final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> order from a court of
competent jurisdiction) for an amount (the aggregate amount for all Offset Claims, the &#147;<U>Offset Final Resolution Amount</U>&#148;) that is less than the Aggregate Offset Amount, then Buyer shall (and Parent shall cause Buyer to) deposit
(1)&nbsp;with the Paying Agent an amount equal to the aggregate Offset Claims Per Share Payment owed, with respect to all shares of Company Capital Stock and Company Warrants, to the former holders of shares of Company Capital Stock and Company
Warrants and (2)&nbsp;with the Company an amount equal to the aggregate Offset Claims Per Share Payment owed, with respect to all Company Options, to the former holders of Company Options. The Paying Agent shall promptly disburse the funds received
pursuant to this <U>Section</U><U></U><U>&nbsp;8.4(c)</U> to the former holders of Company Capital Stock and Company Warrants and the Company shall promptly disburse, through the Company&#146;s payroll (or by check for any holder who is not a
current employee of the Company), the funds received pursuant to this <U>Section</U><U></U><U>&nbsp;8.4(c)</U> to the former holders of Company Options, in each case in accordance with <U>Article II</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) &#147;<U>Offset Claims Per Share Payment</U>&#148; means an amount equal to the quotient of (A)&nbsp;(i) the Aggregate Offset Amount minus
(ii)&nbsp;the Offset Final Resolution Amount <U>divided by</U> (B)&nbsp;the then-applicable Fully Diluted Share Number. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e)
Notwithstanding anything herein to the contrary, Milestone Payments shall not be reduced by more than $36,250,000 as a result of indemnification claims pursuant to <U>Section</U><U></U><U>&nbsp;8.2(a)(i)</U>; <U>provided</U> that the foregoing
limitation shall not apply with respect to breaches of or inaccuracies in the Specified Representations of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) The Parties shall treat any indemnification payment made pursuant to this <U>Article VIII</U>
as an adjustment to the Final Purchase Price for income Tax purposes. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MISCELLANEOUS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.1. <U>Amendment and Modification</U>. Subject to applicable Law, this Agreement may be amended, modified and supplemented in
any and all respects, whether before or after obtaining the Company Stockholder Approval, by written agreement of the Parties hereto at any time prior to the Closing Date with respect to any of the terms contained herein; <U>provided</U>, that
following receipt of such stockholder approval, no amendment, modification or supplement of this Agreement shall be made that by applicable Law requires any further approval or authorization of such stockholders, without such approval or
authorization by such stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.2. <U>Extension; Waiver</U>. At any time prior to the Closing, each Party may
(a)&nbsp;extend the time for the performance of any of the obligations or other acts of the other Parties, (b)&nbsp;waive any inaccuracies in the representations and warranties of the other Parties contained in this Agreement or in any document
delivered pursuant to this Agreement or (c)&nbsp;waive compliance with any of the agreements or conditions of the other Parties contained in this Agreement. Any agreement on the part of a Party to any such extension or waiver shall be valid only if
set forth in an instrument in writing signed on behalf of such Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.3. <U>Expenses</U>. Except as otherwise provided in
this Agreement, all fees and expenses incurred by the Parties hereto shall be borne solely by the Party that has incurred such fees and expenses whether or not the Merger is consummated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.4. <U>Notices</U>. All notices and other communications in connection with this Agreement will be in writing and will be deemed
duly given (a)&nbsp;on the date of delivery if delivered personally, by facsimile or by electronic mail so long as confirmation of delivery is obtained or (b)&nbsp;on the first Business Day following the date of dispatch if delivered by a recognized
<FONT STYLE="white-space:nowrap">next-day</FONT> courier service. All notices in connection with this Agreement will be delivered as set forth below or pursuant to such other instructions as may be designated in writing by the Party to receive such
notice: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(a) if to Parent, Buyer or Merger Sub, to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Teleflex Incorporated </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">550 E.
Swedesford Rd., Suite 400 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Wayne, Pennsylvania 19087 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Attention: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;James J. Leyden </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Facsimile&nbsp;No.: &nbsp;&nbsp;&nbsp;&nbsp;(610) <FONT STYLE="white-space:nowrap">225-8780</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;james.leyden@teleflex.com
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">with a copy to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Simpson
Thacher&nbsp;&amp; Bartlett LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">425 Lexington Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">New York, New York 10017 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Attention: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mario Ponce </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Facsimile No.:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(212) <FONT STYLE="white-space:nowrap">455-2502</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;mponce@stblaw.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(b) if to the Company, to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">NeoTract, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">4473 Willow
Road, Suite 100 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Pleasanton, California 94588 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Attention: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jason Throne, Vice President, General Counsel </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;jthrone@neotract.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">with a copy to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Wilson
Sonsini Goodrich&nbsp;&amp; Rosati, P.C. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">650 Page Mill Road </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Palo Alto, California 94304 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Attention: Philip H. Oettinger </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Facsimile No: (650) <FONT STYLE="white-space:nowrap">493-6811</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Email: poettinger@wsgr.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Wilson Sonsini
Goodrich&nbsp;&amp; Rosati, P.C. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">1 Market Street, Suite 3300 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">San Francisco, California 94105 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Attention: Robert T. Ishii </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Facsimile No: (415) <FONT STYLE="white-space:nowrap">947-2099</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Email: rishii@wsgr.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(c) if
to the Stockholder Representative, to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Shareholder Representative Services LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">950 17<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>&nbsp;Street, Suite 1400 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Denver, CO 80202 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Attention:
Managing Director </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Email:&nbsp;deals@srsacquiom.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Facsimile No.:&nbsp;(303) <FONT STYLE="white-space:nowrap">623-0294</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Telephone No:&nbsp;(303) <FONT STYLE="white-space:nowrap">648-4085</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">with a copy to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Wilson
Sonsini Goodrich&nbsp;&amp; Rosati, P.C. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">650 Page Mill Road </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Palo Alto, California 94304 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Attention: Philip H. Oettinger </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Facsimile No: (650) <FONT STYLE="white-space:nowrap">493-6811</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Email: poettinger@wsgr.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Wilson Sonsini Goodrich&nbsp;&amp; Rosati, P.C. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">1 Market Street, Suite 3300 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">San Francisco, California 94105 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Attention: Robert T. Ishii </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Facsimile No: (415) <FONT STYLE="white-space:nowrap">947-2099</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">Email: rishii@wsgr.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.5. <U>Entire Agreement</U>. This Agreement (including the Exhibits hereto), the Company Disclosure Letter, the Parent
Disclosure Letter and the Confidentiality Agreement constitute the entire agreement and supersede all prior agreements and understandings, both written and oral, among the Parties with respect to the subject matter hereof and thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.6. <U>Third Party Beneficiaries</U>. This Agreement is not intended to confer any rights (including the right to rely upon the
representations, warranties and covenants set forth herein), benefits, remedies, obligations or liabilities upon any Person other than the Parties hereto and their respective successors and assigns, except that (i)&nbsp;following the Effective Time,
the provisions of <U>Section</U><U></U><U>&nbsp;5.6</U> shall be enforceable by each Company Indemnified Party and his or her heirs, executors or administrators and representatives, (ii)&nbsp;following the Effective Time, the provisions of
<U>Article II</U> with respect to the rights of holders of shares of Company Capital Stock and Company Options to receive the payments set forth in <U>Article II</U> shall be enforceable by such holders, and (iii)&nbsp;following the Effective Time,
the provisions of <U>Section</U><U></U><U>&nbsp;5.7</U> shall be enforceable by the Stockholder Representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.7.
<U>Severability</U>. If any term, provision, covenant or restriction (or part thereof) of this Agreement is held by a court of competent jurisdiction or other Governmental Entity to be invalid, void, unenforceable or against its regulatory policy,
the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated, so long as the economic and legal substance of the transactions
contemplated hereby, taken as a whole, are not affected in a manner materially adverse to any Party hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.8.
<U>Assignment</U>. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the Parties in whole or in part (whether by operation of Law or otherwise) without the prior written consent of the other
Parties, and any such assignment without such consent shall be null and void. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.9. <U>Governing Law</U>. This Agreement
shall be governed and construed in accordance with the Laws of the State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.10. <U>Exclusive Jurisdiction</U>.
Each of the Parties (a)&nbsp;consents to submit itself, and hereby submits itself, to the personal jurisdiction of the Court of Chancery of the State of Delaware and any federal court located in the State of Delaware, or, if neither of such courts
has subject matter jurisdiction, any state court of the State of Delaware having subject matter jurisdiction, in the event any dispute arises out of this Agreement or any of the transactions contemplated by this Agreement, (b)&nbsp;agrees that it
will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court, and agrees not to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
plead or claim any objection to the laying of venue in any such court or that any judicial proceeding in any such court has been brought in an inconvenient forum, (c)&nbsp;agrees that it will not
bring any action relating to this Agreement or any of the transactions contemplated by this Agreement in any court other than the Court of Chancery of the State of Delaware and any federal court located in the State of Delaware, or, if neither of
such courts has subject matter jurisdiction, any state court of the State of Delaware having subject matter jurisdiction, and (d)&nbsp;consents to service of process being made through the notice procedures set forth in
<U>Section</U><U></U><U>&nbsp;9.5</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.11. <U>Specific Performance</U>. The Parties agree that irreparable damage would
occur and that the Parties would not have any adequate remedy at law in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the
Parties shall be entitled to an injunction or injunctions to prevent breaches or threatened breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in the Court of Chancery of the State of Delaware or, if
under applicable Law exclusive jurisdiction over such matter is vested in the federal courts, any federal court located in the State of Delaware without proof of actual damages or otherwise (and, to the fullest extent permitted by Law, each Party
hereby waives any requirement for the securing or posting of any bond in connection with such remedy), this being in addition to any other remedy to which they are entitled at law or in equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.12. <U>Stockholder Representative</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) By virtue of the adoption of this Agreement by the Company Stockholder Approval, and without any further action of any of the holders of
Company Capital Stock or the Company, Shareholder Representative Services LLC is hereby irrevocably nominated, constituted and appointed as the exclusive representative, agent and true and lawful attorney in fact of holders of Company Capital Stock
(the &#147;<U>Stockholder Representative</U>&#148;), with full power of substitution (and, if substituted, the Stockholder Representative will promptly notify Parent and Buyer of such substitution) to act in the name, place and stead of the holders
of Company Capital Stock with respect to this Agreement, as the same may be from time to time amended, and with respect to the transactions contemplated hereby, and to do or refrain from doing all such acts and things, and to execute all such
documents, as the Stockholder Representative shall deem necessary or appropriate in connection with this Agreement, any agreements contemplated by this Agreement or any of the transactions contemplated hereby or thereby. Without limiting the
generality of the foregoing, the Stockholder Representatives is hereby authorized to take all actions on behalf of the holders of Company Capital Stock in connection with any actions taken or to be taken under <U>Section</U><U></U><U>&nbsp;2.5</U>,
<U>Section</U><U></U><U>&nbsp;2.6</U> and <U>Article VIII</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) All decisions and actions of the Stockholder Representative shall be
final, binding and conclusive on the holders of Company Capital Stock and may be relied upon by Parent, Buyer and their Affiliates as the decisions and actions of the holders of Company Capital Stock. The Stockholder Representative shall not be
liable to any of the holders of Company Capital Stock for any act done or omitted by the Stockholder Representative in good faith pursuant to this Agreement or any agreement ancillary hereto or any mistake of fact or Law unless caused by the
Stockholder Representative&#146;s willful misconduct in the performance of its duties under this Agreement. The holders of shares of Company Capital Stock will indemnify, defend and hold harmless the Stockholder Representative from and against any
and all losses, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
liabilities, damages, claims, penalties, fines, forfeitures, actions, fees, costs and expenses (including the fees and expenses of counsel and experts and their staffs and all expense of document
location, duplication and shipment) (collectively, &#147;<U>Representative Losses</U>&#148;) arising out of or in connection with the Stockholder Representative&#146;s execution and performance of this Agreement and any agreements ancillary hereto,
in each case as such Representative Loss is suffered or incurred; <U>provided</U>, that in the event that any such Representative Loss is finally adjudicated to have been directly caused by the gross negligence or willful misconduct of the
Stockholder Representative, the Stockholder Representative will reimburse the holders of shares of Company Capital Stock the amount of such indemnified Representative Loss to the extent attributable to such gross negligence or willful misconduct. If
not paid directly to the Stockholder Representative by the holders of shares of Company Capital Stock, any such Representative Losses may be recovered by the Stockholder Representative from (i)&nbsp;the funds in the Stockholder Representative
Expense Funds, (ii)&nbsp;the amounts in the Indemnity Escrow Funds and Purchase Price Adjustment Escrow Funds at such time as remaining amounts would otherwise be distributable to the holders of shares of Company Capital Stock, and (iii)&nbsp;from
any Milestone Payments at such time as any such amounts would otherwise be distributable to the holders of shares of Company Capital Stock; <U>provided</U>, that while this section allows the Stockholder Representative to be paid from the
aforementioned sources of funds, this does not relieve the holders of shares of Company Capital Stock from their obligation to promptly pay such Representative Losses as they are suffered or incurred, nor does it prevent the Stockholder
Representative from seeking any remedies available to it at law or otherwise. In no event will the Stockholder Representative be required to advance its own funds on behalf of the holders of shares of Company Capital Stock or otherwise.
Notwithstanding anything in this Agreement to the contrary, any restrictions or limitations on liability or indemnification obligations of the holders of shares of Company Capital Stock set forth elsewhere in this Agreement are not intended to be
applicable to the indemnities provided to the Stockholder Representative under this Section. The foregoing indemnities will survive the Closing, the resignation or removal of the Stockholder Representative or the termination of this Agreement. In
taking any action or refraining from taking any action whatsoever the Stockholder Representative shall be protected in relying upon any notice, paper or other document reasonably believed by it to be genuine, or upon any evidence reasonably deemed
by it to be sufficient. The Stockholder Representative may consult with counsel in connection with its duties and shall be fully protected in any act taken, suffered or permitted by it in good faith in accordance with the advice of counsel. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) The holders of shares of Company Capital Stock will not receive any interest or earnings on the Stockholder Representative Expense Funds
and irrevocably transfer and assign to the Stockholder Representative any ownership right that they may otherwise have had in any such interest or earnings. The Stockholder Representative will not be liable for any loss of principal of the
Stockholder Representative Expense Funds other than as a result of its gross negligence or willful misconduct. The Stockholder Representative will hold these funds separate from its corporate funds, will not use these funds for its operating
expenses or any other corporate purposes and will not voluntarily make these funds available to its creditors in the event of bankruptcy. For tax purposes, the Stockholder Representative Expense Funds will be treated as having been received and
voluntarily set aside by the Company&#146;s shareholders at the time of Closing. If there are any Stockholder Representative Expense Funds remaining following the payment by the Stockholder Representative of all costs and expenses that may be
reasonably expected to be incurred by the Stockholder Representative, in its capacity </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
as such, in connection the transactions contemplated by this Agreement, at such time the Stockholder Representative shall deposit (a)&nbsp;with the Paying Agent an amount equal to the aggregate
Stockholder Representative Unused Funds Per Share Payment owed, with respect to all shares of Company Capital Stock, to the former holders of shares of Company Capital Stock and (b)&nbsp;with the Surviving Corporation an amount equal to the
aggregate Stockholder Representative Unused Funds Per Share Payment owed, with respect to all Company Options, to the former holders of Company Options. The Paying Agent shall promptly disburse the funds received pursuant to this
<U>Section</U><U></U><U>&nbsp;9.12(c)</U> to the former holders of Company Capital Stock and the Company shall promptly disburse, through the Company&#146;s payroll (or by check for any holder who is not a current employee of the Company), the funds
received pursuant to this <U>Section</U><U></U><U>&nbsp;9.12(c)</U> to the former holders of Company Options, in each case in accordance with <U>Article II</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.13. <U>Legal Representation</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Wilson Sonsini Goodrich&nbsp;&amp; Rosati (&#147;<U>WSGR</U>&#148;) has acted as counsel for the securityholders, the Company (prior to
and including the Effective Time) and the Stockholder Representative (collectively, the &#147;<U>Company Parties</U>&#148;) in connection with the transaction documents and the transactions contemplated hereby and thereby (the &#147;<U>Acquisition
Engagement</U>&#148;) and, in that connection, not as counsel for any other Person, including, without limitation, Parent, Buyer or any of its Affiliates (including the Surviving Corporation). Only the Company Parties shall be considered clients of
WSGR in the Acquisition Engagement. If the Stockholder Representative so desires, WSGR shall be permitted, without the need for any future waiver or consent, to represent any of the securityholders or the Stockholder Representative after the Closing
in connection with any matter related to the matters contemplated by any of the transaction documents or any disagreement or dispute relating thereto and may in connection therewith represent the Representatives or Affiliates of the securityholders
and the Stockholder Representative, in any of the foregoing cases including, without limitation, in any action, dispute, litigation or other adversary proceeding against, with or involving Parent, Buyer, the Surviving Corporation or any of their
Representatives or Affiliates. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) To the extent that communications between a Company Party, on the one hand, and WSGR, on the other
hand, relate to the Acquisition Engagement, such communication shall be deemed to be attorney-client confidences that belong solely to the Stockholder Representative, for and on behalf of the secuityholders. Neither Parent nor any of its Affiliates,
including the Buyer and Surviving Corporation, shall have access to (and Parent hereby waives, on behalf of each, any right of access it may otherwise have with respect to) any such communications or the files or work product of WSGR, to the extent
that they relate to the Acquisition Engagement, whether or not the Closing occurs. Without limiting the generality of the foregoing, Parent acknowledges and agrees, for itself and on behalf of its Affiliates, including the Surviving Corporation,
upon and after the Closing: (i)&nbsp;the Stockholder Representative, for and on behalf of the securityholders, and WSGR shall be the sole holders of the attorney-client privilege of the Company Parties with respect to the Acquisition Engagement, and
neither Parent nor any of its Affiliates, including the Buyer and the Surviving Corporation, shall be a holder thereof; (ii)&nbsp;to the extent that files or work product of WSGR in respect of the Acquisition Engagement constitute property of a
client of WSGR, only the Stockholder Representative, for and on behalf of the securityholders, shall hold such property rights of any Company Parties and have the right to waive or modify such property rights; and (iii)&nbsp;WSGR
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shall have no duty whatsoever to reveal or disclose any such attorney-client communications, files or work product to Parent or any of its Affiliates, including the Buyer and the Surviving
Corporation, by reason of any attorney-client relationship between WSGR and the Company Parties or otherwise; <U>provided</U> that, to the extent any communication is both related and unrelated to the Acquisition Engagement, WSGR shall provide (and
the Stockholder Representative, for and on behalf of the other Company Parties, shall instruct WSGR to provide) appropriately redacted versions of such communications, files or work product to Parent or its Affiliates, including the Buyer and the
Surviving Corporation. Notwithstanding the foregoing, in the event that a dispute arises between any of Parent, Buyer or the Surviving Corporation or their Affiliates, on the one hand, and any of the secuityholders or the Stockholder Representative,
on the other hand, concerning the matters contemplated in any of the transaction documents, Parent, for itself and on behalf of its Affiliates and the Buyer, Surviving Corporation and its Affiliates, agrees that Parent, Buyer, the Surviving
Corporation and their Affiliates shall not offer into evidence or otherwise attempt to use or assert the foregoing attorney-client communications, files or work product against the Stockholder Representative or the securityholders. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Without limitation of the foregoing, any other communication between a Company Party, on the one hand, and any Representative of a Company
Party (other than WSGR) or any other third person (other than Parent and its Affiliates), prior to the Closing and relating to the Acquisition Engagement shall be deemed confidential information of the securityholders, and from and after the
Closing, such communications shall be deemed to be confidential information that belong solely to the Stockholder Representative, for and on behalf of the securityholders. Prior to the Closing, the Company shall be entitled to transfer possession of
such communications (including any tangible and intangible copies of such communications) to the Stockholder Representative. Notwithstanding the foregoing, in the event that a dispute arises between any of Parent, Buyer or the Surviving Corporation
or their Affiliates, on the one hand, and any of the securityholders or the Stockholder Representative, on the other hand, concerning the matters contemplated in any of the transaction documents Parent, for itself and on behalf of its Affiliates and
the Buyer, the Surviving Corporation and its Affiliates, agrees that Parent, the Buyer the Surviving Corporation and their Affiliates shall not offer into evidence or otherwise attempt to use or assert the foregoing communications against the
Stockholder Representative or the securityholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.14. <U>Counterparts</U>. This Agreement may be executed in two or more
counterparts, all of which shall be considered one and the same agreement and shall become effective when two or more counterparts have been signed by each of the Parties and delivered to the other Parties (including by facsimile or via portable
document format (.pdf)), it being understood that all Parties need not sign the same counterpart. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.15.
<U>Interpretation</U>. The words &#147;include,&#148; &#147;includes,&#148; and &#147;including&#148; shall be deemed to be followed by &#147;without limitation&#148; whether or not they are in fact followed by such words or words of like import.
The words &#147;hereof,&#148; &#147;herein&#148; and &#147;hereunder&#148; and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. References to
&#147;this Agreement&#148; shall include the Parent Disclosure Letter and the Company Disclosure Letter. The word &#147;will&#148; shall be construed to have the same meaning and effect as the word &#147;shall.&#148; All terms defined in this
Agreement shall have the defined meanings when used in any certificate or other document made </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or delivered pursuant hereto unless otherwise defined therein. The Company Disclosure Letter and the Parent Disclosure Letter are hereby incorporated in and made a part of this Agreement as if
set forth in full herein. The definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term. Any Contract, instrument
or Law defined or referred to herein means such Contract, instrument or Law as from time to time amended, modified or supplemented in a manner consistent with this Agreement, including (in the case of Contracts or instruments) by waiver or consent
and (in the case of Laws) by succession of comparable successor Laws and references to all attachments thereto and instruments incorporated therein. References to a Person are also to its permitted successors and assigns. This Agreement is the
product of negotiations by the Parties having the assistance of counsel and other advisers. It is the intention of the Parties that this Agreement not be construed more strictly with regard to one Party than with regard to the others. The
descriptive headings used herein are inserted for convenience of reference only and are not intended to be part of or to affect the meaning or interpretation of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.16. <U>Definitions</U>. The following terms and those set forth in the Index of Defined Terms shall have the meanings specified
in this <U>Section</U><U></U><U>&nbsp;9.15</U> or on the corresponding page number of the Index of Defined Terms: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; of any Person means another Person that directly or indirectly, through one or more intermediaries, Controls, is
controlled by, or is under common control with, such first Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Advisor Fees</U>&#148; means payment due to J.P. Morgan
pursuant to the Engagement Letter between J.P. Morgan and the Company dated August&nbsp;31, 2017 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means
any day except a Saturday, a Sunday or other day on which banking institutions in the New York, New York are authorized or required by Law to be closed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Cash</U>&#148; means (1)&nbsp;cash and cash equivalents, including (x)&nbsp;any uncleared checks, drafts, other instruments
immediately convertible to cash or wires that are not yet credited to the account of the Company or the Company Subsidiaries (<U>minus</U> any outstanding checks written by the Company or the Company Subsidiaries (but not yet cashed)), and
(y)&nbsp;cash held in blocked accounts, cash management accounts, cash collateral accounts and reserve or escrow accounts, and (2)&nbsp;marketable securities, in each case of (1)&nbsp;and (2), as determined in accordance with GAAP as applied in a
manner consistent with the accounting practices and methodology used in preparing the Financial Statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Change of
Control</U>&#148; means (i)&nbsp;a merger or consolidation or sale of voting securities of Parent (or the Surviving Corporation) in a transaction or series of related transactions that results in more than 50% of the total voting power of all voting
securities of Parent (or the Surviving Corporation) or the surviving, resulting or parent entity in such transaction or series of related transactions that are outstanding immediately after the consummation thereof being held by Persons other than
those Persons that (individually or collectively) held 50% of the voting securities of Parent (or the Surviving Corporation) immediately prior to the consummation thereof, (ii)&nbsp;a sale or other disposition of all or substantially all of the
assets or voting securities </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of Parent (or the Surviving Corporation) to any Person (other than an Affiliate of Parent (or the Surviving Corporation)) in a transaction or series of related transactions or (iii)&nbsp;a sale,
license, transfer or other disposition, directly or indirectly, to any Person (other than an Affiliate of Parent) of a majority of all of the assets or rights (measured on either a fair market value or book value basis) that currently comprise the
Company Business or the Products in a transaction or series of related transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Charter Amendment</U>&#148; means an
amendment to the Company&#146;s certificate of incorporation permitting automatic conversion into Common Stock of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock or Series D Preferred Stock upon the date specified by
written consent or agreement of the holders of majority of the outstanding shares of such series of Company Preferred Stock, voting together as a single class on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Benefit Plan</U>&#148; means each &#147;employee benefit plan,&#148; within the meaning of Section&nbsp;3(3) of ERISA,
including multiemployer plans (within the meaning of Section&nbsp;3(37) of ERISA), and each other stock grant, stock purchase, stock option, restricted stock, other equity or equity-related, severance, employment, consulting, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control,</FONT></FONT> retention, fringe benefit, loan, collective bargaining, bonus, incentive, sabbatical, medical, dental, vision, disability, cafeteria benefit, dependent
care, welfare benefit, life insurance or accident insurance, retirement, supplemental retirement, deferred compensation or other compensation or benefit plan, agreement, program, policy or arrangement, currently sponsored, maintained, entered into
or contributed to (or required to be contributed to) by the Company or any of its ERISA Affiliates, or to which the Company or any of its ERISA Affiliates is a party, whether written or oral, for the benefit of any current or former Company Employee
(including their dependents or beneficiaries) or with respect to which the Company or any of its ERISA Affiliates has any liability (contingent or otherwise). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Business</U>&#148; means the business of developing, producing, marketing and selling the Products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Commercially Reasonable Efforts</U>&#148; means the expenditure of efforts and resources, consistent with the usual practice of
Parent (together with its Affiliates), with respect to marketing, sales and development of its other important products of similar market potential being actively and diligently marketed and sold by Parent (together with its Affiliates), including
using commercially reasonable efforts to expand, retain and incentivize the United States sales workforce of the Company, in each case taking into account the circumstances at the time, (x)&nbsp;including: (a) the competitiveness of alternative
products sold by third parties in the marketplace; and (b)&nbsp;the profitability of product, but (y)&nbsp;excluding (i) payments made or to be made pursuant to this Agreement and (ii)&nbsp;efforts, resources, sales or profitability of any Competing
Products owned, marketed or sold by Parent or its Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Board</U>&#148; means the Board of Directors of the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Common Stock</U>&#148; means the Company&#146;s common stock, par value $0.01 per share. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Employee</U>&#148; means any employee, consultant or director of the Company or
any of the Company Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Material Adverse Effect</U>&#148; means any event, change, condition, occurrence or
effect that, individually or in the aggregate with all other events, changes, conditions, occurrences or effects, (x)&nbsp;has had or would reasonably be expected to have a material adverse effect on the business or operations of the Company and the
Company Subsidiaries, taken as a whole, or (y)&nbsp;that prevents or materially delays or materially impairs, or that would reasonably be expected to prevent, materially delay or materially impair, the Company&#146;s ability to perform its
obligations under this Agreement or consummate the transactions contemplated hereby on a timely basis by the Outside Date, <U>provided</U>, that in determining whether a Company Material Adverse Effect has occurred pursuant to clause (x)&nbsp;above,
no event, change, condition, occurrence or effect resulting from any of the following shall be deemed to be or taken into account in determining whether there has been or will be, a &#147;Company Material Adverse Effect&#148;: (a) any event, change,
condition, occurrence or effect in or affecting financial, economic, social or political conditions generally or the securities, credit or financial markets in general, including interest rates or exchange rates, or any changes therein, in the
United States or other countries in which the Company or any of the Company Subsidiaries conduct operations, (b)&nbsp;any change, event or development generally affecting the industries in which the Company or any of the Company Subsidiaries
operate, (c)&nbsp;any adoption, implementation, proposal or change after the date hereof in any applicable Law or GAAP or interpretation of any of the foregoing, (d)&nbsp;the commencement, occurrence, continuation or escalation of any war, armed
hostilities or acts of terrorism, (e)&nbsp;the existence, occurrence or continuation of any force majeure events, including any earthquakes, floods, hurricanes, tropical storms, fires or other natural disasters or any national, international or
regional calamity, (f)&nbsp;the entry into or the announcement, pendency or performance of this Agreement or the transactions contemplated hereby or the consummation of any transactions contemplated hereby, and (g)&nbsp;the failure of the Company or
any Company Subsidiary to meet any internal or public projections, budgets, forecasts or estimates of revenues, earnings or other financial results for any period ending on or after the date of this Agreement; <U>provided</U>, <U>however</U>, that
the exception in this clause (g)&nbsp;shall not prevent the underlying facts giving rise or contributing to such failure, if not otherwise excluded from the definition of Company Material Adverse Effect, from being taken into account in determining
whether a Company Material Adverse Effect has occurred; <U>provided</U> <U>further</U> that with respect to clauses (a), (b), (c) and (d), such events, changes, conditions, occurrences or effects shall be taken into account to the extent they
disproportionately adversely affect the Company and the Company Subsidiaries, taken as a whole, compared to other companies operating in the industry in which the Company and the Company Subsidiaries operate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Option</U>&#148; means any option to purchase shares of Company Common Stock granted under any Company Benefit Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Stockholder Approval</U>&#148; means the adoption of this Agreement by the holders of a majority of the outstanding shares of
Company Capital Stock, voting on an as converted basis and the adoption of this Agreement by the holders of a majority of the outstanding shares of Company Preferred Stock, voting together as a class. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Subsidiary</U>&#148; means a Subsidiary of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Warrant</U>&#148; means Series A Warrants and Series C Warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Competing Product</U>&#148; means any product intended as a therapy for treatment of benign prostatic hyperplasia other than <FONT
STYLE="white-space:nowrap">Gel-Bead</FONT> embolization spheres (and any product that is a modification or derivative thereof). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Confidentiality Agreement</U>&#148; means the confidentiality agreement, dated April&nbsp;27, 2017 between Parent and the Company, as
the same may be further amended, supplemented or otherwise modified by the Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Constituent Documents</U>&#148; means, with
respect to any Person, the charter, the certificate or articles of incorporation or formation, bylaws, limited liability company or operating agreement or comparable organizational documents of such Person, as the same may be amended, supplemented
or otherwise modified from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Contract</U>&#148; means any note, bond, debenture, mortgage, indenture, deed of trust,
license, lease, agreement or other contract, agreement, commitment, instrument or obligation, in each case, including all amendments, supplements or other modifications thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Control</U>&#148; (including the terms &#147;<U>controlled by</U>&#148; and &#147;<U>under common control with</U>&#148;), with
respect to the relationship between or among two or more Persons, means the possession, directly or indirectly, of the power to direct or cause the direction of the affairs or management of a Person, whether through the ownership of voting
securities, as trustee or executor, by contract or any other means. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Credit Facilities</U>&#148; means (a)&nbsp;the Term Loan
Agreement, dated as of March&nbsp;24, 2014 as amended from time to time, by and among Capital Royalty Partners II L.P., Capital Royalty Partners II &#150; Parallel Fund &#147;A&#148; L.P., Parallel Investment Opportunities Partners II L.P., the
Company and the other parties thereto and (b)&nbsp;the Loan and Security Agreement, dated as of July&nbsp;10, 2015 as amended from time to time, by and among Comerica Bank, the Company and the other parties thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Current Assets</U>&#148; means those current assets of the Company and the Company Subsidiaries set forth on <U>Exhibit E</U> (which
shall exclude any deferred Tax assets and Cash),<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>in all cases as determined in accordance with GAAP as applied in a manner consistent with the accounting practices and methodology used in
preparing the Audited Financial Statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Current Liabilities</U>&#148; means those current liabilities of the Company and the
Company Subsidiaries set forth on <U>Exhibit E</U> (which shall exclude any deferred Tax liabilities, the current portion of any Indebtedness and accrued interest on any Indebtedness) in all cases determined in accordance with GAAP as applied in a
manner consistent with the accounting practices and methodology used in preparing the Audited Financial Statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA</U>&#148; means the Employee Retirement Income Security Act of 1974, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA Affiliate</U>&#148; means, with respect to any Person, each trade or business,
whether or not incorporated, that, together with such Person, would be deemed a &#147;single employer&#148; within the meaning of Section&nbsp;4001(b) of ERISA or Section&nbsp;414 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Escrow Agreement</U>&#148; means the escrow agreement between the Escrow Agent, Parent and the Stockholder Representative in
substantially the form attached hereto as <U>Exhibit C</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act of 1934, as
amended, and the related rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>GAAP</U>&#148; means generally accepted accounting
principles in the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Governmental Entity</U>&#148; means, anywhere in the world, any supranational, national,
federal, state, provincial, municipal, local or foreign government, governmental or quasi-governmental authority, regulatory or administrative agency, governmental commission, department, board, bureau, agency or instrumentality, court, arbitral
body or other tribunal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR Act</U>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the
regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indebtedness</U>&#148; means, as to any Person (i)&nbsp;the outstanding principal amount of
indebtedness of such Person for borrowed money (including in respect of any credit card obligations) plus any accrued interest thereon, secured or unsecured, or in respect of loans, (ii)&nbsp;the outstanding principal amount of indebtedness of such
Person evidenced by notes, bonds, debentures or similar instruments, plus any accrued interest thereon, (iii)&nbsp;all obligations of such Person with respect to surety bonds, letters of credit or similar facilities (in each case, only to the extent
drawn), (iv) the liability of such Person under any interest rate, currency or other swap or hedge agreement or similar transactions to terminate or unwind such agreement or transaction (with any amounts that would be paid to such Person in
connection with such termination or unwinding to reduce the amount of Indebtedness of such Person), (v) all capitalized lease obligations of such Person, (vi)&nbsp;all obligations of such Person for deferred purchase price of property, assets or
services or for earn-outs, holdbacks of purchase price or other similar obligations, (vii)&nbsp;any prepayment penalties, breakage costs and expenses and make-whole premiums which are due at the Closing, under any Indebtedness set forth in the other
clauses of this definition, as a result of the consummation of the transactions contemplated by this Agreement and (viii)&nbsp;direct or indirect guarantees of any of the foregoing of any other Person. For the avoidance of doubt,
&#147;Indebtedness&#148; does not include any intercompany indebtedness between or among the Company and any Company Subsidiaries (or between or among any Company Subsidiaries) or any ordinary course trade payables that are not over 60 days past due
or being disputed in good faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Intellectual Property</U>&#148; means all worldwide intellectual and industrial property
rights, including all (i)&nbsp;patents, patent applications and inventions, (ii)&nbsp;trademarks, service marks, corporate names, trade names, domain names, social and mobile media identifiers, logos, trade dress, design rights, and other
designations of source or origin, together with the goodwill symbolized by any of the foregoing, (iii)&nbsp;copyrights, (iv) trade secrets, <FONT STYLE="white-space:nowrap">know-how,</FONT> technology, methods, processes, algorithms and confidential
information, (v)&nbsp;artists&#146; and performers&#146; rights, including rights of performance, publicity, attribution and integrity, and (vi)&nbsp;all applications, registrations, renewals, continuations, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> divisionals, reissues, <FONT STYLE="white-space:nowrap">re-examinations,</FONT> extensions and foreign counterparts of any of the foregoing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Knowledge</U>&#148; means the actual knowledge of (a)&nbsp;with respect to the Company,
the persons set forth in <U>Section</U><U></U><U>&nbsp;9.15(a)</U> of the Company Disclosure Letter and (b)&nbsp;with respect to Parent, Buyer and Merger Sub, the officers and directors of Parent, Buyer and Merger Sub, as applicable, in each case as
of the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Laws</U>&#148; means any United States, federal, state or local or any foreign law (in each case,
statutory, common or otherwise), constitution, treaty, convention, ordinance, code, rule, statute, regulation or other similar requirement enacted, issued, adopted, promulgated, entered into or applied by a Governmental Entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Lien</U>&#148; means any lien (statutory or otherwise), pledge, hypothecation, mortgage, charge, encumbrance, or security interest of
any kind or nature whatsoever, but excluding any Intellectual Property licenses granted or to be granted to third parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Loss</U>&#148; means, for any Person, any and all losses, liabilities, damages, claims, awards, judgments, amounts paid in
settlement, costs, Taxes, interest, penalties and expenses (including reasonable attorneys&#146; fees and fees of other advisors) suffered or incurred by such Person,. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Materials of Environmental Concern</U>&#148; means any pollutant, contaminant, hazardous or toxic substance or waste, or terms of
similar meaning defined or regulated as such under, and any other substance for which liability can be imposed pursuant to, any Environmental Law, including any petroleum or petroleum-containing products, asbestos, asbestos containing materials,
urea-formaldehyde insulation, radioactivity, polychlorinated biphenyls, and toxic molds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Milestone Payment</U>&#148; means the
2018 Initial Milestone Payment, the Milestone 1 Payment, the Milestone 2 Payment, the Milestone 3 Payment and/or the Milestone Delay Payment, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Net Sales</U>&#148; means the gross sales revenue, determined in accordance with GAAP, from sales of the Products by the Company or
an Affiliate or licensee thereof, less returns, allowances for returns, cash discounts, rebates and fees paid or payable to any general purchasing organization to the extent such fees are in amounts customary in the trade and actually paid in the
ordinary course of business consistent with the past practices of Parent and its Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Net Working Capital</U>&#148; means
Current Assets minus Current Liabilities. For the avoidance of doubt, Net Working Capital shall not include or be calculated to take into account Cash, Indebtedness or Transaction Expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Order</U>&#148; means any order, writ, injunction, decree, judgment, award, injunction, settlement or stipulation issued,
promulgated, made, rendered or entered into by or with any Governmental Entity (in each case, whether temporary, preliminary or permanent). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parent Material Adverse Effect</U>&#148; means any event, change, condition, occurrence
or effect that, individually or in the aggregate with all other events, changes, conditions, occurrences or effects, (x)&nbsp;has had or would reasonably be expected to have a material adverse effect on the business, financial condition or results
of operations of the Company and the Company Subsidiaries, taken as a whole, or (y)&nbsp;that prevents or materially delays or materially impairs, or that would reasonably be expected to prevent, materially delay or materially impair, Parent&#146;s
ability to perform its obligations under this Agreement or consummate the transactions contemplated hereby on a timely basis by the Outside Date; <U>provided</U>, that in determining whether a Parent Material Adverse Effect has occurred pursuant to
clause (x)&nbsp;above, no event, change, condition, occurrence or effect resulting from any of the following shall be deemed to be or taken into account in determining whether there has been or will be, a &#147;Parent Material Adverse Effect&#148;:
(a) any event, change, condition, occurrence or effect in or affecting financial, economic, social or political conditions generally or the securities, credit or financial markets in general, including interest rates or exchange rates, or any
changes therein, in the United States or other countries in which Parent or any of its Subsidiaries conduct operations, (b)&nbsp;any change, event or development generally affecting the industries in which Parent or any of its Subsidiaries operate,
(c)&nbsp;any adoption, implementation, proposal or change after the date hereof in any applicable Law or GAAP or interpretation of any of the foregoing, (d)&nbsp;the commencement, occurrence, continuation or escalation of any war, armed hostilities
or acts of terrorism, (e)&nbsp;the existence, occurrence or continuation of any force majeure events, including any earthquakes, floods, hurricanes, tropical storms, fires or other natural disasters or any national, international or regional
calamity, (f)&nbsp;the entry into or the announcement, pendency or performance of this Agreement or the transactions contemplated hereby or the consummation of any transactions contemplated hereby, and (g)&nbsp;the failure of Parent or any of its
Subsidiaries to meet any internal or public projections, budgets, forecasts or estimates of revenues, earnings or other financial results for any period ending on or after the date of this Agreement; <U>provided</U>, <U>however</U>, that the
exception in this clause (g)&nbsp;shall not prevent the underlying facts giving rise or contributing to such failure, if not otherwise excluded from the definition of Parent or any of its Subsidiaries, from being taken into account in determining
whether a Company Material Adverse Effect has occurred; <U>provided</U>, <U>further</U> that with respect to clauses (a), (b), (c) and (d), such events, changes, conditions, occurrences or effects shall be taken into account to the extent they
disproportionately adversely affect the Parent and its Subsidiaries, taken as a whole, compared to other companies operating in the industries in which Parent and its Subsidiaries operate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permit</U>&#148; means any governmental license, permit, certificate, approval or authorization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Lien</U>&#148; means (i)&nbsp;any Lien for Taxes not yet delinquent or which are being contested in good faith by
appropriate proceedings and for which adequate reserves in accordance with GAAP have been established to the extent required by GAAP, (ii)&nbsp;carriers&#146;, warehousemen&#146;s, mechanics&#146;, materialmen&#146;s, repairmen&#146;s or other
similar Liens, including statutory liens, in each case incurred in the ordinary course of business to secure claims which are not yet delinquent or which are being contested in good faith by appropriate proceedings and for which adequate reserves
have been established, (iii)&nbsp;pledges or deposits in connection with workers&#146; compensation, unemployment insurance and other social security legislation, (iv)&nbsp;statutory landlords&#146; Liens and Liens granted to landlords under any
lease Liens representing any interest or title of a lessors, licensor, sublessor, or sublicensor under any lease, sublease, license or sublicense, (v)&nbsp;any purchase money security interests, equipment leases or similar financing arrangements,
(vi)&nbsp;Liens or encumbrances imposed on the underlying fee interest in real property subject to a Lease, (vii)&nbsp;leases, subleases, licenses, and sublicenses, in each case, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
granted in the ordinary course of business, (viii)&nbsp;Liens in favor of customs and revenue authorities arising as a matter of law, (ix)&nbsp;deposits to secure the performance of bids, trade
contracts, leases, statutory obligations, surety and appeal bonds, performance bonds and other similar obligations, and (x)&nbsp;Liens securing overdraft and related liabilities arising from treasury, cash management, or depository services or
automated clearinghouse funds transfers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means any individual, corporation, partnership, limited liability
company, association, trust or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof, and for the avoidance of doubt shall include any &#147;group&#148; (as set forth in
Section&nbsp;13(d)(3) of the Exchange Act) of Persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Proceeding</U>&#148; means any suit, action, proceeding, arbitration,
mediation, audit, hearing, inquiry commenced, brought, conducted or heard by or before, or otherwise involving, any Governmental Entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Product</U>&#148; means any product (i)&nbsp;marketed, manufactured, created, distributed or sold by or on behalf of the Company or
any Company Subsidiary as of the Effective Time, including the UroLift System and UroLift 2, and (ii)&nbsp;that is a modification or derivative of a product contemplated by clause (i), or that would otherwise infringe on the Intellectual Property of
the Company as of the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Representatives</U>&#148; means, with respect to any Person, such Person&#146;s and its
Affiliates officers, agents, employees, consultants, professional advisers (including attorneys, accountants and financial advisors) and debt financing sources. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities Act</U>&#148; means the Securities Act of 1933, as amended, and the related rules and regulations promulgated thereunder.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary</U>&#148; means, with respect to any Person, any other corporation, partnership, joint venture, limited liability
company or any other entity (i)&nbsp;of which such first Person or a Subsidiary of such first Person is a general partner or managing member or (ii)&nbsp;at least a majority of the securities or other interests of which having by their terms
ordinary voting power to elect a majority of the board of directors or Persons performing similar functions with respect to such entity is directly or indirectly owned or controlled by such first Person and/or one or more Subsidiaries thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Target Working Capital Range</U>&#148; means $19,500,000 to $21,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax Return</U>&#148; means any report, return, document, declaration or other information or filing that is filed or required to be
filed with respect to Taxes (whether or not a payment is required to be made with respect to such filing), including, without limitation, information returns, declarations of estimated Taxes, amended returns or claims for refunds (and any
attachments thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Taxes</U>&#148; means any and all federal, state, local, foreign or other taxes, charges, fees, levies, or
other assessments of any kind (together with any and all interest, penalties, additions to tax and additional amounts imposed with respect thereto) imposed by any Governmental Entity, including any income, franchises, windfall or other profits,
gross receipts, property, capital, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sales, use, transfer, registration, property, inventory, license, capital stock, payroll, employment, unemployment, social security, workers&#146; compensation, severance, stamp, customs, duties,
occupation, premium or net worth, excise, withholding, ad valorem, value added, estimated or other tax, charge, fee, levy, or other assessments of any kind. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transaction Expenses</U>&#148; means the following fees and expenses of the Company and the Company Subsidiaries incurred in
connection with this Agreement and the transactions contemplated hereby (and any discussions, negotiations and other preparation with respect to the sale of the Company or initial public offering of the Company): (a) fees and expenses of investment
bankers, attorneys, accountants and other consultants, advisors and agents in connection with this Agreement and the transactions contemplated hereby (and any discussions, negotiations and other preparation with respect to the sale or initial public
offering of the Company) including Advisor Fees, (b)&nbsp;all amounts payable as a result of the consummation of the transactions contemplated by this Agreement pursuant to any change in control, transaction or similar bonuses or retention
agreements or arrangements to any current or former employee, director, officer, agent or independent consultant of the Company or any of its Subsidiaries, solely to the extent that such amounts are or become due or payable on or prior to the
Effective Time and expressly excluding any &#147;double-trigger&#148; payments, (c) 50% of any transfer Taxes arising out of or resulting from the transactions contemplated by this Agreement, and (d) $750,000 of any Transaction Payroll Taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transaction Payroll Taxes</U>&#148; means the employer portion of any payroll or employment Taxes incurred in connection with any
change in control, transaction or similar bonuses, cash out or other settlement of Company Options, and any other compensatory payments made in connection with the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Treasury Regulations</U>&#148; means the United States Treasury Regulations promulgated under the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>WARN Act</U>&#148; means the Worker Adjustment and Retraining Notification Act of 1988 and any similar &#147;mass layoff&#148; or
&#147;plant closing&#148; Laws, or other Laws requiring advance notice of termination of employment and/or payments to affected employees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Warrant Termination Agreement</U>&#148; means a Warrant Termination Agreement in the form set forth in <U>Exhibit F</U> between a
holder of Company Warrants and the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>The remainder of this page is intentionally left blank.</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Parent, Buyer, Merger Sub, the Company and the Stockholder Representative
have caused this Agreement to be duly executed, all as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TELEFLEX INCORPORATED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Liam Kelly</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Liam Kelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President and Chief Operating Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TELEFLEX UROLOGY LIMITED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Gerard McCaffrey</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Gerard McCaffrey</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">NAPLES MERGER SUB INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James J. Leyden</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">James J. Leyden</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Secretary</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">NEOTRACT, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David R. Amerson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">David R. Amerson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President and Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">SHAREHOLDER REPRESENTATIVE SERVICES LLC, solely in its capacity as the Stockholder Representative</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sam Riffe</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Sam Riffe</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Executive Director</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Merger Agreement] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
